CYP1A2 Human (+)-artemisinin increases expression ISO Cyp1a2 (Mus musculus) 6480464 artemisinin results in increased expression of CYP1A2 mRNA CTD PMID:17962186 CYP1A2 Human (+)-artemisinin increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 artemisinin results in increased expression of CYP1A2 mRNA CTD PMID:16919048 CYP1A2 Human (+)-artemisinin decreases activity EXP 6480464 artemisinin results in decreased activity of CYP1A2 protein CTD PMID:11124226 CYP1A2 Human (+)-catechin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin more ... CTD PMID:25663641 CYP1A2 Human (+)-epicatechin-3-O-gallate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin more ... CTD PMID:25663641 CYP1A2 Human (+)-schisandrin B multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA] CTD PMID:31150632 CYP1A2 Human (+/-)-Aegeline multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with more ... CTD PMID:28843594 CYP1A2 Human (-)-cotinine increases activity EXP 6480464 Cotinine results in increased activity of CYP1A2 protein CTD PMID:16203240 CYP1A2 Human (-)-cotinine decreases activity EXP 6480464 Cotinine results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human (-)-epigallocatechin 3-gallate affects binding ISO Cyp1a2 (Rattus norvegicus) 6480464 epigallocatechin gallate binds to CYP1A2 protein CTD PMID:23010222 CYP1A2 Human (-)-epigallocatechin 3-gallate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin more ... CTD PMID:25663641 CYP1A2 Human (-)-selegiline affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Selegiline CTD PMID:16198659 CYP1A2 Human (-)-trans-epsilon-viniferin decreases activity EXP 6480464 epsilon-viniferin results in decreased activity of CYP1A2 protein CTD PMID:12818727 CYP1A2 Human (1->4)-beta-D-glucan multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP1A2 mRNA CTD PMID:36331819 CYP1A2 Human (1E,4E,8E)-alpha-humulene decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 humulene results in decreased activity of CYP1A2 protein CTD PMID:29074051 CYP1A2 Human (2-hydroxyphenyl)acetic acid multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of coumarin] which results in increased abundance of 2-hydroxyphenylacetic more ... CTD PMID:34334558 CYP1A2 Human (E)-cinnamyl alcohol affects expression EXP 6480464 cinnamyl alcohol affects the expression of CYP1A2 mRNA CTD PMID:38715282 CYP1A2 Human (E)-cinnamyl alcohol increases expression EXP 6480464 cinnamyl alcohol results in increased expression of CYP1A2 mRNA CTD PMID:38715282 CYP1A2 Human (E,E)-germacrone decreases activity EXP 6480464 germacrone results in decreased activity of CYP1A2 protein CTD PMID:23850985 CYP1A2 Human (R)-lipoic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A1 protein co-treated with CYP1A2 protein] affects the reaction [[Thioctic Acid results in decreased activity more ... CTD PMID:21932800 CYP1A2 Human (R)-lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated more ... CTD PMID:24120545 CYP1A2 Human (R,R,R)-alpha-tocopherol increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 alpha-Tocopherol results in increased activity of CYP1A2 protein CTD PMID:15665910 CYP1A2 Human (R,R,R)-alpha-tocopherol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 more ... CTD PMID:26102010 CYP1A2 Human (RS)-coclaurine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with more ... CTD PMID:28843594 CYP1A2 Human (RS)-norcoclaurine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with more ... CTD PMID:28843594 CYP1A2 Human (S)-coclaurine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with more ... CTD PMID:28843594 CYP1A2 Human (S)-duloxetine hydrochloride multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [furafylline results in decreased activity of CYP1A2 protein] which results in decreased glutathionylation of Duloxetine more ... CTD PMID:20669986 CYP1A2 Human (S)-naringenin decreases activity EXP 6480464 naringenin results in decreased activity of CYP1A2 protein CTD PMID:21053930|PMID:29753067 CYP1A2 Human (S)-nicotine decreases activity EXP 6480464 Nicotine results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human (S)-nicotine decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Nicotine results in decreased expression of CYP1A2 mRNA CTD PMID:26463278 CYP1A2 Human (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of CYP1A2 protein CTD PMID:11849738 CYP1A2 Human 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane CTD PMID:9047321 CYP1A2 Human 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane CTD PMID:9733665 CYP1A2 Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO Cyp1a2 (Mus musculus) 6480464 o,p'-DDT affects the expression of CYP1A2 mRNA CTD PMID:18925944 CYP1A2 Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o,p'-DDT results in increased expression of CYP1A2 mRNA CTD PMID:21924250 CYP1A2 Human 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased activity of CYP1A2 protein CTD PMID:15542068 CYP1A2 Human 1,2,3,7,8-Pentachlorodibenzodioxin increases expression ISO Cyp1a2 (Mus musculus) 6480464 1,2,3,7,8-pentachlorodibenzo-p-dioxin results in increased expression of CYP1A2 mRNA CTD PMID:23674508 CYP1A2 Human 1,2,3,7,8-Pentachlorodibenzofuran increases expression ISO Cyp1a2 (Mus musculus) 6480464 1,2,3,7,8-pentachlorodibenzofuran results in increased expression of CYP1A2 mRNA CTD PMID:24713691 CYP1A2 Human 1,2,4,5-tetrachlorobenzene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 1,2,4,5-tetrachlorobenzene results in increased expression of CYP1A2 protein CTD PMID:10696772 CYP1A2 Human 1,2,4-trichlorobenzene increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of 1,2,4-trichlorobenzene CTD PMID:7747284 CYP1A2 Human 1,2-dichlorobenzene increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of 2-dichlorobenzene CTD PMID:7747284 CYP1A2 Human 1,2-dichloroethane decreases expression ISO Cyp1a2 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of CYP1A2 mRNA CTD PMID:28189721|PMID:28960355 CYP1A2 Human 1,2-dichloroethene affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 1,2-dichloroethylene affects the expression of CYP1A2 protein CTD PMID:9493318 CYP1A2 Human 1,2-dichloroethene decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 1,2-dichloroethylene results in decreased activity of CYP1A2 protein CTD PMID:9671540 CYP1A2 Human 1,2-dimethylhydrazine decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 1,2-Dimethylhydrazine results in decreased expression of CYP1A2 mRNA CTD PMID:32387197 CYP1A2 Human 1,2-dimethylnaphthalene decreases activity EXP 6480464 1,2-dimethylnaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 1,3,7-trimethyluric acid multiple interactions EXP 6480464 [CYP1A2 protein binds to and results in increased metabolism of Caffeine] which results in increased more ... CTD PMID:31132250 CYP1A2 Human 1,3-Dinitropyrene multiple interactions EXP 6480464 [CYP1A2 protein co-treated with POR protein] results in decreased metabolism of 1,3-dinitropyrene CTD PMID:11113705 CYP1A2 Human 1,3-Dinitropyrene affects metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein affects the metabolism of 1,3-dinitropyrene CTD PMID:2180560 CYP1A2 Human 1,4-dichlorobenzene increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of 4-dichlorobenzene CTD PMID:7747284 CYP1A2 Human 1,4-dimethylnaphthalene decreases activity EXP 6480464 1,4-dimethylnaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 1,4-naphthoquinone increases expression EXP 6480464 1,4-naphthoquinone results in increased expression of CYP1A2 mRNA CTD PMID:18602459 CYP1A2 Human 1,4-naphthoquinone increases abundance EXP 6480464 CYP1A2 protein results in increased abundance of 1,4-naphthoquinone CTD PMID:16243959 CYP1A2 Human 1,6-dimethylnaphthalene decreases activity EXP 6480464 1,6-dimethylnaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 1,6-Dinitropyrene affects metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein affects the metabolism of 1,6-dinitropyrene CTD PMID:2180560 CYP1A2 Human 1,7-dimethylxanthine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of 1,7-dimethylxanthine CTD PMID:1302044 CYP1A2 Human 1,7-dimethylxanthine increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of 1,7-dimethylxanthine CTD PMID:19215233 CYP1A2 Human 1,7-dimethylxanthine multiple interactions EXP 6480464 [CYP1A2 protein binds to and results in increased metabolism of Caffeine] which results in increased more ... CTD PMID:19215233|PMID:31132250 CYP1A2 Human 1,7-dimethylxanthine increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of 1,7-dimethylxanthine CTD PMID:15980104 CYP1A2 Human 1,7-dimethylxanthine increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of 1,7-dimethylxanthine CTD PMID:1302044 CYP1A2 Human 1,7-phenanthroline multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 1,7-phenanthroline inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of more ... CTD PMID:17967931 CYP1A2 Human 1,7-phenanthroline increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 1,7-phenanthroline results in increased expression of CYP1A2 protein CTD PMID:17967931 CYP1A2 Human 1,8-Dinitropyrene affects metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein affects the metabolism of 1,8-dinitropyrene CTD PMID:2180560 CYP1A2 Human 1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol decreases activity EXP 6480464 stiripentol results in decreased activity of CYP1A2 protein CTD PMID:16022579 CYP1A2 Human 1-aminobenzotriazole decreases activity EXP 6480464 1-aminobenzotriazole results in decreased activity of CYP1A2 protein CTD PMID:15618748 CYP1A2 Human 1-aminobenzotriazole multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [1-aminobenzotriazole co-treated with Oxygen] results in increased activity of CYP1A2 protein; [Oxygen co-treated with 1-aminobenzotriazole] more ... CTD PMID:10640292 CYP1A2 Human 1-aminobenzotriazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 1-aminobenzotriazole results in increased expression of CYP1A2 protein CTD PMID:10640292 CYP1A2 Human 1-Aminopyrene increases activity EXP 6480464 CYP1A2 protein results in increased activity of 1-aminopyrene CTD PMID:15728263 CYP1A2 Human 1-benzofuran decreases activity EXP 6480464 benzofuran analog results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 1-hydroxyanthraquinone decreases activity EXP 6480464 1-hydroxyanthraquinone results in decreased activity of CYP1A2 protein CTD PMID:33438235 CYP1A2 Human 1-methyl-7H-xanthine decreases activity EXP 6480464 1-methylxanthine results in decreased activity of CYP1A2 protein CTD PMID:11465391 CYP1A2 Human 1-methyl-7H-xanthine multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of 1,7-dimethylxanthine] which results in increased chemical synthesis of more ... CTD PMID:19215233 CYP1A2 Human 1-methylnaphthalene decreases activity EXP 6480464 1-methylnaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 1-Methylpyrene multiple interactions EXP 6480464 [CYP1A2 protein co-treated with SULT1A1 protein] results in increased susceptibility to 1-methylpyrene CTD PMID:33035519 CYP1A2 Human 1-naphthol decreases activity EXP 6480464 1-naphthol results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 1-naphthol affects binding EXP 6480464 1-naphthol binds to CYP1A2 protein CTD PMID:32278787 CYP1A2 Human 1-naphthol increases abundance EXP 6480464 CYP1A2 protein results in increased abundance of 1-naphthol CTD PMID:16243959 CYP1A2 Human 1-naphthyl isothiocyanate multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [1-Naphthylisothiocyanate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in decreased expression of CYP1A2 protein; [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with 1-Naphthylisothiocyanate] more ... CTD PMID:15598703 CYP1A2 Human 1-naphthyl isothiocyanate multiple interactions EXP 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CYP1A2 mRNA CTD PMID:27344345 CYP1A2 Human 1-naphthyl isothiocyanate increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of CYP1A2 mRNA CTD PMID:20551477 CYP1A2 Human 1-naphthyl isothiocyanate decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP1A2 protein CTD PMID:15598703 CYP1A2 Human 1-nitropyrene multiple interactions EXP 6480464 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; CYP1A2 affects the more ... CTD PMID:10727902|PMID:18493746 CYP1A2 Human 1-nitropyrene affects response to substance EXP 6480464 CYP1A2 affects the susceptibility to 1-nitropyrene CTD PMID:10727902 CYP1A2 Human 1-nitropyrene multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human 17alpha-ethynylestradiol increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Ethinyl Estradiol CTD PMID:15304426 CYP1A2 Human 17alpha-ethynylestradiol decreases activity EXP 6480464 Ethinyl Estradiol results in decreased activity of CYP1A2 protein CTD PMID:18816299 CYP1A2 Human 17alpha-ethynylestradiol multiple interactions EXP 6480464 [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in more ... CTD PMID:16198659|PMID:16291717 CYP1A2 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of CYP1A2 mRNA; [Estradiol co-treated more ... CTD PMID:16790556|PMID:19619570|PMID:20404318|PMID:35747940 CYP1A2 Human 17beta-estradiol decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Estradiol results in decreased expression of CYP1A2 mRNA CTD PMID:39298647 CYP1A2 Human 17beta-estradiol increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Estradiol results in increased expression of CYP1A2 mRNA CTD PMID:31119341|PMID:32145629 CYP1A2 Human 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CYP1A2 mRNA CTD PMID:28357125 CYP1A2 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CYP1A2 mRNA CTD PMID:19619570 CYP1A2 Human 17beta-estradiol increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Estradiol CTD PMID:16790556 CYP1A2 Human 17beta-estradiol increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Estradiol CTD PMID:15961252 CYP1A2 Human 2'-deoxyguanosine multiple interactions EXP 6480464 CYP1A2 protein promotes the reaction [Aflatoxin B1 binds to Deoxyguanosine]; CYP1A2 protein promotes the reaction more ... CTD PMID:21907773 CYP1A2 Human 2,2',3,3',6,6'-hexachlorobiphenyl increases expression ISO Cyp1a2 (Mus musculus) 6480464 2,3,6,2',3',6'-hexachlorobiphenyl results in increased expression of CYP1A2 protein CTD PMID:28431184 CYP1A2 Human 2,2',3,3',6,6'-hexachlorobiphenyl decreases expression ISO Cyp1a2 (Mus musculus) 6480464 2,3,6,2',3',6'-hexachlorobiphenyl results in decreased expression of CYP1A2 mRNA CTD PMID:28431184 CYP1A2 Human 2,2',4,4',5,5'-hexachlorobiphenyl decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 2,4,5,2',4',5'-hexachlorobiphenyl CTD PMID:21571617 CYP1A2 Human 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO Cyp1a2 (Mus musculus) 6480464 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CYP1A2 mRNA CTD PMID:21851831 CYP1A2 Human 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CYP1A2 protein CTD PMID:3302669 CYP1A2 Human 2,2',4,4',5,5'-hexachlorobiphenyl increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of CYP1A2 protein CTD PMID:16835634 CYP1A2 Human 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein; [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] more ... CTD PMID:16835634|PMID:17160104 CYP1A2 Human 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]; [3,4,3',4'-tetrachlorobiphenyl co-treated with more ... CTD PMID:20961953|PMID:28433925 CYP1A2 Human 2,2',4,4',5,5'-hexachlorobiphenyl increases activity EXP 6480464 2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of CYP1A2 protein CTD PMID:15743714 CYP1A2 Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CYP1A2 mRNA CTD PMID:32679240 CYP1A2 Human 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2,5,2',5'-tetrachlorobiphenyl results in increased expression of CYP1A2 mRNA CTD PMID:21703328 CYP1A2 Human 2,2',5,5'-tetrachlorobiphenyl affects response to substance EXP 6480464 CYP1A2 protein affects the susceptibility to 2,5,2',5'-tetrachlorobiphenyl CTD PMID:27913846 CYP1A2 Human 2,3',4,4',5-Pentachlorobiphenyl decreases activity EXP 6480464 2,3',4,4',5-pentachlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human 2,3',4,4',5-Pentachlorobiphenyl multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl] results in increased activity of CYP1A2 protein CTD PMID:17342196 CYP1A2 Human 2,3',4,4',5-Pentachlorobiphenyl decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 2,3',4,4',5-pentachlorobiphenyl CTD PMID:21571617 CYP1A2 Human 2,3',4,4',5-Pentachlorobiphenyl decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 2,3',4,4',5-pentachlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Cyp1a2 (Mus musculus) 6480464 2,3',4,4',5-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA CTD PMID:23674508 CYP1A2 Human 2,3',4,4',5-Pentachlorobiphenyl increases activity ISO Cyp1a2 (Mus musculus) 6480464 2,3',4,4',5-pentachlorobiphenyl results in increased activity of CYP1A2 protein CTD PMID:10986007 CYP1A2 Human 2,3',4,4',5-Pentachlorobiphenyl multiple interactions EXP 6480464 2,3',4,4',5-pentachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human 2,3',4,4',5-Pentachlorobiphenyl multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 2,3',4,4',5-pentachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]; [3,4,3',4'-tetrachlorobiphenyl co-treated with more ... CTD PMID:20961953 CYP1A2 Human 2,3,3',4,4',5,5'-Heptachlorobiphenyl increases activity EXP 6480464 2,2',3,3',4,4',5-heptachlorobiphenyl results in increased activity of CYP1A2 protein CTD PMID:15743714 CYP1A2 Human 2,3,3',4,4',5-Hexachlorobiphenyl multiple interactions EXP 6480464 2,3,3',4,4',5-hexachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human 2,3,3',4,4',5-Hexachlorobiphenyl increases expression ISO Cyp1a2 (Mus musculus) 6480464 2,3,3',4,4',5-hexachlorobiphenyl results in increased expression of CYP1A2 mRNA CTD PMID:23674508 CYP1A2 Human 2,3,3',4,4',5-Hexachlorobiphenyl decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 2,3,3',4,4',5-hexachlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human 2,3,3',4,4',5-Hexachlorobiphenyl decreases activity EXP 6480464 2,3,3',4,4',5-hexachlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human 2,3,3',4,4',5-Hexachlorobiphenyl increases activity ISO Cyp1a2 (Mus musculus) 6480464 2,3,3',4,4',5-hexachlorobiphenyl results in increased activity of CYP1A2 protein CTD PMID:10986007 CYP1A2 Human 2,3,4,3',4'-Pentachlorobiphenyl decreases activity EXP 6480464 2,3,3',4,4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human 2,3,4,3',4'-Pentachlorobiphenyl decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 2,3,3',4,4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human 2,3,4,3',4'-Pentachlorobiphenyl decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 2,3,3',4,4'-pentachlorobiphenyl CTD PMID:21571617 CYP1A2 Human 2,3,4,3',4'-Pentachlorobiphenyl increases activity ISO Cyp1a2 (Mus musculus) 6480464 2,3,3',4,4'-pentachlorobiphenyl results in increased activity of CYP1A2 protein CTD PMID:10986007 CYP1A2 Human 2,3,4,3',4'-Pentachlorobiphenyl multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 2,3,3',4,4'-pentachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]; [3,4,3',4'-tetrachlorobiphenyl co-treated with more ... CTD PMID:20961953 CYP1A2 Human 2,3,4,3',4'-Pentachlorobiphenyl multiple interactions EXP 6480464 2,3,3',4,4'-pentachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human 2,3,4,7,8-Pentachlorodibenzofuran multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Tetrachlorodibenzodioxin co-treated with 2,3,4,7,8-pentachlorodibenzofuran co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein CTD PMID:17342195 CYP1A2 Human 2,3,4,7,8-Pentachlorodibenzofuran increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2,3,4,7,8-pentachlorodibenzofuran results in increased expression of CYP1A2 mRNA CTD PMID:20705892|PMID:21724226 CYP1A2 Human 2,3,4,7,8-Pentachlorodibenzofuran increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 2,3,4,7,8-pentachlorodibenzofuran results in increased activity of CYP1A2 protein CTD PMID:17160103|PMID:20705892 CYP1A2 Human 2,3,4,7,8-Pentachlorodibenzofuran increases activity EXP 6480464 2,3,4,7,8-pentachlorodibenzofuran results in increased activity of CYP1A2 protein CTD PMID:20705892 CYP1A2 Human 2,3,4,7,8-Pentachlorodibenzofuran affects abundance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the abundance of 2,3,4,7,8-pentachlorodibenzofuran CTD PMID:10448125|PMID:9240455 CYP1A2 Human 2,3,4,7,8-Pentachlorodibenzofuran increases expression ISO Cyp1a2 (Mus musculus) 6480464 2,3,4,7,8-pentachlorodibenzofuran results in increased expression of CYP1A2 mRNA CTD PMID:23674508|PMID:24713691 CYP1A2 Human 2,3,4,7,8-Pentachlorodibenzofuran increases expression EXP 6480464 2,3,4,7,8-pentachlorodibenzofuran results in increased expression of CYP1A2 mRNA CTD PMID:20705892 CYP1A2 Human 2,3,7,8-tetrabromodibenzodioxine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 2,3,7,8-tetrabromodibenzo-4-dioxin results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:27604104 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; 2,3',4,4',5-pentachlorobiphenyl inhibits the more ... CTD PMID:11064004|PMID:12927368|PMID:14709624|PMID:14729655|PMID:16426572|PMID:17090139|PMID:17183067|PMID:17785579|PMID:17959153|PMID:18493746|PMID:19022236|PMID:19276279|PMID:19376845|PMID:19542225|PMID:19619570|PMID:20188822|PMID:20619336|PMID:21493753|PMID:25110319|PMID:25929522|PMID:27535091|PMID:28357125|PMID:28478156|PMID:29162470|PMID:29209748|PMID:32739440|PMID:33811995|PMID:34403729|PMID:35872050|PMID:38403205 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cyp1a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CYP1A2 mRNA CTD PMID:20819909|PMID:26377647|PMID:36222588 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA; Tetrachlorodibenzodioxin results in increased expression of CYP1A2 more ... CTD PMID:11064004|PMID:11368318|PMID:11370663|PMID:12107646|PMID:12451431|PMID:12927368|PMID:14729655|PMID:15056799|PMID:16258175|PMID:16426572|PMID:16527260|PMID:16608920|PMID:16697128|PMID:16985168|PMID:17183067|PMID:17785579|PMID:17959153|PMID:19022236|PMID:19276279|PMID:19376845|PMID:19542225|PMID:19619570|PMID:19686824|PMID:19692669|PMID:19854261|PMID:20035023|PMID:20106945|PMID:20705892|PMID:21419197|PMID:21493753|PMID:21802500|PMID:21998131|PMID:22310298|PMID:22490669|PMID:22903824|PMID:23669205|PMID:24038852|PMID:24583342|PMID:25110319|PMID:25929522|PMID:26159488|PMID:26196221|PMID:27535091|PMID:28279696|PMID:28357125|PMID:28478156|PMID:28571685|PMID:29209748|PMID:31201936|PMID:33811995|PMID:34403729|PMID:34974051|PMID:35872050|PMID:7554073|PMID:9783729 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP1A2 mRNA CTD PMID:15034205 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein CTD PMID:12062927|PMID:16781091|PMID:16835633|PMID:18493746|PMID:20705892|PMID:22813907|PMID:2315923 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA; Tetrachlorodibenzodioxin results in increased expression of CYP1A2 more ... CTD PMID:10568693|PMID:10910964|PMID:12361703|PMID:12606150|PMID:1596902|PMID:16054898|PMID:16901605|PMID:16966094|PMID:17656490|PMID:17690134|PMID:18178546|PMID:18465118|PMID:18796159|PMID:19497421|PMID:19692669|PMID:20558275|PMID:20705892|PMID:20959002|PMID:21187122|PMID:21215274|PMID:21724226|PMID:22159698|PMID:22342509|PMID:23000282|PMID:2315923|PMID:23859880|PMID:24355419|PMID:25529477|PMID:26232522|PMID:28433708|PMID:32109520|PMID:32387183|PMID:34747641|PMID:38735589|PMID:8419313|PMID:8485713|PMID:9144388 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine increases activity EXP 6480464 Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein CTD PMID:16426572|PMID:17183067|PMID:18493746|PMID:20188822|PMID:20705892|PMID:22310298|PMID:31776611 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of CYP1A2 mRNA CTD PMID:22298810|PMID:31511937 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYP1A2 mRNA CTD PMID:22298810 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO Cyp1a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein CTD PMID:10986007|PMID:16636061|PMID:22082335|PMID:22579925|PMID:9443932 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; 2,4-Dinitrophenol inhibits the more ... CTD PMID:11585058|PMID:12062927|PMID:12635099|PMID:16901605|PMID:16966094|PMID:17342195|PMID:17690134|PMID:18493746|PMID:22159698|PMID:23859880|PMID:9707506 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine affects response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 affects the susceptibility to Tetrachlorodibenzodioxin; CYP1A2 protein affects the susceptibility to Tetrachlorodibenzodioxin CTD PMID:16636061|PMID:21095216 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine affects abundance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the abundance of Tetrachlorodibenzodioxin CTD PMID:10448125|PMID:19695277|PMID:9240455 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein affects the abundance of Tetrachlorodibenzodioxin] inhibits the reaction [CYP1A1 protein results in increased more ... CTD PMID:11043581|PMID:1313028|PMID:15003330|PMID:15034205|PMID:15252868|PMID:16214954|PMID:19695277|PMID:20935161|PMID:21534955|PMID:21889950|PMID:22496397|PMID:22535251|PMID:22579925|PMID:22611038|PMID:23231920|PMID:23369756|PMID:23423713|PMID:2512931|PMID:25975270|PMID:28213091|PMID:28433925|PMID:31776611|PMID:35872050|PMID:36245390|PMID:36893905|PMID:37423394|PMID:38403205|PMID:8215422|PMID:9443932 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine decreases activity EXP 6480464 Tetrachlorodibenzodioxin results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine affects response to substance EXP 6480464 CYP1A2 protein affects the susceptibility to Tetrachlorodibenzodioxin CTD PMID:16636061 CYP1A2 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cyp1a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP1A2; Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA; more ... CTD PMID:11043581|PMID:1313028|PMID:15722456|PMID:15902423|PMID:16214954|PMID:16636061|PMID:16929009|PMID:17949056|PMID:17997381|PMID:18163543|PMID:18295293|PMID:18372398|PMID:18434241|PMID:18796159|PMID:19770486|PMID:20007409|PMID:20595379|PMID:20702594|PMID:20935161|PMID:21095216|PMID:21354282|PMID:21851831|PMID:21889950|PMID:22082335|PMID:22230337|PMID:22491429|PMID:22496397|PMID:22579925|PMID:22611038|PMID:23231920|PMID:23369756|PMID:23423713|PMID:23674508|PMID:24213002|PMID:24713691|PMID:2505256|PMID:2512931|PMID:25270620|PMID:25958198|PMID:25975270|PMID:26290441|PMID:28213091|PMID:31511937|PMID:31776611|PMID:35872050|PMID:36245390|PMID:36893905|PMID:37172768|PMID:37423394|PMID:3785172|PMID:39401686|PMID:6749129|PMID:7238523|PMID:9230184|PMID:9443932|PMID:9875294 CYP1A2 Human 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2,3,7,8-tetrachlorodibenzofuran results in increased expression of CYP1A2 mRNA CTD PMID:20705892 CYP1A2 Human 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO Cyp1a2 (Mus musculus) 6480464 2,3,7,8-tetrachlorodibenzofuran results in increased expression of CYP1A2 mRNA CTD PMID:20702594|PMID:24713691|PMID:25768209|PMID:39140734 CYP1A2 Human 2,3,7,8-Tetrachlorodibenzofuran multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 AHR protein affects the reaction [2,3,7,8-tetrachlorodibenzofuran results in increased expression of CYP1A2 mRNA]; AHR protein more ... CTD PMID:25768209|PMID:39140734 CYP1A2 Human 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2,3,7,8-tetrachlorodibenzofuran results in increased expression of CYP1A2 mRNA CTD PMID:20705892|PMID:21724226|PMID:32109520 CYP1A2 Human 2,3,7,8-Tetrachlorodibenzofuran increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 2,3,7,8-tetrachlorodibenzofuran results in increased activity of CYP1A2 protein CTD PMID:20705892 CYP1A2 Human 2,3,7,8-Tetrachlorodibenzofuran increases activity EXP 6480464 2,3,7,8-tetrachlorodibenzofuran results in increased activity of CYP1A2 protein CTD PMID:20705892 CYP1A2 Human 2,3-dihydrobenzofuran decreases activity EXP 6480464 coumaran results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP1A2 protein CTD PMID:18079364 CYP1A2 Human 2,4,6-Triphenyl-1-hexene decreases expression ISO Cyp1a2 (Mus musculus) 6480464 2,4,6-triphenyl-1-hexene results in decreased expression of CYP1A2 mRNA CTD PMID:18560529 CYP1A2 Human 2,4-D increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2,4-Dichlorophenoxyacetic Acid results in increased expression of CYP1A2 mRNA CTD PMID:10910964 CYP1A2 Human 2,4-diaminotoluene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2,4-diaminotoluene results in increased expression of CYP1A2 protein CTD PMID:8685904 CYP1A2 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2,2',4,4',5-brominated diphenyl ether results in increased expression of CYP1A2 mRNA CTD PMID:22331496 CYP1A2 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Cyp1a2 (Mus musculus) 6480464 2,2',4,4',5-brominated diphenyl ether affects the expression of CYP1A2 mRNA CTD PMID:38648751 CYP1A2 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2,2',4,4',5-brominated diphenyl ether results in increased expression of CYP1A2 mRNA CTD PMID:19270788 CYP1A2 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [CYP1A2 protein results in increased oxidation of 2,2',4,4',5-brominated diphenyl ether] which results in increased abundance more ... CTD PMID:21673328 CYP1A2 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases oxidation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased oxidation of 2,2',4,4',5-brominated diphenyl ether CTD PMID:21673328 CYP1A2 Human 2,4-dinitrophenol multiple interactions EXP 6480464 2,4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human 2,4-dinitrophenol multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 2,4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human 2,6-dimethylnaphthalene decreases activity EXP 6480464 2,6-dimethylnaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Verapamil results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Praziquantel CTD PMID:12920490 CYP1A2 Human 2-acetamidofluorene increases hydrolysis EXP 6480464 CYP1A2 results in increased hydrolysis of 2-Acetylaminofluorene CTD PMID:2334931 CYP1A2 Human 2-acetamidofluorene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2-Acetylaminofluorene results in increased expression of CYP1A2 protein CTD PMID:28245158 CYP1A2 Human 2-acetamidofluorene increases activity EXP 6480464 CYP1A2 protein results in increased activity of 2-Acetylaminofluorene CTD PMID:15450435 CYP1A2 Human 2-acetamidofluorene affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of 2-Acetylaminofluorene CTD PMID:2655891 CYP1A2 Human 2-acetamidofluorene increases expression ISO Cyp1a2 (Mus musculus) 6480464 2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA CTD PMID:16381673 CYP1A2 Human 2-acetamidofluorene decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2-Acetylaminofluorene analog results in decreased expression of CYP1A2 protein; 2-Acetylaminofluorene results in decreased expression of more ... CTD PMID:15916741 CYP1A2 Human 2-acetamidofluorene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA] CTD PMID:16381673 CYP1A2 Human 2-amino-2-deoxy-D-galactopyranose decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Galactosamine results in decreased expression of CYP1A2 protein CTD PMID:16208626 CYP1A2 Human 2-Amino-3-methyl-9H-pyrido[2,3-b]indole multiple interactions EXP 6480464 CYP1A2 protein results in increased activity of and results in increased hydroxylation of 2-amino-3-methyl-9H-pyrido(2,3-b)indole; CYP1A2 more ... CTD PMID:14729582|PMID:28160022 CYP1A2 Human 2-Amino-3-methyl-9H-pyrido[2,3-b]indole increases expression EXP 6480464 2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA CTD PMID:27644595 CYP1A2 Human 2-Amino-3-methyl-9H-pyrido[2,3-b]indole multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA]; lead nitrate more ... CTD PMID:8902619 CYP1A2 Human 2-Amino-3-methyl-9H-pyrido[2,3-b]indole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA; 2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 more ... CTD PMID:8902619 CYP1A2 Human 2-amino-4,6-dinitrotoluene affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2-amino-4,6-dinitrotoluene affects the expression of CYP1A2 mRNA CTD PMID:21346803 CYP1A2 Human 2-Amino-9H-pyrido[2,3-b]indole multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased metabolism of and results in increased activity of 2-amino-9H-pyrido(2,3-b)indole CTD PMID:1913651 CYP1A2 Human 2-Amino-9H-pyrido[2,3-b]indole increases expression EXP 6480464 2-amino-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA CTD PMID:27644595 CYP1A2 Human 2-Amino-9H-pyrido[2,3-b]indole multiple interactions EXP 6480464 [CYP1A2 protein co-treated with NAT2 gene polymorphism] promotes the reaction [2-amino-9H-pyrido(2,3-b)indole binds to and results more ... CTD PMID:1913651|PMID:19243127|PMID:23898916|PMID:28160022 CYP1A2 Human 2-benzoxazolinone decreases activity EXP 6480464 benzoxazolone results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 2-chlorobiphenyl decreases activity EXP 6480464 2-chlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 2-hydroxy-17beta-estradiol increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol CTD PMID:16790556 CYP1A2 Human 2-hydroxy-17beta-estradiol multiple interactions EXP 6480464 Carbaryl inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol]; Chlorpyrifos inhibits more ... CTD PMID:16790556 CYP1A2 Human 2-hydroxychrysophanol increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of 2-hydroxychrysophanol CTD PMID:29698620 CYP1A2 Human 2-hydroxychrysophanol multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis more ... CTD PMID:29698620 CYP1A2 Human 2-Methoxynaphthalene decreases activity EXP 6480464 2-methoxynaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 2-methyl-1H-indole increases expression EXP 6480464 2-methylindole results in increased expression of CYP1A2 protein CTD PMID:31201936 CYP1A2 Human 2-methyl-6-(phenylethynyl)pyridine decreases activity EXP 6480464 6-methyl-2-(phenylethynyl)pyridine results in decreased activity of CYP1A2 protein CTD PMID:15193955 CYP1A2 Human 2-methylnaphthalene decreases activity EXP 6480464 2-methylnaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 2-naphthol increases abundance EXP 6480464 CYP1A2 protein results in increased abundance of 2-naphthol CTD PMID:16243959 CYP1A2 Human 2-naphthol affects binding EXP 6480464 2-naphthol binds to CYP1A2 protein CTD PMID:32278787 CYP1A2 Human 2-naphthol decreases activity EXP 6480464 2-naphthol results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 2-naphthylamine increases activity EXP 6480464 CYP1A2 protein results in increased activity of 2-Naphthylamine CTD PMID:15450435 CYP1A2 Human 2-nitroanisole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2-nitroanisole results in increased expression of CYP1A2; 2-nitroanisole results in increased expression of CYP1A2 protein CTD PMID:11409192|PMID:16601807 CYP1A2 Human 3',4'-dimethoxyflavone decreases activity EXP 6480464 3',4'-dimethoxyflavone results in decreased activity of CYP1A2 protein CTD PMID:21053930 CYP1A2 Human 3',4'-dimethoxyflavone multiple interactions EXP 6480464 3',4'-dimethoxyflavone affects the reaction [Tobacco Smoke Pollution analog results in increased expression of CYP1A2 mRNA]; more ... CTD PMID:26204831|PMID:28357125 CYP1A2 Human 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3,4,5,3',4'-pentachlorobiphenyl analog results in increased expression of CYP1A2 mRNA; 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of more ... CTD PMID:16049271|PMID:19692669|PMID:25068733|PMID:36372259 CYP1A2 Human 3,3',4,4',5-pentachlorobiphenyl affects expression ISO Cyp1a2 (Mus musculus) 6480464 3,4,5,3',4'-pentachlorobiphenyl affects the expression of CYP1A2 mRNA CTD PMID:31563530 CYP1A2 Human 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Cyp1a2 (Mus musculus) 6480464 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA CTD PMID:20702594|PMID:21335049|PMID:23674508|PMID:26770886|PMID:28163111|PMID:28973532|PMID:30312631 CYP1A2 Human 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA; 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 more ... CTD PMID:16049271|PMID:19692669|PMID:20959002|PMID:25530946|PMID:34256052 CYP1A2 Human 3,3',4,4',5-pentachlorobiphenyl increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 3,4,5,3',4'-pentachlorobiphenyl results in increased activity of CYP1A2 protein CTD PMID:16628245 CYP1A2 Human 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]; [3,4,3',4'-tetrachlorobiphenyl co-treated with more ... CTD PMID:20961953|PMID:26770886|PMID:28163111|PMID:28973532|PMID:30312631 CYP1A2 Human 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [CYP1A2 protein results in decreased methylation of 7-methoxyresorufin]; [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:12635099|PMID:16835634|PMID:17160104|PMID:17342195|PMID:17342196|PMID:34256052 CYP1A2 Human 3,3',4,4',5-pentachlorobiphenyl increases activity ISO Cyp1a2 (Mus musculus) 6480464 3,4,5,3',4'-pentachlorobiphenyl results in increased activity of CYP1A2 protein CTD PMID:10986007 CYP1A2 Human 3,3',4,4',5-pentachlorobiphenyl decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 3,4,5,3',4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human 3,3',4,4',5-pentachlorobiphenyl decreases activity EXP 6480464 3,4,5,3',4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human 3,3',4,4',5-pentachlorobiphenyl decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 3,4,5,3',4'-pentachlorobiphenyl CTD PMID:21571617 CYP1A2 Human 3,3',4,4'-tetrachlorobiphenyl decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 3,4,3',4'-tetrachlorobiphenyl CTD PMID:21571617 CYP1A2 Human 3,3',4,4'-tetrachlorobiphenyl increases expression EXP 6480464 3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A2 protein CTD PMID:31733235 CYP1A2 Human 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [CYP1A2 protein results in decreased methylation of 7-methoxyresorufin] CTD PMID:12635099 CYP1A2 Human 3,3',4,4'-tetrachlorobiphenyl increases expression ISO Cyp1a2 (Mus musculus) 6480464 3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A2 mRNA CTD PMID:12117779|PMID:19467301 CYP1A2 Human 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 3,4,3',4'-tetrachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]; [3,4,3',4'-tetrachlorobiphenyl co-treated with more ... CTD PMID:20961953 CYP1A2 Human 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of CYP1A2 mRNA CTD PMID:28478156 CYP1A2 Human 3,3',5-triiodo-L-thyronine multiple interactions EXP 6480464 Triiodothyronine affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; Triiodothyronine inhibits the more ... CTD PMID:28478156 CYP1A2 Human 3,3'-diindolylmethane increases expression EXP 6480464 3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA; 3,3'-diindolylmethane results in increased expression of CYP1A2 more ... CTD PMID:15672752|PMID:19770484 CYP1A2 Human 3,3'-diindolylmethane increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 3,3'-diindolylmethane results in increased expression of CYP1A2 protein CTD PMID:8384853 CYP1A2 Human 3,3'-diindolylmethane decreases activity EXP 6480464 3,3'-diindolylmethane results in decreased activity of CYP1A2 protein CTD PMID:19770484 CYP1A2 Human 3,3'-diindolylmethane increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane CTD PMID:16544949 CYP1A2 Human 3,3'-diindolylmethane multiple interactions EXP 6480464 [3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA] which results in increased abundance of aflatoxin more ... CTD PMID:16544949|PMID:19770484 CYP1A2 Human 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-decanol decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 fluorotelomer alcohols results in decreased expression of CYP1A2 mRNA CTD PMID:38903859 CYP1A2 Human 3,4,5,3',4',5'-Hexachlorobiphenyl decreases activity EXP 6480464 3,4,5,3',4',5'-hexachlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human 3,4,5,3',4',5'-Hexachlorobiphenyl multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 3,4,5,3',4',5'-hexachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]; [3,4,3',4'-tetrachlorobiphenyl co-treated with more ... CTD PMID:20961953 CYP1A2 Human 3,4,5,3',4',5'-Hexachlorobiphenyl decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 3,4,5,3',4',5'-hexachlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human 3,4,5,3',4',5'-Hexachlorobiphenyl decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 3,4,5,3',4',5'-hexachlorobiphenyl CTD PMID:21571617 CYP1A2 Human 3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine increases expression EXP 6480464 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of CYP1A2 mRNA CTD PMID:23810796 CYP1A2 Human 3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine multiple interactions EXP 6480464 CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine CTD PMID:28160022 CYP1A2 Human 3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine increases activity EXP 6480464 CYP1A2 results in increased activity of 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine CTD PMID:2334931 CYP1A2 Human 3,4-dichloroaniline increases expression EXP 6480464 3,4-dichloroaniline results in increased expression of CYP1A2 mRNA; 3,4-dichloroaniline results in increased expression of CYP1A2 more ... CTD PMID:21784029 CYP1A2 Human 3,4-dihydroxybenzoic acid multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] CTD PMID:15302093 CYP1A2 Human 3,4-methylenedioxymethamphetamine decreases activity EXP 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in decreased activity of CYP1A2 protein CTD PMID:24211539 CYP1A2 Human 3,5-xylenol multiple interactions EXP 6480464 [CYP1A2 protein results in increased oxidation of 3,5-xylenol analog] which results in increased abundance of more ... CTD PMID:27665777 CYP1A2 Human 3,5-xylenol increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of 3,5-xylenol analog CTD PMID:27665777 CYP1A2 Human 3-(indol-3-yl)pyruvic acid increases expression EXP 6480464 indol-3-yl pyruvic acid results in increased expression of CYP1A2 mRNA CTD PMID:38641223 CYP1A2 Human 3-(Methylthio)-1-propene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 allyl methyl sulfide results in increased expression of CYP1A2 protein CTD PMID:16000231 CYP1A2 Human 3-Amino-1-methyl-5H-pyrido[4,3-b]indole affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of 3-amino-1-methyl-5H-pyrido(4,3-b)indole CTD PMID:2655891 CYP1A2 Human 3-Amino-1-methyl-5H-pyrido[4,3-b]indole multiple interactions EXP 6480464 CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 3-amino-1-methyl-5H-pyrido(4,3-b)indole CTD PMID:28160022 CYP1A2 Human 3-Amino-1-methyl-5H-pyrido[4,3-b]indole increases expression EXP 6480464 3-amino-1-methyl-5H-pyrido(4,3-b)indole results in increased expression of CYP1A2 mRNA CTD PMID:27644595 CYP1A2 Human 3-Amino-1-methyl-5H-pyrido[4,3-b]indole increases activity ISO Cyp1a2 (Mus musculus) 6480464 3-amino-1-methyl-5H-pyrido(4,3-b)indole results in increased activity of CYP1A2 protein CTD PMID:12744663 CYP1A2 Human 3-Amino-1-methyl-5H-pyrido[4,3-b]indole affects response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the susceptibility to 3-amino-1-methyl-5H-pyrido(4,3-b)indole CTD PMID:19140158 CYP1A2 Human 3-isobutyl-1-methyl-7H-xanthine decreases activity EXP 6480464 1-Methyl-3-isobutylxanthine results in decreased activity of CYP1A2 protein CTD PMID:11465391 CYP1A2 Human 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of 2-amino-3-methylimidazo(4,5-f)quinoline CTD PMID:2655891 CYP1A2 Human 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases expression EXP 6480464 2-amino-3-methylimidazo(4,5-f)quinoline results in increased expression of CYP1A2 mRNA CTD PMID:27644595|PMID:31542801 CYP1A2 Human 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline CTD PMID:11752233 CYP1A2 Human 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein co-treated with 2-amino-3-methylimidazo(4,5-f)quinoline] results in increased mutagenesis of APRT gene CTD PMID:2023932 CYP1A2 Human 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases activity EXP 6480464 CYP1A2 protein results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline; CYP1A2 results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline CTD PMID:15728263|PMID:2334931 CYP1A2 Human 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine affects response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the susceptibility to 2-amino-3-methylimidazo(4,5-f)quinoline CTD PMID:2023932 CYP1A2 Human 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine multiple interactions EXP 6480464 [CYP1A2 protein co-treated with POR protein co-treated with OAT protein] results in increased susceptibility to more ... CTD PMID:10503888|PMID:14725854|PMID:28160022|PMID:9581821 CYP1A2 Human 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Quercetin inhibits the reaction [CYP1A2 results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline] CTD PMID:11752233 CYP1A2 Human 3-methylcholanthrene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Methylcholanthrene binds to and results in increased activity of AHR protein] which results in increased more ... CTD PMID:21498875|PMID:25174530|PMID:32726451|PMID:6749129 CYP1A2 Human 3-methylcholanthrene increases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 gene mutant form results in increased susceptibility to Methylcholanthrene CTD PMID:32726451 CYP1A2 Human 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of CYP1A2 mRNA; Methylcholanthrene results in increased expression of CYP1A2 more ... CTD PMID:12107646|PMID:15769886|PMID:16167840|PMID:19022236|PMID:19118567|PMID:19135037|PMID:20067464|PMID:20171196|PMID:23603339|PMID:27644595|PMID:27917125|PMID:28887089|PMID:33811995|PMID:8120057|PMID:9744552|PMID:9783729 CYP1A2 Human 3-methylcholanthrene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Methylcholanthrene results in increased expression of CYP1A2 mRNA; Methylcholanthrene results in increased expression of CYP1A2 more ... CTD PMID:10476907|PMID:10772642|PMID:11285323|PMID:11328961|PMID:11999409|PMID:15144902|PMID:16639589|PMID:19118567|PMID:19951702|PMID:20226384|PMID:20881032|PMID:23273579|PMID:28174063|PMID:30842367|PMID:7493548|PMID:8902619|PMID:9152597 CYP1A2 Human 3-methylcholanthrene increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Methylcholanthrene results in increased activity of CYP1A2 protein CTD PMID:15302093|PMID:15590115|PMID:1617633|PMID:16639589|PMID:19118567 CYP1A2 Human 3-methylcholanthrene increases activity EXP 6480464 Methylcholanthrene results in increased activity of CYP1A2 protein CTD PMID:19022236|PMID:19118567|PMID:19135037|PMID:19497360|PMID:31776611 CYP1A2 Human 3-methylcholanthrene multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [[Methylcholanthrene results in increased expression of CYP1A1 protein] co-treated with [Methylcholanthrene results in increased expression more ... CTD PMID:11999409|PMID:15302093|PMID:15946133|PMID:1617633|PMID:18486174|PMID:18493746|PMID:19788401|PMID:1994898|PMID:8902619 CYP1A2 Human 3-methylcholanthrene affects response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 affects the susceptibility to Methylcholanthrene CTD PMID:19772856 CYP1A2 Human 3-methylcholanthrene multiple interactions EXP 6480464 [Celsior co-treated with Methylcholanthrene] results in increased expression of CYP1A2 mRNA; [Dexamethasone co-treated with Mifepristone] more ... CTD PMID:15448115|PMID:18493746|PMID:19022236|PMID:20067464|PMID:20171196|PMID:23603339|PMID:33811995 CYP1A2 Human 3-methylcholanthrene increases expression ISO Cyp1a2 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of CYP1A2 mRNA; Methylcholanthrene results in increased expression of CYP1A2 more ... CTD PMID:11356909|PMID:11549291|PMID:12117779|PMID:16167840|PMID:16639589|PMID:19525444|PMID:19679878|PMID:20595379|PMID:23169610|PMID:25174530|PMID:30503582|PMID:32726451|PMID:3785172|PMID:6749129|PMID:7238523|PMID:9233375 CYP1A2 Human 3-methylcholanthrene increases activity ISO Cyp1a2 (Mus musculus) 6480464 Methylcholanthrene results in increased activity of CYP1A2 protein CTD PMID:16639589|PMID:4054433 CYP1A2 Human 3-Methylchrysene increases expression EXP 6480464 3-methylchrysene results in increased expression of CYP1A2 mRNA CTD PMID:31087746 CYP1A2 Human 3-methylquinoline decreases activity EXP 6480464 3-methylquinoline results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 3-Nitrofluoranthene increases expression EXP 6480464 3-nitrofluoranthene results in increased expression of CYP1A2 mRNA CTD PMID:12107646 CYP1A2 Human 3-phenoxybenzoic acid affects binding EXP 6480464 3-phenoxybenzoic acid binds to CYP1A2 protein CTD PMID:32278787 CYP1A2 Human 3H-1,2-dithiole-3-thione decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 1,2-dithiol-3-thione results in decreased expression of CYP1A2 mRNA CTD PMID:19162173 CYP1A2 Human 4',5,7-trihydroxy-3'-methoxyflavone multiple interactions EXP 6480464 chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:20553787 CYP1A2 Human 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 musk ketone results in increased expression of CYP1A2 protein CTD PMID:10630706 CYP1A2 Human 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 musk ketone results in increased activity of CYP1A2 protein CTD PMID:10630706 CYP1A2 Human 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases expression ISO Cyp1a2 (Mus musculus) 6480464 musk ketone results in increased expression of CYP1A2 mRNA CTD PMID:9441723 CYP1A2 Human 4,4'-sulfonyldiphenol decreases expression ISO Cyp1a2 (Mus musculus) 6480464 bisphenol S results in decreased expression of CYP1A2 mRNA CTD PMID:39298647 CYP1A2 Human 4,4'-sulfonyldiphenol decreases activity EXP 6480464 bisphenol S results in decreased activity of CYP1A2 protein CTD PMID:33312107 CYP1A2 Human 4-(methylsulfinyl)phenol increases abundance EXP 6480464 CYP1A2 protein results in increased abundance of 4-(methylsulfinyl)phenol analog CTD PMID:27665777 CYP1A2 Human 4-(methylsulfinyl)phenol multiple interactions EXP 6480464 [CYP1A2 protein results in increased oxidation of 3,5-xylenol analog] which results in increased abundance of more ... CTD PMID:27665777 CYP1A2 Human 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions EXP 6480464 CYP1A2 protein affects the metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:11774366 CYP1A2 Human 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases activity EXP 6480464 CYP1A2 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:15728263 CYP1A2 Human 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene] which results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene more ... CTD PMID:29285606 CYP1A2 Human 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases abundance EXP 6480464 CYP1A2 protein results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene CTD PMID:29285606 CYP1A2 Human 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene CTD PMID:29285606 CYP1A2 Human 4-chlorobiphenyl decreases activity EXP 6480464 4-chlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human 4-Hydroxy-N-desmethyltamoxifen increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen CTD PMID:29285606 CYP1A2 Human 4-Hydroxy-N-desmethyltamoxifen multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen] which results in increased abundance of 4-hydroxy-N-desmethyltamoxifen more ... CTD PMID:29285606 CYP1A2 Human 4-Hydroxybenzyl isothiocyanate increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 4-hydroxybenzyl isothiocyanate results in increased expression of CYP1A2 mRNA CTD PMID:22664424 CYP1A2 Human 4-Hydroxybenzyl isothiocyanate multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 4-hydroxybenzyl isothiocyanate results in increased activity of [CYP1A1 protein co-treated with CYP1A2 protein] CTD PMID:22664424 CYP1A2 Human 4-hydroxychalcone affects chemical synthesis ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein affects the chemical synthesis of 4-hydroxychalcone CTD PMID:15863696 CYP1A2 Human 4-hydroxynon-2-enal multiple interactions EXP 6480464 [CYP1A2 protein results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of more ... CTD PMID:21766881 CYP1A2 Human 4-hydroxyphenyl retinamide increases expression ISO Cyp1a2 (Mus musculus) 6480464 Fenretinide results in increased expression of CYP1A2 mRNA CTD PMID:28973697 CYP1A2 Human 4-Ipomeanol increases activity EXP 6480464 CYP1A2 protein results in increased activity of 4-ipomeanol CTD PMID:15892579 CYP1A2 Human 4-Methylchrysene increases expression EXP 6480464 4-methylchrysene results in increased expression of CYP1A2 mRNA CTD PMID:31087746 CYP1A2 Human 4-nitroaniline increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 4-nitroaniline analog results in increased activity of CYP1A2 protein CTD PMID:9545601 CYP1A2 Human 4-nitroaniline increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 4-nitroaniline analog results in increased expression of CYP1A2 mRNA; 4-nitroaniline analog results in increased expression more ... CTD PMID:7553614|PMID:9545601 CYP1A2 Human 4-nitrophenol increases hydroxylation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased hydroxylation of 4-nitrophenol CTD PMID:11911841 CYP1A2 Human 4-phenoxyphenol affects binding EXP 6480464 4-phenoxyphenol binds to CYP1A2 protein CTD PMID:32278787 CYP1A2 Human 5,7-dihydroxy-4'-methoxyflavone decreases activity EXP 6480464 acacetin results in decreased activity of CYP1A2 protein CTD PMID:21053930 CYP1A2 Human 5,7-dihydroxy-4'-methoxyflavone decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 acacetin results in decreased activity of CYP1A2 protein CTD PMID:32738202 CYP1A2 Human 5-(2-chloroethyl)-4-methylthiazole decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Chlormethiazole results in decreased expression of CYP1A2 mRNA CTD PMID:10751552 CYP1A2 Human 5-aza-2'-deoxycytidine increases expression ISO Cyp1a2 (Mus musculus) 6480464 Decitabine results in increased expression of CYP1A2 mRNA CTD PMID:30503582 CYP1A2 Human 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of CYP1A2 mRNA CTD PMID:19274061|PMID:28357125 CYP1A2 Human 5-azacytidine multiple interactions EXP 6480464 Azacitidine promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:12927368 CYP1A2 Human 5-azacytidine increases expression EXP 6480464 Azacitidine results in increased expression of CYP1A2 mRNA CTD PMID:12927368 CYP1A2 Human 5-Hydroxyflavone decreases activity EXP 6480464 5-hydroxyflavone results in decreased activity of CYP1A2 protein CTD PMID:21053930 CYP1A2 Human 5-Hydroxyflavone increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of 5-hydroxyflavone CTD PMID:30964977 CYP1A2 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions EXP 6480464 [Omeprazole results in increased expression of CYP1A2 protein] which results in decreased alkylation of Phenacetin; more ... CTD PMID:15802389|PMID:20171196|PMID:22524704|PMID:31863871 CYP1A2 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Omeprazole results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Omeprazole results in increased expression of CYP1A2 mRNA; Omeprazole results in increased expression of CYP1A2 more ... CTD PMID:19118567|PMID:25626140|PMID:9152597 CYP1A2 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA CTD PMID:22687989 CYP1A2 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases activity EXP 6480464 Omeprazole results in increased activity of CYP1A2 promoter; Omeprazole results in increased activity of CYP1A2 more ... CTD PMID:18502397|PMID:19118567|PMID:19230594|PMID:23274770|PMID:30044681|PMID:36288780 CYP1A2 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole decreases activity EXP 6480464 Omeprazole results in decreased activity of CYP1A2 protein CTD PMID:16035375 CYP1A2 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP1A2 mRNA; Omeprazole results in increased expression of CYP1A2 more ... CTD PMID:12040753|PMID:12623754|PMID:12841937|PMID:15681896|PMID:15802389|PMID:17954527|PMID:18332078|PMID:19118567|PMID:19230594|PMID:20171196|PMID:21784029|PMID:21924250|PMID:22524704|PMID:23274770|PMID:23850985|PMID:24752503|PMID:26204831|PMID:27794450|PMID:30044681|PMID:36288780|PMID:9744552 CYP1A2 Human 5-methoxyindole decreases activity ISO Cyp1a2 (Mus musculus) 6480464 5-methoxyindole results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human 5-Methylchrysene increases expression EXP 6480464 5-methylchrysene results in increased expression of CYP1A2 mRNA CTD PMID:31087746 CYP1A2 Human 5-methyltryptamine multiple interactions EXP 6480464 [5-methyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of more ... CTD PMID:26599973 CYP1A2 Human 5-methyltryptamine decreases activity EXP 6480464 5-methyltryptamine analog results in decreased activity of CYP1A2 protein CTD PMID:26599973 CYP1A2 Human 6-bromoindirubin-3'-oxime increases expression EXP 6480464 6-bromoindirubin-3'-oxime results in increased expression of CYP1A2 mRNA CTD PMID:26259606 CYP1A2 Human 6-bromoindirubin-3'-oxime multiple interactions EXP 6480464 6-bromoindirubin-3'-oxime results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:26259606 CYP1A2 Human 6-chrysenamine increases expression EXP 6480464 6-chrysenamine results in increased expression of CYP1A2 mRNA CTD PMID:12107646 CYP1A2 Human 6-chrysenamine increases activity EXP 6480464 CYP1A2 protein results in increased activity of 6-chrysenamine CTD PMID:15728263 CYP1A2 Human 6-Methylchrysene increases expression EXP 6480464 6-methylchrysene results in increased expression of CYP1A2 mRNA CTD PMID:31087746 CYP1A2 Human 6-Nitrobenzo[a]pyrene increases expression EXP 6480464 6-nitrobenzo(a)pyrene results in increased expression of CYP1A2 mRNA CTD PMID:12107646 CYP1A2 Human 6-Nitrochrysene increases expression EXP 6480464 6-nitrochrysene results in increased expression of CYP1A2 mRNA CTD PMID:12107646 CYP1A2 Human 7,12-dimethyltetraphene increases expression EXP 6480464 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA CTD PMID:17183067|PMID:19276279|PMID:25110319 CYP1A2 Human 7,12-dimethyltetraphene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 protein CTD PMID:36863560 CYP1A2 Human 7,12-dimethyltetraphene multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:18678235 CYP1A2 Human 7,12-dimethyltetraphene increases activity EXP 6480464 9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein CTD PMID:17183067 CYP1A2 Human 7,12-dimethyltetraphene increases activity ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased activity of 9,10-Dimethyl-1,2-benzanthracene CTD PMID:15606143 CYP1A2 Human 7,12-dimethyltetraphene increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein CTD PMID:16054776 CYP1A2 Human 7,12-dimethyltetraphene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene; EPHX1 protein promotes the more ... CTD PMID:8961944 CYP1A2 Human 7,12-dimethyltetraphene multiple interactions EXP 6480464 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]; more ... CTD PMID:17183067|PMID:19276279|PMID:25110319|PMID:8961944 CYP1A2 Human 7-hydroxyflavone decreases activity EXP 6480464 7-hydroxyflavone results in decreased activity of CYP1A2 protein CTD PMID:21053930|PMID:29753067 CYP1A2 Human 7-Nitrobenz[a]anthracene increases expression EXP 6480464 7-nitrobenzanthracene results in increased expression of CYP1A2 mRNA CTD PMID:12107646 CYP1A2 Human 7H-Dibenzo[c,g]carbazole multiple interactions EXP 6480464 CYP1A2 protein affects the metabolism of and results in increased activity of 7H-dibenzo(c,g)carbazole CTD PMID:15534862 CYP1A2 Human 9-phenanthrol multiple interactions EXP 6480464 [CYP1A2 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol CTD PMID:27137136 CYP1A2 Human 9-phenanthrol increases abundance EXP 6480464 CYP1A2 protein results in increased abundance of 9-phenanthrol CTD PMID:27137136 CYP1A2 Human acenaphthene increases activity ISO Cyp1a2 (Mus musculus) 6480464 acenaphthene results in increased activity of CYP1A2 protein CTD PMID:8001243 CYP1A2 Human acenaphthene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with more ... CTD PMID:7750161 CYP1A2 Human acenaphthylene increases expression ISO Cyp1a2 (Mus musculus) 6480464 acenaphthylene results in increased expression of CYP1A2 mRNA; acenaphthylene results in increased expression of CYP1A2 more ... CTD PMID:8001243 CYP1A2 Human acenaphthylene increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of acenaphthylene CTD PMID:25642975 CYP1A2 Human acenaphthylene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with more ... CTD PMID:7750161 CYP1A2 Human acenaphthylene increases activity ISO Cyp1a2 (Mus musculus) 6480464 acenaphthylene results in increased activity of CYP1A2 protein CTD PMID:10977129|PMID:8001243 CYP1A2 Human acenocoumarol affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Acenocoumarol CTD PMID:11918509 CYP1A2 Human acephate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fenarimol co-treated with acephate] affects the expression of CYP1A2 protein; [fenarimol co-treated with vinclozolin co-treated more ... CTD PMID:17686559 CYP1A2 Human acetamide decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 acetamide results in decreased expression of CYP1A2 mRNA CTD PMID:31881176 CYP1A2 Human acetone multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Acetone promotes the reaction [Toluene results in increased expression of CYP1A2 protein] CTD PMID:8996725 CYP1A2 Human acetone increases expression ISO Cyp1a2 (Rattus norvegicus) 401900656 acetone increased expression of Cyp1a2 protein in thoracic aorta of rats RGD CYP1A2 Human Acetyl tributyl citrate decreases expression ISO Cyp1a2 (Mus musculus) 6480464 2-acetyltributylcitrate results in decreased expression of CYP1A2 mRNA CTD PMID:37055963 CYP1A2 Human aconitine multiple interactions EXP 6480464 [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in increased chemical synthesis of more ... CTD PMID:21277363 CYP1A2 Human acridines multiple interactions EXP 6480464 Acridines analog inhibits the reaction [CYP1A2 protein results in increased oxidation of vadimezan] CTD PMID:16120190 CYP1A2 Human acridines decreases activity EXP 6480464 Acridines analog results in decreased activity of CYP1A2 protein CTD PMID:16120190 CYP1A2 Human actinomycin D multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [cryptotanshinone results in increased expression of CYP1A2 mRNA]; Dactinomycin inhibits the more ... CTD PMID:21262253 CYP1A2 Human Aescin increases expression ISO Cyp1a2 (Rattus norvegicus) 401900603 Aescin increased expression of Cyp1a2 mRNA in rat liver RGD CYP1A2 Human Aescin increases activity ISO Cyp1a2 (Rattus norvegicus) 401900603 Aescin increased activity of cyp1a2 protein enzyme in rat plasma RGD CYP1A2 Human afimoxifene multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of afimoxifene] which results in increased abundance of afimoxifene more ... CTD PMID:29285606 CYP1A2 Human afimoxifene increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of afimoxifene CTD PMID:29285606 CYP1A2 Human aflatoxin B1 increases activity EXP 6480464 CYP1A2 protein results in increased activity of Aflatoxin B1 CTD PMID:15988000 CYP1A2 Human aflatoxin B1 multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Curcumin inhibits the reaction [Aflatoxin B1 results in decreased expression of CYP1A2 mRNA] CTD PMID:35063475 CYP1A2 Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CYP1A2 mRNA CTD PMID:27153756 CYP1A2 Human aflatoxin B1 increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of CYP1A2 mRNA CTD PMID:26260870 CYP1A2 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CYP1A2 mRNA CTD PMID:21994236|PMID:32234424 CYP1A2 Human aflatoxin B1 increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Aflatoxin B1 CTD PMID:22743290|PMID:36442682 CYP1A2 Human aflatoxin B1 multiple interactions EXP 6480464 [CYP1A1 protein results in increased susceptibility to Aflatoxin B1] which results in increased expression of more ... CTD PMID:20707407|PMID:21907773|PMID:23397584|PMID:36442682|PMID:38382706 CYP1A2 Human aflatoxin B1 decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of CYP1A2 mRNA CTD PMID:19770486|PMID:35063475 CYP1A2 Human aflatoxin B1 increases response to substance EXP 6480464 CYP1A2 protein results in increased susceptibility to Aflatoxin B1 CTD PMID:11189750|PMID:27913846|PMID:31706005|PMID:31733235 CYP1A2 Human aflatoxin B1 exo-8,9-epoxide multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of Aflatoxin B1] which results in increased chemical synthesis more ... CTD PMID:20707407 CYP1A2 Human Aflatoxin G1 increases expression EXP 6480464 aflatoxin G1 results in increased expression of CYP1A2 protein CTD PMID:36997055 CYP1A2 Human Aflatoxin G1 increases response to substance EXP 6480464 CYP1A2 protein results in increased susceptibility to aflatoxin G1 CTD PMID:11189750 CYP1A2 Human aflatoxin M1 multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of Aflatoxin B1] which results in increased abundance of more ... CTD PMID:20707407|PMID:36442682 CYP1A2 Human alachlor increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 alachlor results in increased expression of CYP1A2 protein CTD PMID:11850968 CYP1A2 Human albendazole increases expression EXP 6480464 Albendazole results in increased expression of CYP1A2 mRNA CTD PMID:12451431 CYP1A2 Human albendazole affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Albendazole CTD PMID:12920490 CYP1A2 Human aldehydo-D-glucose multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of more ... CTD PMID:31776611 CYP1A2 Human alizarin decreases activity EXP 6480464 alizarin results in decreased activity of CYP1A2 protein CTD PMID:12379470|PMID:33438235 CYP1A2 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of CYP1A2 mRNA CTD PMID:16985168 CYP1A2 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of CYP1A2 mRNA CTD PMID:16882163|PMID:7697808 CYP1A2 Human all-trans-retinoic acid decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Tretinoin results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human allocryptopine increases expression EXP 6480464 allocryptopine results in increased expression of CYP1A2 mRNA CTD PMID:21419197 CYP1A2 Human almotriptan decreases methylation EXP 6480464 CYP1A2 protein results in decreased methylation of almotriptan CTD PMID:12642466 CYP1A2 Human Aloe emodin decreases activity EXP 6480464 aloe emodin results in decreased activity of CYP1A2 protein CTD PMID:27633141|PMID:33438235 CYP1A2 Human alpha-linolenic acid decreases activity EXP 6480464 alpha-Linolenic Acid results in decreased activity of CYP1A2 protein CTD PMID:16978661 CYP1A2 Human alpha-methyltryptamine multiple interactions EXP 6480464 [indopan analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of more ... CTD PMID:26599973 CYP1A2 Human alpha-methyltryptamine decreases activity EXP 6480464 indopan analog results in decreased activity of CYP1A2 protein; indopan results in decreased activity of more ... CTD PMID:26599973 CYP1A2 Human alpha-naphthoflavone increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of alpha-naphthoflavone CTD PMID:17702393 CYP1A2 Human alpha-naphthoflavone affects binding EXP 6480464 CYP1A2 protein binds to alpha-naphthoflavone CTD PMID:27966929 CYP1A2 Human alpha-naphthoflavone increases expression EXP 6480464 alpha-naphthoflavone results in increased expression of CYP1A2 mRNA; alpha-naphthoflavone results in increased expression of CYP1A2 more ... CTD PMID:19828881|PMID:28887089 CYP1A2 Human alpha-naphthoflavone affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of alpha-naphthoflavone CTD PMID:2180560 CYP1A2 Human alpha-naphthoflavone decreases activity EXP 6480464 alpha-naphthoflavone results in decreased activity of CYP1A2 protein CTD PMID:15306208|PMID:15766918|PMID:15860655|PMID:21053930|PMID:26599973|PMID:29074051|PMID:33253783|PMID:33438235 CYP1A2 Human alpha-naphthoflavone multiple interactions EXP 6480464 [alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; more ... CTD PMID:18493746|PMID:20816883|PMID:26599973|PMID:28887089|PMID:9305587 CYP1A2 Human alpha-naphthoflavone increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 alpha-naphthoflavone results in increased expression of CYP1A2 protein CTD PMID:20448087 CYP1A2 Human alpha-naphthoflavone multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with alpha-naphthoflavone] results in increased expression of CYP1A2 protein; alpha-naphthoflavone inhibits the reaction more ... CTD PMID:18493746|PMID:20448087 CYP1A2 Human alpha-naphthoflavone multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity more ... CTD PMID:21766881|PMID:21932800 CYP1A2 Human ametryn multiple interactions EXP 6480464 POR protein promotes the reaction [CYP1A2 protein results in increased metabolism of ametryne] CTD PMID:8971136 CYP1A2 Human ametryn increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of ametryne CTD PMID:8971136 CYP1A2 Human amiodarone decreases activity EXP 6480464 Amiodarone results in decreased activity of CYP1A2 protein CTD PMID:16449812|PMID:26599973 CYP1A2 Human amiodarone multiple interactions EXP 6480464 [Amiodarone results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin CTD PMID:26599973 CYP1A2 Human amiodarone decreases response to substance EXP 6480464 CYP1A2 protein results in decreased susceptibility to Amiodarone CTD PMID:26477383 CYP1A2 Human amitraz increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 amitraz results in increased expression of CYP1A2 protein CTD PMID:15350676|PMID:31029719 CYP1A2 Human amitriptyline increases metabolic processing EXP 6480464 Amitriptyline results in increased metabolism of CYP1A2 protein; CYP1A2 protein results in increased metabolism of more ... CTD PMID:18359012|PMID:27320963 CYP1A2 Human amitriptyline multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:23397584 CYP1A2 Human amitriptylinoxide increases abundance EXP 6480464 CYP1A2 protein results in increased abundance of amitriptyline N-oxide CTD PMID:27320963 CYP1A2 Human amodiaquine decreases activity EXP 6480464 Amodiaquine results in decreased activity of CYP1A2 protein CTD PMID:11124226 CYP1A2 Human amodiaquine increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Amodiaquine CTD PMID:31629065 CYP1A2 Human amodiaquine multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of Amodiaquine] which results in increased abundance of desethylamodiaquine; more ... CTD PMID:26599973|PMID:31629065 CYP1A2 Human amphetamine decreases methylation EXP 6480464 CYP1A2 protein results in decreased methylation of Amphetamine analog CTD PMID:29277574 CYP1A2 Human amphetamine increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Amphetamine analog CTD PMID:29277574 CYP1A2 Human amphetamine affects chemical synthesis EXP 6480464 CYP1A2 protein affects the chemical synthesis of Amphetamine CTD PMID:15294457 CYP1A2 Human ampicillin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in more ... CTD PMID:30545405 CYP1A2 Human andrographolide decreases expression EXP 6480464 andrographolide results in decreased expression of CYP1A2 mRNA CTD PMID:19041297 CYP1A2 Human andrographolide multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 andrographolide affects the reaction [CYP1A2 protein results in increased metabolism of Theophylline] CTD PMID:20096675 CYP1A2 Human andrographolide increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 andrographolide results in increased expression of CYP1A2 mRNA CTD PMID:19041297 CYP1A2 Human andrographolide increases expression ISO Cyp1a2 (Mus musculus) 6480464 andrographolide results in increased expression of CYP1A2 mRNA CTD PMID:17825862 CYP1A2 Human andrographolide multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA; [andrographolide co-treated with beta-Naphthoflavone] more ... CTD PMID:17825862|PMID:19737545 CYP1A2 Human angelicin increases expression ISO Cyp1a2 (Mus musculus) 6480464 angelicin results in increased expression of CYP1A2 protein CTD PMID:18692084 CYP1A2 Human aniline multiple interactions EXP 6480464 CYP1A2 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 CYP1A2 Human aniline increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 aniline analog results in increased expression of CYP1A2 mRNA; aniline analog results in increased expression more ... CTD PMID:16639589 CYP1A2 Human aniline increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 aniline analog results in increased activity of CYP1A2 protein CTD PMID:16639589 CYP1A2 Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; resveratrol inhibits the more ... CTD PMID:17959153 CYP1A2 Human anthra[1,9-cd]pyrazol-6(2H)-one increases expression EXP 6480464 pyrazolanthrone results in increased expression of CYP1A2 mRNA CTD PMID:17959153 CYP1A2 Human anthracen-2-amine multiple interactions EXP 6480464 CYB5A protein promotes the reaction [CYP1A2 protein results in increased activity of 2-anthramine] CTD PMID:15728263 CYP1A2 Human anthracen-2-amine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of 2-anthramine CTD PMID:2655891 CYP1A2 Human anthracen-2-amine increases activity EXP 6480464 CYP1A2 protein results in increased activity of 2-anthramine CTD PMID:15728263 CYP1A2 Human anthracene increases activity ISO Cyp1a2 (Mus musculus) 6480464 anthracene results in increased activity of CYP1A2 protein CTD PMID:8001243 CYP1A2 Human anthracene affects binding EXP 6480464 anthracene binds to CYP1A2 protein CTD PMID:32278787 CYP1A2 Human anthracene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with more ... CTD PMID:7750161 CYP1A2 Human anthracene multiple interactions EXP 6480464 alyssin inhibits the reaction [anthracene results in increased activity of CYP1A2 protein]; sulforaphane inhibits the more ... CTD PMID:19362136 CYP1A2 Human anthracene increases activity EXP 6480464 anthracene results in increased activity of CYP1A2 protein CTD PMID:19362136 CYP1A2 Human anthracene-1,8,9-triol decreases activity EXP 6480464 Anthralin results in decreased activity of CYP1A2 protein CTD PMID:33438235 CYP1A2 Human apigenin decreases activity EXP 6480464 Apigenin results in decreased activity of CYP1A2 protein CTD PMID:20806393|PMID:21053930|PMID:29753067 CYP1A2 Human arachidonic acid increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Arachidonic Acid CTD PMID:12675279 CYP1A2 Human arachidonic acid decreases activity EXP 6480464 Arachidonic Acid results in decreased activity of CYP1A2 protein CTD PMID:16978661 CYP1A2 Human Aranidipine decreases activity EXP 6480464 aranidipine results in decreased activity of CYP1A2 protein CTD PMID:10805063 CYP1A2 Human arecoline increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Arecoline analog results in increased activity of CYP1A2 protein CTD PMID:25056785 CYP1A2 Human aristolochic acid A multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [1-phenylazo-2-naphthol co-treated with aristolochic acid I] results in increased expression of CYP1A2 mRNA; [aristolochic acid more ... CTD PMID:26845733 CYP1A2 Human aristolochic acid A increases metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased metabolism of aristolochic acid I CTD PMID:21362632|PMID:26845733 CYP1A2 Human aristolochic acid A increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of aristolochic acid I CTD PMID:26845733 CYP1A2 Human aristolochic acid A increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 aristolochic acid I results in increased expression of CYP1A2 mRNA CTD PMID:26845733 CYP1A2 Human aristolochic acid A increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of aristolochic acid I metabolite CTD PMID:22086975 CYP1A2 Human aristolochic acid A multiple interactions EXP 6480464 [CYP1A2 protein results in increased oxidation of aristolochic acid I] which results in increased chemical more ... CTD PMID:22086975|PMID:26845733 CYP1A2 Human aristolochic acid A increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of aristolochic acid I CTD PMID:22086975 CYP1A2 Human aristolochic acid A multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity more ... CTD PMID:21932800 CYP1A2 Human aristolochic acid A increases abundance ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased abundance of aristolochic acid I metabolite CTD PMID:21362632 CYP1A2 Human Aroclor 1254 increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Chlorodiphenyl (54% Chlorine) results in increased activity of CYP1A2 protein CTD PMID:11713002|PMID:8471063 CYP1A2 Human Aroclor 1254 increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA; Chlorodiphenyl (54% Chlorine) results in more ... CTD PMID:11163329|PMID:16049271|PMID:18178546|PMID:8471063 CYP1A2 Human Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA; Chlorodiphenyl (54% Chlorine) results in more ... CTD PMID:16049271|PMID:16934159|PMID:17851650 CYP1A2 Human Aroclor 1254 increases expression ISO Cyp1a2 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA CTD PMID:25270620 CYP1A2 Human Aroclor 1254 affects response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 affects the susceptibility to Chlorodiphenyl (54% Chlorine) CTD PMID:19772856 CYP1A2 Human arsane multiple interactions EXP 6480464 [Estradiol co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression more ... CTD PMID:35747940 CYP1A2 Human arsenic atom multiple interactions EXP 6480464 [Estradiol co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression more ... CTD PMID:35747940 CYP1A2 Human arsenite(3-) multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity more ... CTD PMID:22159698 CYP1A2 Human arsenite(3-) multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:23369756 CYP1A2 Human arsenous acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; Arsenic Trioxide more ... CTD PMID:35872050|PMID:37423394 CYP1A2 Human arsenous acid increases expression ISO Cyp1a2 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of CYP1A2 mRNA; Arsenic Trioxide results in increased expression more ... CTD PMID:37423394 CYP1A2 Human arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased more ... CTD PMID:35872050 CYP1A2 Human Artemisin decreases activity EXP 6480464 artemisin results in decreased activity of CYP1A2 protein CTD PMID:16261361 CYP1A2 Human asenapine decreases expression EXP 6480464 Asenapine results in decreased expression of CYP1A2 mRNA CTD PMID:32941854 CYP1A2 Human asenapine decreases activity EXP 6480464 Asenapine results in decreased activity of CYP1A2 protein CTD PMID:32941854 CYP1A2 Human aspartame increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Aspartame results in increased activity of CYP1A2 protein CTD PMID:16937917 CYP1A2 Human atazanavir sulfate multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... CTD PMID:33819548 CYP1A2 Human Atipamezole multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and more ... CTD PMID:16510159 CYP1A2 Human atovaquone increases activity EXP 6480464 Atovaquone results in increased activity of CYP1A2 protein CTD PMID:11124226 CYP1A2 Human atrazine increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Atrazine results in increased activity of CYP1A2 protein CTD PMID:9711812 CYP1A2 Human atrazine affects methylation ISO Cyp1a2 (Rattus norvegicus) 6480464 Atrazine affects the methylation of CYP1A2 gene CTD PMID:35440735 CYP1A2 Human atrazine increases expression ISO Cyp1a2 (Mus musculus) 6480464 Atrazine results in increased expression of CYP1A2 mRNA CTD PMID:26775023 CYP1A2 Human atrazine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Lycopene co-treated with Atrazine] results in increased expression of CYP1A2 mRNA; Lycopene inhibits the reaction more ... CTD PMID:26775023|PMID:36216167 CYP1A2 Human atrazine increases expression EXP 6480464 Atrazine results in increased expression of CYP1A2 mRNA CTD PMID:22310298 CYP1A2 Human atrazine increases activity EXP 6480464 Atrazine results in increased activity of CYP1A2 protein CTD PMID:22310298 CYP1A2 Human Avasimibe decreases activity EXP 6480464 avasimibe results in decreased activity of CYP1A2 protein CTD PMID:15333513 CYP1A2 Human Azoxymethane decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Azoxymethane results in decreased expression of CYP1A2 mRNA CTD PMID:18038451 CYP1A2 Human azoxystrobin increases expression EXP 6480464 azoxystrobin results in increased expression of CYP1A2 mRNA; azoxystrobin results in increased expression of CYP1A2 more ... CTD PMID:21784029 CYP1A2 Human baicalein increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of baicalein CTD PMID:19666078 CYP1A2 Human baicalein decreases activity EXP 6480464 baicalein results in decreased activity of CYP1A2 protein CTD PMID:21053930|PMID:29753067 CYP1A2 Human baicalein multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of more ... CTD PMID:19666078 CYP1A2 Human baicalin multiple interactions EXP 6480464 3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]; 3',4'-dimethoxyflavone inhibits the more ... CTD PMID:26204831 CYP1A2 Human baicalin increases expression EXP 6480464 baicalin results in increased expression of CYP1A2 mRNA; baicalin results in increased expression of CYP1A2 more ... CTD PMID:26204831 CYP1A2 Human baicalin increases expression ISO Cyp1a2 (Mus musculus) 6480464 baicalin results in increased expression of CYP1A2 mRNA; baicalin results in increased expression of CYP1A2 more ... CTD PMID:26204831 CYP1A2 Human baicalin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]; resveratrol inhibits the more ... CTD PMID:26204831 CYP1A2 Human benidipine increases expression EXP 6480464 benidipine results in increased expression of CYP1A2 mRNA CTD PMID:27732883 CYP1A2 Human benoxaprofen increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 benoxaprofen results in increased expression of CYP1A2 protein CTD PMID:2069584 CYP1A2 Human benzene decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Benzene results in decreased expression of CYP1A2; Benzene results in decreased expression of CYP1A2 protein CTD PMID:8517779|PMID:9010585 CYP1A2 Human benzo[a]pyrene multiple interactions EXP 6480464 2-oxohexyl isothiocyanate inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein]; [Benzo(a)pyrene co-treated more ... CTD PMID:10496959|PMID:16970932|PMID:17690111|PMID:18493746|PMID:19202560|PMID:19919601|PMID:20553787|PMID:21256954|PMID:21262253|PMID:27913846|PMID:30439556|PMID:31830554|PMID:32159784|PMID:8961944 CYP1A2 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CYP1A2 mRNA CTD PMID:32234424 CYP1A2 Human benzo[a]pyrene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Benzo(a)pyrene results in increased expression of CYP1A2 mRNA; Benzo(a)pyrene results in increased expression of CYP1A2 more ... CTD PMID:16510159|PMID:17973897|PMID:19497421|PMID:22785257|PMID:24657529|PMID:26466350|PMID:37189300|PMID:8902619 CYP1A2 Human benzo[a]pyrene increases expression ISO Cyp1a2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CYP1A2 mRNA; Benzo(a)pyrene results in increased expression of CYP1A2 more ... CTD PMID:11171528|PMID:11356909|PMID:14562683|PMID:17997381|PMID:18321868|PMID:1849469|PMID:19406224|PMID:19770486|PMID:19896525|PMID:19961161|PMID:20371670|PMID:21715664|PMID:22466549|PMID:31830554|PMID:32417428|PMID:34472326 CYP1A2 Human benzo[a]pyrene decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of CYP1A2 mRNA CTD PMID:15034205 CYP1A2 Human benzo[a]pyrene decreases activity EXP 6480464 Benzo(a)pyrene results in decreased activity of CYP1A2 protein CTD PMID:11162773 CYP1A2 Human benzo[a]pyrene increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Benzo(a)pyrene results in increased activity of CYP1A2 mRNA; Benzo(a)pyrene results in increased activity of CYP1A2 more ... CTD PMID:21505853 CYP1A2 Human benzo[a]pyrene increases activity EXP 6480464 Benzo(a)pyrene results in increased activity of CYP1A2 protein CTD PMID:19202560 CYP1A2 Human benzo[a]pyrene increases activity ISO Cyp1a2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased activity of CYP1A2 protein CTD PMID:15863256|PMID:18321868 CYP1A2 Human benzo[a]pyrene increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Benzo(a)pyrene CTD PMID:2791199 CYP1A2 Human benzo[a]pyrene increases hydrolysis EXP 6480464 CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene CTD PMID:19919601 CYP1A2 Human benzo[a]pyrene affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Benzo(a)pyrene CTD PMID:20542099 CYP1A2 Human benzo[a]pyrene multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects more ... CTD PMID:16510159|PMID:18493746|PMID:18711122|PMID:22785257|PMID:24657529|PMID:26466350|PMID:37189300|PMID:8902619 CYP1A2 Human benzo[a]pyrene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with sodium bichromate] results in decreased expression of CYP1A2 mRNA; [CYP1A2 protein co-treated more ... CTD PMID:15034205|PMID:18321868|PMID:1849469|PMID:22466549|PMID:22613061|PMID:31830554|PMID:7750161|PMID:8961944 CYP1A2 Human benzo[a]pyrene affects metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the metabolism of Benzo(a)pyrene CTD PMID:16256281 CYP1A2 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CYP1A2 mRNA; Benzo(a)pyrene results in increased expression of CYP1A2 more ... CTD PMID:10496959|PMID:11849738|PMID:12107646|PMID:15056799|PMID:16269432|PMID:16545412|PMID:16970932|PMID:17253728|PMID:18174961|PMID:20106945|PMID:20435083|PMID:20542099|PMID:20553787|PMID:21256954|PMID:21262253|PMID:21802500|PMID:22316170|PMID:30439556|PMID:31087746|PMID:31515600|PMID:31542801|PMID:31830554 CYP1A2 Human benzo[b]fluoranthene increases expression ISO Cyp1a2 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of CYP1A2 mRNA CTD PMID:12117779 CYP1A2 Human benzo[b]fluoranthene multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA; [chrysene co-treated with Benzo(a)pyrene co-treated more ... CTD PMID:18711122|PMID:37189300 CYP1A2 Human benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of CYP1A2 mRNA CTD PMID:16269432|PMID:17253728|PMID:30293151 CYP1A2 Human benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA; [propiconazole co-treated with benzo(b)fluoranthene] results more ... CTD PMID:17690111|PMID:30293151 CYP1A2 Human benzo[b]fluoranthene decreases activity EXP 6480464 benzo(b)fluoranthene results in decreased activity of CYP1A2 protein CTD PMID:11162773 CYP1A2 Human benzo[b]fluoranthene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with more ... CTD PMID:7750161 CYP1A2 Human Benzo[b]fluorene increases expression EXP 6480464 benzo(b)fluorene results in increased expression of CYP1A2 mRNA CTD PMID:17253728 CYP1A2 Human Benzo[b]fluorene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 benzo(b)fluorene results in increased expression of CYP1A2 mRNA CTD PMID:38903859 CYP1A2 Human benzo[c]phenanthrene multiple interactions EXP 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene; EPHX1 protein promotes the more ... CTD PMID:8961944 CYP1A2 Human benzo[c]phenanthrene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene; EPHX1 protein promotes the more ... CTD PMID:8961944 CYP1A2 Human Benzo[k]fluoranthene increases expression EXP 6480464 benzo(k)fluoranthene results in increased expression of CYP1A2 mRNA; benzo(k)fluoranthene results in increased expression of CYP1A2 more ... CTD PMID:11162773|PMID:11370663|PMID:17253728 CYP1A2 Human Benzo[k]fluoranthene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with more ... CTD PMID:7750161 CYP1A2 Human Benzo[k]fluoranthene multiple interactions EXP 6480464 sodium arsenite inhibits the reaction [benzo(k)fluoranthene results in increased expression of CYP1A2 mRNA]; sodium arsenite more ... CTD PMID:11162773 CYP1A2 Human Benzo[k]fluoranthene decreases activity EXP 6480464 benzo(k)fluoranthene results in decreased activity of CYP1A2 protein CTD PMID:11162773 CYP1A2 Human benzofurans decreases activity EXP 6480464 Benzofurans analog results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human benzofurans decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Benzofurans analog results in decreased activity of CYP1A2 protein CTD PMID:15659567 CYP1A2 Human benzyl isothiocyanate increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 benzyl isothiocyanate results in increased expression of CYP1A2 mRNA CTD PMID:22664424 CYP1A2 Human benzyl isothiocyanate multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 benzyl isothiocyanate results in increased activity of [CYP1A1 protein co-treated with CYP1A2 protein] CTD PMID:22664424 CYP1A2 Human benzylideneacetone increases oxidation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased oxidation of benzylideneacetone CTD PMID:15863696 CYP1A2 Human berberine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Berberine inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] CTD PMID:22342832 CYP1A2 Human bergomottin increases expression ISO Cyp1a2 (Mus musculus) 6480464 bergamottin results in increased expression of CYP1A2 protein CTD PMID:18692084 CYP1A2 Human Besigomsin decreases activity ISO Cyp1a2 (Mus musculus) 6480464 schizandrol B results in decreased activity of CYP1A2 protein CTD PMID:25753323 CYP1A2 Human beta-carboline multiple interactions EXP 6480464 CYP1A2 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 CYP1A2 Human beta-carotene multiple interactions EXP 6480464 beta Carotene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; Quercetin inhibits more ... CTD PMID:16970932 CYP1A2 Human beta-naphthoflavone increases expression ISO Cyp1a2 (Mus musculus) 6480464 beta-Naphthoflavone results in increased expression of CYP1A2 mRNA; beta-Naphthoflavone results in increased expression of CYP1A2 more ... CTD PMID:19737545|PMID:21745492|PMID:2208584|PMID:22342832|PMID:22491429|PMID:22499231|PMID:25174530|PMID:28201809|PMID:28428138|PMID:29180065|PMID:32435917 CYP1A2 Human beta-naphthoflavone increases response to substance EXP 6480464 CYP1A2 gene mutant form results in increased susceptibility to beta-Naphthoflavone CTD PMID:29180065 CYP1A2 Human beta-naphthoflavone increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 beta-Naphthoflavone results in increased activity of CYP1A2 protein CTD PMID:10463385|PMID:15466162|PMID:16054776|PMID:19118567|PMID:26880746|PMID:29366910 CYP1A2 Human beta-naphthoflavone increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 beta-Naphthoflavone results in increased expression of CYP1A2 mRNA; beta-Naphthoflavone results in increased expression of CYP1A2 more ... CTD PMID:10463385|PMID:15466162|PMID:15607757|PMID:16354159|PMID:19041297|PMID:19118567|PMID:19695238|PMID:20362646|PMID:20448087|PMID:20607812|PMID:22687991|PMID:25370011|PMID:25929820|PMID:26827781|PMID:29366910|PMID:3038308|PMID:36549901|PMID:8419313|PMID:8902619 CYP1A2 Human beta-naphthoflavone increases activity ISO Cyp1a2 (Mus musculus) 6480464 beta-Naphthoflavone results in increased activity of CYP1A2 protein CTD PMID:21745492 CYP1A2 Human beta-naphthoflavone decreases activity EXP 6480464 beta-Naphthoflavone results in decreased activity of CYP1A2 protein CTD PMID:21053930 CYP1A2 Human beta-naphthoflavone multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 protein; [Diethylnitrosamine co-treated with beta-Naphthoflavone] more ... CTD PMID:18164116|PMID:18493746|PMID:20045035|PMID:20448087|PMID:26827781|PMID:26880746|PMID:30842367|PMID:8902619 CYP1A2 Human beta-naphthoflavone increases activity EXP 6480464 beta-Naphthoflavone results in increased activity of CYP1A2 protein CTD PMID:10923861|PMID:14722322|PMID:15893423|PMID:19497360|PMID:19497361|PMID:22843569|PMID:26201057 CYP1A2 Human beta-naphthoflavone multiple interactions EXP 6480464 beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; beta-Naphthoflavone promotes the more ... CTD PMID:10936227|PMID:18493746|PMID:29180065 CYP1A2 Human beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CYP1A2 mRNA; beta-Naphthoflavone results in increased expression of CYP1A2 more ... CTD PMID:12584154|PMID:12623754|PMID:14722322|PMID:15629189|PMID:15855724|PMID:16985168|PMID:19041297|PMID:19118567|PMID:19252307|PMID:19497360|PMID:22258563|PMID:25218365|PMID:25512232|PMID:26201057|PMID:32151702|PMID:36549901 CYP1A2 Human beta-naphthoflavone multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA; [beta-Naphthoflavone results in increased more ... CTD PMID:19737545|PMID:21745492|PMID:22342832|PMID:22491429|PMID:25174530|PMID:28201809|PMID:28428138|PMID:29180065|PMID:31111189 CYP1A2 Human bexarotene decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 bexarotene results in decreased expression of CYP1A2 mRNA CTD PMID:16648578 CYP1A2 Human bicalutamide multiple interactions EXP 6480464 [bicalutamide binds to and results in decreased activity of AR protein] inhibits the reaction [Dehydroepiandrosterone more ... CTD PMID:23603339 CYP1A2 Human bilirubin IXalpha decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Bilirubin results in decreased activity of CYP1A2 protein CTD PMID:16183037 CYP1A2 Human bilobalide multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 bilobalide results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:18421621 CYP1A2 Human bilobalide increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 bilobalide results in increased expression of CYP1A2 mRNA CTD PMID:18421621 CYP1A2 Human binimetinib multiple interactions EXP 6480464 [NADP co-treated with binimetinib] results in decreased activity of CYP1A2 protein CTD PMID:33728909 CYP1A2 Human biochanin A increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of biochanin A CTD PMID:12814970 CYP1A2 Human biochanin A decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 biochanin A results in decreased activity of CYP1A2 protein CTD PMID:26278343 CYP1A2 Human biochanin A decreases activity EXP 6480464 biochanin A results in decreased activity of CYP1A2 protein CTD PMID:26278343 CYP1A2 Human biphenyl decreases activity EXP 6480464 biphenyl results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human biphenyl increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of biphenyl CTD PMID:27137136 CYP1A2 Human biphenyl-2-ol affects binding EXP 6480464 2-phenylphenol binds to CYP1A2 protein CTD PMID:32278787 CYP1A2 Human biphenyl-4-amine increases activity EXP 6480464 CYP1A2 protein results in increased activity of 4-biphenylamine CTD PMID:15450435 CYP1A2 Human biphenyl-4-amine increases oxidation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased oxidation of 4-biphenylamine CTD PMID:2908851 CYP1A2 Human biphenyl-4-amine multiple interactions EXP 6480464 [furafylline results in decreased activity of CYP1A2 protein] which results in decreased susceptibility to 4-biphenylamine; more ... CTD PMID:16988941|PMID:23898916 CYP1A2 Human biphenyl-4-amine increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of 4-biphenylamine CTD PMID:11376689 CYP1A2 Human biphenyl-4-amine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of 4-biphenylamine CTD PMID:2655891 CYP1A2 Human bis(2-ethylhexyl) phthalate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased more ... CTD PMID:28433925|PMID:34670089|PMID:36403809 CYP1A2 Human bis(2-ethylhexyl) phthalate increases expression ISO Cyp1a2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of CYP1A2 mRNA; Diethylhexyl Phthalate results in increased expression more ... CTD PMID:34670089|PMID:36403809 CYP1A2 Human bis(2-ethylhexyl) phthalate decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in decreased expression of CYP1A2 mRNA CTD PMID:35970509 CYP1A2 Human bisphenol A increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of bisphenol A; CYP1A2 protein results in increased hydroxylation more ... CTD PMID:23470418 CYP1A2 Human bisphenol A decreases activity EXP 6480464 bisphenol A results in decreased activity of CYP1A2 protein CTD PMID:33312107 CYP1A2 Human bisphenol A decreases expression ISO Cyp1a2 (Mus musculus) 6480464 bisphenol A results in decreased expression of CYP1A2 mRNA CTD PMID:29477810 CYP1A2 Human bisphenol A affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 bisphenol A affects the expression of CYP1A2 mRNA CTD PMID:30903817 CYP1A2 Human bisphenol A multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Cesium-137 co-treated with bisphenol A] results in decreased expression of CYP1A2 mRNA; [Tetrachlorodibenzodioxin co-treated with more ... CTD PMID:28433925|PMID:29477810 CYP1A2 Human bisphenol A decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of CYP1A2 mRNA CTD PMID:25181051 CYP1A2 Human bisphenol A increases expression ISO Cyp1a2 (Mus musculus) 6480464 bisphenol A results in increased expression of CYP1A2 mRNA CTD PMID:30790712 CYP1A2 Human bisphenol A increases glutathionylation EXP 6480464 CYP1A2 protein results in increased glutathionylation of bisphenol A; CYP1A2 protein results in increased glutathionylation more ... CTD PMID:23470418 CYP1A2 Human bisphenol AF increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of bisphenol AF CTD PMID:23470418 CYP1A2 Human bisphenol F increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of 4,4'-bisphenol F CTD PMID:23470418 CYP1A2 Human bisphenol F decreases activity EXP 6480464 bisphenol F results in decreased activity of CYP1A2 protein CTD PMID:33312107 CYP1A2 Human bisphenol F increases glutathionylation EXP 6480464 CYP1A2 protein results in increased glutathionylation of 4,4'-bisphenol F CTD PMID:23470418 CYP1A2 Human bortezomib affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Bortezomib CTD PMID:15764713 CYP1A2 Human brequinar increases expression EXP 6480464 brequinar results in increased expression of CYP1A2 mRNA CTD PMID:39900124 CYP1A2 Human bromfenac increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of bromfenac metabolite CTD PMID:31815452 CYP1A2 Human bromodichloromethane increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of bromodichloromethane CTD PMID:12076521 CYP1A2 Human bromodichloromethane increases metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased metabolism of bromodichloromethane CTD PMID:11295256|PMID:12076521 CYP1A2 Human bromodichloromethane multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 isosafrole inhibits the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane]; Tetrachlorodibenzodioxin promotes the reaction more ... CTD PMID:12062927 CYP1A2 Human bromodichloromethane affects metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein affects the metabolism of bromodichloromethane CTD PMID:12062927 CYP1A2 Human bromodichloromethane increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 bromodichloromethane results in increased expression of CYP1A2 protein CTD PMID:11295256 CYP1A2 Human bromodichloromethane decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 bromodichloromethane results in decreased expression of CYP1A2 protein CTD PMID:11295256 CYP1A2 Human bromuconazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 bromuconazole results in increased expression of CYP1A2 mRNA CTD PMID:33789219 CYP1A2 Human brucine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP1A2 protein CTD PMID:21800547 CYP1A2 Human bucladesine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Bucladesine affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:1849469 CYP1A2 Human Bufuralol increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of bufuralol CTD PMID:9429232 CYP1A2 Human buta-1,3-diene decreases expression ISO Cyp1a2 (Mus musculus) 6480464 1,3-butadiene results in decreased expression of CYP1A2 mRNA CTD PMID:29038090 CYP1A2 Human butylated hydroxyanisole multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 CTNNB1 gene mutant form inhibits the reaction [Butylated Hydroxyanisole results in increased expression of CYP1A2 more ... CTD PMID:25174530 CYP1A2 Human butylated hydroxyanisole increases expression ISO Cyp1a2 (Mus musculus) 6480464 Butylated Hydroxyanisole results in increased expression of CYP1A2 mRNA CTD PMID:25174530 CYP1A2 Human Butylbenzyl phthalate decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 butylbenzyl phthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 CYP1A2 Human butylcyclohexane decreases activity EXP 6480464 butylcyclohexane results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human Butylparaben decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 butylparaben results in decreased activity of CYP1A2 protein CTD PMID:27432241 CYP1A2 Human butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of CYP1A2 mRNA CTD PMID:30439556 CYP1A2 Human butyric acid multiple interactions EXP 6480464 Benzo(a)pyrene promotes the reaction [Butyric Acid results in increased expression of CYP1A2 mRNA]; Butyric Acid more ... CTD PMID:30439556 CYP1A2 Human C.I. Natural Red 20 decreases activity EXP 6480464 shikonin results in decreased activity of CYP1A2 protein CTD PMID:28941798 CYP1A2 Human C.I. Natural Red 20 decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 shikonin results in decreased activity of CYP1A2 protein CTD PMID:28941798 CYP1A2 Human C60 fullerene decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 fullerene C60 results in decreased expression of CYP1A2 mRNA CTD PMID:19167457 CYP1A2 Human cadmium dichloride decreases activity EXP 6480464 Cadmium Chloride results in decreased activity of CYP1A2 protein CTD PMID:11162773 CYP1A2 Human cadmium dichloride multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [NFE2L2 co-treated with Cadmium Chloride] results in decreased expression of CYP1A2 mRNA CTD PMID:39938575 CYP1A2 Human caffeine affects binding EXP 6480464 CYP1A2 protein binds to Caffeine CTD PMID:9334905 CYP1A2 Human caffeine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with more ... CTD PMID:28843594 CYP1A2 Human caffeine multiple interactions EXP 6480464 [CYP1A2 protein binds to and results in increased metabolism of Caffeine] which results in increased more ... CTD PMID:11145498|PMID:11907490|PMID:15659567|PMID:15856409|PMID:16934051|PMID:19215233|PMID:20716633|PMID:31132250 CYP1A2 Human caffeine increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Caffeine CTD PMID:11907490|PMID:19215233|PMID:20716633 CYP1A2 Human caffeine decreases activity EXP 6480464 Caffeine results in decreased activity of CYP1A2 protein CTD PMID:11465391|PMID:24211539 CYP1A2 Human caffeine decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Caffeine results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human caffeine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Caffeine; CYP1A2 protein affects the metabolism of Caffeine metabolite CTD PMID:1302044|PMID:14586384|PMID:14586387|PMID:15022032|PMID:15199075|PMID:15286053|PMID:15327588|PMID:15980104 CYP1A2 Human caffeine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Caffeine; more ... CTD PMID:12706856|PMID:15659567|PMID:26599973 CYP1A2 Human caffeine affects metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein affects the metabolism of Caffeine CTD PMID:15619608 CYP1A2 Human caffeine increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Caffeine results in increased activity of CYP1A2 protein CTD PMID:15822860 CYP1A2 Human caffeine decreases methylation ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in decreased methylation of Caffeine CTD PMID:11376689 CYP1A2 Human caffeine decreases methylation EXP 6480464 CYP1A2 protein results in decreased methylation of Caffeine CTD PMID:11145498|PMID:12433797 CYP1A2 Human canadine increases expression ISO Cyp1a2 (Mus musculus) 6480464 canadine results in increased expression of CYP1A2 mRNA; canadine results in increased expression of CYP1A2 more ... CTD PMID:28257954 CYP1A2 Human cannabidiol decreases activity EXP 6480464 Cannabidiol results in decreased activity of CYP1A2 protein CTD PMID:24667653 CYP1A2 Human cannabidiol increases expression ISO Cyp1a2 (Mus musculus) 6480464 Cannabidiol results in increased expression of CYP1A2 mRNA CTD PMID:31052254 CYP1A2 Human cannabidiol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of CYP1A2 more ... CTD PMID:33096940 CYP1A2 Human canthaxanthin increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Canthaxanthin results in increased expression of CYP1A2 mRNA CTD PMID:9271336 CYP1A2 Human canthaxanthin increases expression ISO Cyp1a2 (Mus musculus) 6480464 Canthaxanthin results in increased expression of CYP1A2 mRNA CTD PMID:9271336 CYP1A2 Human capsaicin decreases activity EXP 6480464 Capsaicin results in decreased activity of CYP1A2 protein CTD PMID:22375877 CYP1A2 Human carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of CYP1A2 mRNA CTD PMID:17112801 CYP1A2 Human carbamazepine multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:23397584 CYP1A2 Human carbamazepine decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Carbamazepine results in decreased expression of CYP1A2 mRNA CTD PMID:17381134 CYP1A2 Human carbaryl multiple interactions EXP 6480464 Carbaryl inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol]; Carbaryl inhibits more ... CTD PMID:16790556 CYP1A2 Human carbaryl increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Carbaryl results in increased expression of CYP1A2 protein CTD PMID:9858662 CYP1A2 Human carbaryl decreases activity EXP 6480464 Carbaryl results in decreased activity of CYP1A2 protein CTD PMID:16790556 CYP1A2 Human carbendazim increases expression EXP 6480464 carbendazim results in increased expression of CYP1A2 mRNA; carbendazim results in increased expression of CYP1A2 more ... CTD PMID:21784029 CYP1A2 Human carbofuran increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Carbofuran CTD PMID:15560889 CYP1A2 Human carbon nanotube decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Nanotubes, Carbon analog results in decreased expression of CYP1A2 mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25620056 CYP1A2 Human Carnosol decreases activity EXP 6480464 carnosol results in decreased activity of CYP1A2 protein CTD PMID:34592323 CYP1A2 Human carotenoid affects response to substance EXP 6480464 CYP1A2 protein polymorphism affects the susceptibility to Carotenoids CTD PMID:15095308 CYP1A2 Human caryophyllene oxide decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 caryophyllene oxide results in decreased activity of CYP1A2 protein CTD PMID:29074051 CYP1A2 Human caryophyllene oxide decreases activity EXP 6480464 caryophyllene oxide results in decreased activity of CYP1A2 protein CTD PMID:29074051 CYP1A2 Human catechols multiple interactions EXP 6480464 [CYP1A2 protein results in increased hydroxylation of zearalenol] which results in increased chemical synthesis of more ... CTD PMID:19931366 CYP1A2 Human celecoxib decreases activity EXP 6480464 Celecoxib results in decreased activity of CYP1A2 protein CTD PMID:18816299 CYP1A2 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to CYP1A2 gene] CTD PMID:28238834 CYP1A2 Human chalcone increases hydroxylation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased hydroxylation of Chalcone CTD PMID:15863696 CYP1A2 Human chelidonine multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of chelidonine] which results in increased abundance of Glutathione more ... CTD PMID:31102647 CYP1A2 Human chelidonine increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of chelidonine CTD PMID:31102647 CYP1A2 Human chenodeoxycholic acid decreases expression EXP 6480464 Chenodeoxycholic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:27174168 CYP1A2 Human chenodeoxycholic acid multiple interactions EXP 6480464 [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with more ... CTD PMID:33819548|PMID:34589561 CYP1A2 Human CHIR 99021 increases expression EXP 6480464 Chir 99021 results in increased expression of CYP1A2 mRNA CTD PMID:26259606 CYP1A2 Human CHIR 99021 multiple interactions EXP 6480464 Chir 99021 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:34403729 CYP1A2 Human chlorohydrocarbon multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of more ... CTD PMID:30744511 CYP1A2 Human chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine] CTD PMID:7946932 CYP1A2 Human chlorotoluron decreases response to substance EXP 6480464 CYP1A2 protein results in decreased susceptibility to chlortoluron CTD PMID:24920432 CYP1A2 Human chlorpromazine multiple interactions EXP 6480464 [Chlorpromazine co-treated with Cholic Acids] affects the expression of CYP1A2 mRNA; [CYP1A2 protein co-treated with more ... CTD PMID:18493746|PMID:19482014|PMID:23397584|PMID:27344345 CYP1A2 Human chlorpromazine decreases response to substance EXP 6480464 CYP1A2 protein results in decreased susceptibility to Chlorpromazine CTD PMID:26477383 CYP1A2 Human chlorpromazine increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Chlorpromazine results in increased expression of CYP1A2 mRNA CTD PMID:25596134 CYP1A2 Human chlorpromazine increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of Chlorpromazine CTD PMID:20615392 CYP1A2 Human chlorpromazine affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Chlorpromazine affects the expression of CYP1A2 mRNA CTD PMID:18246545 CYP1A2 Human chlorpromazine decreases methylation EXP 6480464 CYP1A2 protein results in decreased methylation of Chlorpromazine CTD PMID:20615392 CYP1A2 Human chlorpyrifos multiple interactions EXP 6480464 Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol]; Chlorpyrifos inhibits more ... CTD PMID:16790556 CYP1A2 Human chlorpyrifos increases expression ISO Cyp1a2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of CYP1A2 mRNA CTD PMID:29097212 CYP1A2 Human chlorpyrifos multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Dietary Fats results in increased susceptibility to Chlorpyrifos] which results in decreased expression of CYP1A2 more ... CTD PMID:29097212|PMID:29935250 CYP1A2 Human chlorpyrifos decreases activity EXP 6480464 Chlorpyrifos results in decreased activity of CYP1A2 protein CTD PMID:16790556|PMID:20183062|PMID:22634058 CYP1A2 Human chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of CYP1A2 mRNA CTD PMID:16190164|PMID:19326769|PMID:21784029|PMID:22310298 CYP1A2 Human chlorpyrifos affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Chlorpyrifos CTD PMID:15557345|PMID:17079358 CYP1A2 Human chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of CYP1A2 protein CTD PMID:21784029 CYP1A2 Human chlorzoxazone affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Chlorzoxazone CTD PMID:14586387 CYP1A2 Human chlorzoxazone affects metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein affects the metabolism of Chlorzoxazone CTD PMID:15879494 CYP1A2 Human chlorzoxazone increases hydroxylation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased hydroxylation of Chlorzoxazone CTD PMID:11911841 CYP1A2 Human choline multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Choline deficiency co-treated with Methionine deficiency] results in decreased activity of CYP1A2 protein; [Choline deficiency more ... CTD PMID:18798224|PMID:38663832 CYP1A2 Human choline multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [3,4,5,3',4'-pentachlorobiphenyl co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of CYP1A2 more ... CTD PMID:27712037|PMID:28163111|PMID:28973532|PMID:29127188 CYP1A2 Human chromium(6+) increases expression EXP 6480464 chromium hexavalent ion results in increased expression of CYP1A2 protein CTD PMID:36368423 CYP1A2 Human chromium(6+) multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [chromium hexavalent ion results in increased expression of CYP1A2 more ... CTD PMID:36368423 CYP1A2 Human chrysazin decreases activity EXP 6480464 danthron results in decreased activity of CYP1A2 protein CTD PMID:33438235 CYP1A2 Human chrysene multiple interactions EXP 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene; EPHX1 protein promotes the more ... CTD PMID:8961944 CYP1A2 Human chrysene multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of more ... CTD PMID:37189300 CYP1A2 Human chrysene increases expression EXP 6480464 chrysene results in increased expression of CYP1A2 mRNA CTD PMID:12107646|PMID:17253728|PMID:31087746 CYP1A2 Human chrysene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene; [fluoranthene co-treated with pyrene more ... CTD PMID:7750161|PMID:8961944 CYP1A2 Human chrysin increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of chrysin CTD PMID:19666078 CYP1A2 Human chrysin increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of chrysin CTD PMID:30964977 CYP1A2 Human chrysin multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of more ... CTD PMID:19666078 CYP1A2 Human chrysin decreases activity EXP 6480464 chrysin results in decreased activity of CYP1A2 protein CTD PMID:20806393|PMID:21053930 CYP1A2 Human chrysophanol decreases activity EXP 6480464 chrysophanic acid results in decreased activity of CYP1A2 protein CTD PMID:27633141|PMID:33438235 CYP1A2 Human chrysophanol increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of chrysophanic acid CTD PMID:29698620 CYP1A2 Human chrysophanol multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis more ... CTD PMID:29698620 CYP1A2 Human ciglitazone multiple interactions EXP 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of CYP1A2 mRNA; more ... CTD PMID:16197558 CYP1A2 Human cimetidine decreases activity EXP 6480464 Cimetidine results in decreased activity of CYP1A2 protein CTD PMID:19909766|PMID:31863871 CYP1A2 Human cimetidine multiple interactions EXP 6480464 Cimetidine inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine]; NADP promotes the more ... CTD PMID:19909766|PMID:7946932 CYP1A2 Human cinnamyl alcohol affects expression EXP 6480464 cinnamyl alcohol affects the expression of CYP1A2 mRNA CTD PMID:38715282 CYP1A2 Human cinnamyl alcohol increases expression EXP 6480464 cinnamyl alcohol results in increased expression of CYP1A2 mRNA CTD PMID:38715282 CYP1A2 Human ciprofibrate decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 ciprofibrate results in decreased expression of CYP1A2 mRNA CTD PMID:7676460 CYP1A2 Human ciprofibrate decreases expression ISO Cyp1a2 (Mus musculus) 6480464 ciprofibrate results in decreased expression of CYP1A2 mRNA CTD PMID:17962186 CYP1A2 Human ciprofibrate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 ciprofibrate inhibits the reaction [Phenobarbital results in increased expression of CYP1A2 mRNA] CTD PMID:17962186 CYP1A2 Human ciprofloxacin multiple interactions EXP 6480464 [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of Clozapine; more ... CTD PMID:11145498|PMID:11151749|PMID:15592331 CYP1A2 Human ciprofloxacin decreases activity EXP 6480464 Ciprofloxacin results in decreased activity of CYP1A2 protein CTD PMID:11145498|PMID:15592331|PMID:18816299 CYP1A2 Human cisplatin multiple interactions EXP 6480464 Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of CYP1A2 mRNA CTD PMID:38498338 CYP1A2 Human cisplatin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human clarithromycin multiple interactions EXP 6480464 [Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] CTD PMID:11408986 CYP1A2 Human clenbuterol multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]; Propranolol inhibits the more ... CTD PMID:15710352 CYP1A2 Human clodronic acid increases expression EXP 6480464 Clodronic Acid results in increased expression of CYP1A2 mRNA CTD PMID:25596134 CYP1A2 Human clofibrate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYP1A2 mRNA; PPARA affects the reaction [[Clofibrate more ... CTD PMID:17585979 CYP1A2 Human clofibrate decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Clofibrate results in decreased expression of CYP1A2 mRNA; Clofibrate results in decreased expression of CYP1A2 more ... CTD PMID:11328961|PMID:12851107|PMID:15033592|PMID:17967931|PMID:18670166 CYP1A2 Human clofibrate decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Clofibrate results in decreased expression of CYP1A2 mRNA CTD PMID:17585979 CYP1A2 Human clofibric acid affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Clofibric Acid affects the expression of CYP1A2 mRNA CTD PMID:17602206 CYP1A2 Human clopidogrel multiple interactions EXP 6480464 CYP1A2 protein results in increased oxidation of and results in increased cleavage of clopidogrel metabolite; more ... CTD PMID:19170597|PMID:19812348 CYP1A2 Human clopidogrel increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of clopidogrel CTD PMID:19812348 CYP1A2 Human clothianidin multiple interactions EXP 6480464 [clothianidin co-treated with enilconazole] results in increased expression of CYP1A2 mRNA; [enilconazole co-treated with thiacloprid more ... CTD PMID:32201337 CYP1A2 Human clothianidin increases expression EXP 6480464 clothianidin results in increased expression of CYP1A2 mRNA CTD PMID:32201337 CYP1A2 Human clotrimazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Clotrimazole results in increased expression of CYP1A2 protein CTD PMID:7986207 CYP1A2 Human clotrimazole multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Clotrimazole inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] CTD PMID:19858067 CYP1A2 Human clozapine multiple interactions EXP 6480464 [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of Clozapine; more ... CTD PMID:11151749|PMID:16044115|PMID:18493746|PMID:23397584 CYP1A2 Human clozapine increases metabolic processing EXP 6480464 CYP1A2 gene SNP results in increased metabolism of Clozapine; CYP1A2 protein results in increased metabolism more ... CTD PMID:11763009|PMID:15206669|PMID:16044115|PMID:18809730|PMID:27320963 CYP1A2 Human clozapine decreases metabolic processing EXP 6480464 CYP1A2 gene SNP results in decreased metabolism of Clozapine CTD PMID:12919186 CYP1A2 Human clozapine decreases response to substance EXP 6480464 CYP1A2 gene SNP results in decreased susceptibility to Clozapine CTD PMID:11763009 CYP1A2 Human clozapine affects response to substance EXP 6480464 CYP1A2 gene SNP affects the susceptibility to Clozapine; CYP1A2 protein affects the susceptibility to Clozapine CTD PMID:12919186|PMID:15206669 CYP1A2 Human clozapine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human clozapine increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of Clozapine CTD PMID:12969762 CYP1A2 Human clozapine increases expression ISO Cyp1a2 (Mus musculus) 6480464 Clozapine results in increased expression of CYP1A2 mRNA CTD PMID:12969762 CYP1A2 Human clozapine affects metabolic processing EXP 6480464 CYP1A2 gene polymorphism affects the metabolism of Clozapine; CYP1A2 protein affects the metabolism of Clozapine; more ... CTD PMID:15286053|PMID:15883149|PMID:15949157|PMID:16044115 CYP1A2 Human Clozapine N-oxide increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of clozapine N-oxide CTD PMID:18809730 CYP1A2 Human Clozapine N-oxide increases abundance EXP 6480464 CYP1A2 protein results in increased abundance of clozapine N-oxide CTD PMID:27320963 CYP1A2 Human Clozapine N-oxide multiple interactions EXP 6480464 Fluvoxamine inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of clozapine N-oxide] CTD PMID:18809730 CYP1A2 Human cobalt dichloride decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 cobaltous chloride results in decreased expression of CYP1A2 mRNA CTD PMID:24386269 CYP1A2 Human colforsin daropate hydrochloride multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Colforsin inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] CTD PMID:15710352 CYP1A2 Human colforsin daropate hydrochloride multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Colforsin affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:1849469 CYP1A2 Human copper atom multiple interactions EXP 6480464 [CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol CTD PMID:15576237 CYP1A2 Human copper(0) multiple interactions EXP 6480464 [CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol CTD PMID:15576237 CYP1A2 Human copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of CYP1A2 mRNA CTD PMID:19549813 CYP1A2 Human corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of CYP1A2 mRNA CTD PMID:35301062 CYP1A2 Human corticosterone increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Corticosterone results in increased expression of CYP1A2 mRNA CTD PMID:35301062 CYP1A2 Human corticosterone multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Corticosterone promotes the reaction [Ethanol results in increased expression of CYP1A2 mRNA] CTD PMID:35301062 CYP1A2 Human coumarin decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 coumarin results in decreased expression of CYP1A2 mRNA CTD PMID:18480146 CYP1A2 Human coumarin increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of coumarin CTD PMID:34334558 CYP1A2 Human coumarin multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of coumarin] which results in increased abundance of 2-hydroxyphenylacetic more ... CTD PMID:34334558 CYP1A2 Human coumarin affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 coumarin affects the expression of CYP1A2 mRNA CTD PMID:16963487 CYP1A2 Human Cryptotanshinone multiple interactions EXP 6480464 cryptotanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; cryptotanshinone promotes the more ... CTD PMID:21262253 CYP1A2 Human Cryptotanshinone increases expression EXP 6480464 cryptotanshinone results in increased expression of CYP1A2 mRNA; cryptotanshinone results in increased expression of CYP1A2 more ... CTD PMID:21262253 CYP1A2 Human curcumin decreases activity EXP 6480464 Curcumin results in decreased activity of CYP1A2 protein CTD PMID:15841493 CYP1A2 Human curcumin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased activity of CYP1A2 protein]; Curcumin inhibits more ... CTD PMID:16288784|PMID:34802538 CYP1A2 Human curcumin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Curcumin inhibits the reaction [Aflatoxin B1 results in decreased expression of CYP1A2 mRNA]; Curcumin inhibits more ... CTD PMID:18321868|PMID:35063475 CYP1A2 Human cyclobarbital increases expression ISO Cyp1a2 (Mus musculus) 6480464 cyclobarbital results in increased expression of CYP1A2 mRNA CTD PMID:10064569 CYP1A2 Human cycloheximide multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Cycloheximide affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:1849469 CYP1A2 Human cyclophosphamide decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Cyclophosphamide results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human cyclosporin A decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Cyclosporine results in decreased expression of CYP1A2 mRNA CTD PMID:25596134 CYP1A2 Human cyclosporin A multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... CTD PMID:33819548 CYP1A2 Human cyhalothrin increases activity EXP 6480464 cyhalothrin results in increased activity of CYP1A2 protein CTD PMID:22310298 CYP1A2 Human cyhalothrin increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 cyhalothrin results in increased expression of CYP1A2 mRNA CTD PMID:29727961 CYP1A2 Human cyhalothrin increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 cyhalothrin results in increased activity of CYP1A2 protein CTD PMID:29727961 CYP1A2 Human cylindrospermopsin increases expression EXP 6480464 cylindrospermopsin results in increased expression of CYP1A2 mRNA CTD PMID:21607682 CYP1A2 Human cylindrospermopsin decreases expression ISO Cyp1a2 (Mus musculus) 6480464 cylindrospermopsin results in decreased expression of CYP1A2 mRNA CTD PMID:20936652 CYP1A2 Human cypermethrin decreases activity ISO Cyp1a2 (Mus musculus) 6480464 cypermethrin results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human cypermethrin increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 cypermethrin results in increased expression of CYP1A2 mRNA CTD PMID:23447098|PMID:26115703 CYP1A2 Human cyproconazole multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 NR1I3 promotes the reaction [cyproconazole results in increased expression of CYP1A2 mRNA] CTD PMID:25656644 CYP1A2 Human cyproconazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 cyproconazole results in increased expression of CYP1A2 protein CTD PMID:33150952 CYP1A2 Human cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of CYP1A2 mRNA; cyproconazole results in increased expression of CYP1A2 more ... CTD PMID:29995386|PMID:33150952 CYP1A2 Human cyproconazole increases expression ISO Cyp1a2 (Mus musculus) 6480464 cyproconazole results in increased expression of CYP1A2 mRNA CTD PMID:22334560|PMID:25656644 CYP1A2 Human D-glucose multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of more ... CTD PMID:31776611 CYP1A2 Human dabrafenib decreases activity EXP 6480464 dabrafenib results in decreased activity of CYP1A2 protein CTD PMID:34780725 CYP1A2 Human dacarbazine increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Dacarbazine metabolite CTD PMID:11751525 CYP1A2 Human dacarbazine multiple interactions EXP 6480464 O(6)-benzylguanine inhibits the reaction [CYP1A2 protein results in increased metabolism of Dacarbazine metabolite] CTD PMID:11751525 CYP1A2 Human daidzein decreases activity ISO Cyp1a2 (Mus musculus) 6480464 daidzein results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human dantrolene multiple interactions EXP 6480464 Dantrolene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human DDT increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 DDT results in increased expression of CYP1A2 mRNA CTD PMID:29477483 CYP1A2 Human decabromodiphenyl ether increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 decabromobiphenyl ether results in increased activity of CYP1A2 protein CTD PMID:18495385 CYP1A2 Human decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of CYP1A2 mRNA CTD PMID:19270788 CYP1A2 Human decabromodiphenyl ether increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 decabromobiphenyl ether results in increased expression of CYP1A2 mRNA; decabromobiphenyl ether results in increased expression more ... CTD PMID:18495385|PMID:20686340|PMID:32679240 CYP1A2 Human dehydroepiandrosterone decreases expression EXP 6480464 Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA CTD PMID:23603339 CYP1A2 Human dehydroepiandrosterone multiple interactions EXP 6480464 [bicalutamide binds to and results in decreased activity of AR protein] inhibits the reaction [Dehydroepiandrosterone more ... CTD PMID:23603339 CYP1A2 Human dehydroepiandrosterone increases degradation EXP 6480464 Dehydroepiandrosterone results in increased degradation of CYP1A2 mRNA CTD PMID:23603339 CYP1A2 Human Dendrobine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 dendrobine inhibits the reaction [[Isoniazid co-treated with Rifampin] results in decreased expression of CYP1A2 mRNA]; more ... CTD PMID:32633153 CYP1A2 Human deoxycholic acid multiple interactions EXP 6480464 [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with more ... CTD PMID:33819548|PMID:34589561 CYP1A2 Human Deoxyschizandrin decreases activity ISO Cyp1a2 (Mus musculus) 6480464 schizandrin A results in decreased activity of CYP1A2 protein CTD PMID:25753323 CYP1A2 Human desogestrel decreases activity EXP 6480464 Desogestrel results in decreased activity of CYP1A2 protein CTD PMID:18816299 CYP1A2 Human dexamethasone multiple interactions EXP 6480464 [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein]; more ... CTD PMID:19022236 CYP1A2 Human dexamethasone decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of CYP1A2 mRNA CTD PMID:11328961|PMID:20607812|PMID:20832446 CYP1A2 Human dexamethasone increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Dexamethasone results in increased expression of CYP1A2 mRNA CTD PMID:15607757 CYP1A2 Human dexamethasone multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; Mifepristone inhibits the more ... CTD PMID:17690134 CYP1A2 Human dexamethasone affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Dexamethasone affects the expression of CYP1A2 mRNA CTD PMID:15102944 CYP1A2 Human dexamethasone decreases activity EXP 6480464 Dexamethasone results in decreased activity of CYP1A2 protein CTD PMID:19022236 CYP1A2 Human dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CYP1A2 protein CTD PMID:19022236 CYP1A2 Human dexmedetomidine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and more ... CTD PMID:16510159 CYP1A2 Human dextran sulfate decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Dextran Sulfate results in decreased activity of CYP1A2 protein CTD PMID:28438436 CYP1A2 Human dextran sulfate multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Dextran Sulfate results in decreased activity of CYP1A2 protein] which results in decreased chemical synthesis more ... CTD PMID:28438436 CYP1A2 Human dextromethorphan affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Dextromethorphan CTD PMID:15199075 CYP1A2 Human diallyl disulfide increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 diallyl disulfide results in increased expression of CYP1A2 protein CTD PMID:16000231 CYP1A2 Human Diallyl sulfide multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 allyl sulfide inhibits the reaction [Diethylnitrosamine results in decreased expression of and results in decreased more ... CTD PMID:23494807 CYP1A2 Human Diallyl sulfide increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 allyl sulfide results in increased expression of CYP1A2 mRNA CTD PMID:19695238|PMID:8849338 CYP1A2 Human diallyl trisulfide multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 diallyl trisulfide inhibits the reaction [n-hexane results in increased expression of CYP1A2 protein] CTD PMID:28115069 CYP1A2 Human diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased more ... CTD PMID:35872050 CYP1A2 Human diarsenic trioxide increases expression ISO Cyp1a2 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of CYP1A2 mRNA; Arsenic Trioxide results in increased expression more ... CTD PMID:37423394 CYP1A2 Human diarsenic trioxide multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; Arsenic Trioxide more ... CTD PMID:35872050|PMID:37423394 CYP1A2 Human diarylheptanoid decreases activity EXP 6480464 Diarylheptanoids results in decreased activity of CYP1A2 protein CTD PMID:23850985 CYP1A2 Human diazinon multiple interactions EXP 6480464 CYP1A2 protein results in decreased sulfation of and results in increased activity of Diazinon; CYP1A2 more ... CTD PMID:11708902|PMID:15764407 CYP1A2 Human diazinon affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Diazinon CTD PMID:15557345|PMID:15764407 CYP1A2 Human diazinon multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Streptozocin results in increased expression of CYP1A2 protein] which results in increased metabolism of Diazinon CTD PMID:17442507 CYP1A2 Human diazinon increases expression EXP 6480464 Diazinon results in increased expression of CYP1A2 mRNA; Diazinon results in increased expression of CYP1A2 more ... CTD PMID:21784029 CYP1A2 Human Dibenz[a,c]anthracene increases expression EXP 6480464 benzotriphenylene results in increased expression of CYP1A2 mRNA CTD PMID:17253728 CYP1A2 Human dibenz[a,h]anthracene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA; [CYP1A2 protein co-treated with Trichloroepoxypropane] more ... CTD PMID:17690111|PMID:19362136|PMID:8638931|PMID:8961944 CYP1A2 Human dibenz[a,h]anthracene multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects more ... CTD PMID:18711122 CYP1A2 Human dibenz[a,h]anthracene increases expression EXP 6480464 1,2,5,6-dibenzanthracene results in increased expression of CYP1A2 mRNA CTD PMID:16269432|PMID:17253728 CYP1A2 Human dibenz[a,h]anthracene decreases activity EXP 6480464 1,2,5,6-dibenzanthracene results in decreased activity of CYP1A2 protein CTD PMID:11162773 CYP1A2 Human dibenz[a,h]anthracene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; EPHX1 protein promotes the more ... CTD PMID:8961944 CYP1A2 Human dibenz[a,h]anthracene increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene CTD PMID:8638931 CYP1A2 Human dibenz[a,h]anthracene increases activity EXP 6480464 1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein CTD PMID:19362136 CYP1A2 Human dibenziodolium multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A2 protein] CTD PMID:26880746 CYP1A2 Human dibenziodolium decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 diphenyleneiodonium results in decreased activity of CYP1A2 protein CTD PMID:26880746 CYP1A2 Human dibenzo[a,l]pyrene increases activity ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased activity of dibenzo(a,l)pyrene CTD PMID:15606143 CYP1A2 Human dibenzo[a,l]pyrene multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects more ... CTD PMID:18711122 CYP1A2 Human dibenzo[a,l]pyrene increases expression EXP 6480464 dibenzo(a,l)pyrene results in increased expression of CYP1A2 mRNA CTD PMID:16269432 CYP1A2 Human dibenzo[a,l]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA CTD PMID:17690111 CYP1A2 Human dibenzofuran increases activity ISO Cyp1a2 (Mus musculus) 6480464 dibenzofuran results in increased activity of CYP1A2 protein CTD PMID:8001243 CYP1A2 Human dibenzofuran multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with more ... CTD PMID:7750161 CYP1A2 Human dibenzofuran increases activity EXP 6480464 dibenzofuran metabolite results in increased activity of CYP1A2 protein CTD PMID:26032510 CYP1A2 Human dibenzofurans increases expression ISO Cyp1a2 (Mus musculus) 6480464 Dibenzofurans results in increased expression of CYP1A2 mRNA CTD PMID:34254344 CYP1A2 Human dibutyl phthalate decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 CYP1A2 Human dichloroacetic acid decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:28962523 CYP1A2 Human dichloromethane affects expression ISO Cyp1a2 (Mus musculus) 6480464 Methylene Chloride affects the expression of CYP1A2 mRNA CTD PMID:28392392 CYP1A2 Human diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of CYP1A2 mRNA; Diclofenac results in increased expression of CYP1A2 more ... CTD PMID:21784029 CYP1A2 Human diclofenac decreases activity EXP 6480464 Diclofenac metabolite results in decreased activity of CYP1A2 protein CTD PMID:28960974 CYP1A2 Human diclofenac multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:23397584 CYP1A2 Human dicofol increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Dicofol results in increased expression of CYP1A2 mRNA CTD PMID:19595748 CYP1A2 Human dicrotophos increases expression EXP 6480464 dicrotophos results in increased expression of CYP1A2 mRNA CTD PMID:28302478 CYP1A2 Human dicyclanil increases expression ISO Cyp1a2 (Mus musculus) 6480464 dicyclanil results in increased expression of CYP1A2 mRNA CTD PMID:15664270 CYP1A2 Human dicyclanil multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] which results in increased more ... CTD PMID:20118626 CYP1A2 Human Dicyclohexyl phthalate decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 dicyclohexyl phthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 CYP1A2 Human dieldrin increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Dieldrin results in increased expression of CYP1A2 mRNA CTD PMID:10910964 CYP1A2 Human diethyl phthalate decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 diethyl phthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 CYP1A2 Human diethyldithiocarbamic acid multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Ditiocarb inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human diethyldithiocarbamic acid multiple interactions EXP 6480464 Ditiocarb inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human diethylstilbestrol affects response to substance EXP 6480464 CYP1A2 protein affects the susceptibility to Diethylstilbestrol CTD PMID:8242868 CYP1A2 Human difenoconazole multiple interactions EXP 6480464 [difenoconazole co-treated with fludioxonil] results in increased expression of CYP1A2 mRNA CTD PMID:33575850 CYP1A2 Human difenoconazole increases expression ISO Cyp1a2 (Mus musculus) 6480464 difenoconazole results in increased expression of CYP1A2 mRNA CTD PMID:34425431 CYP1A2 Human difenoconazole increases expression EXP 6480464 difenoconazole results in increased expression of CYP1A2 mRNA CTD PMID:33575850 CYP1A2 Human diflubenzuron affects binding EXP 6480464 Diflubenzuron binds to CYP1A2 protein CTD PMID:32278787 CYP1A2 Human dihydroartemisinin decreases activity EXP 6480464 artenimol results in decreased activity of CYP1A2 protein CTD PMID:11124226 CYP1A2 Human dihydrocapsaicin decreases activity EXP 6480464 dihydrocapsaicin results in decreased activity of CYP1A2 protein CTD PMID:22375877 CYP1A2 Human Dihydrotanshinone I increases expression EXP 6480464 dihydrotanshinone I results in increased expression of CYP1A2 mRNA; dihydrotanshinone I results in increased expression more ... CTD PMID:21262253 CYP1A2 Human Dihydrotanshinone I multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [dihydrotanshinone I results in increased expression of CYP1A2 mRNA]; dihydrotanshinone I more ... CTD PMID:21262253 CYP1A2 Human dimethocaine increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of dimethocaine CTD PMID:24309420 CYP1A2 Human Dimethyl phthalate decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 dimethyl phthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 CYP1A2 Human dimethyl sulfoxide affects expression EXP 6480464 Dimethyl Sulfoxide affects the expression of CYP1A2 mRNA CTD PMID:12843640 CYP1A2 Human dimethyl sulfoxide increases expression EXP 6480464 Dimethyl Sulfoxide results in increased expression of CYP1A2 mRNA CTD PMID:30262279 CYP1A2 Human dimethyl sulfoxide multiple interactions EXP 6480464 [Dimethyl Sulfoxide co-treated with TGFB1 protein] results in decreased expression of CYP1A2 mRNA; [Dimethyl Sulfoxide more ... CTD PMID:18347083|PMID:35366062 CYP1A2 Human dimethylarsinic acid increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Cacodylic Acid results in increased expression of CYP1A2 mRNA CTD PMID:17481689 CYP1A2 Human dimethylmercury decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 dimethyl mercury results in decreased expression of CYP1A2 protein CTD PMID:21424224 CYP1A2 Human dimethylmercury multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased more ... CTD PMID:21424224 CYP1A2 Human diosmetin decreases activity EXP 6480464 diosmetin results in decreased activity of CYP1A2 protein CTD PMID:28867436 CYP1A2 Human diosmetin increases response to substance EXP 6480464 CYP1A2 protein results in increased susceptibility to diosmetin CTD PMID:33727136 CYP1A2 Human diosmetin multiple interactions EXP 6480464 [CYP1A2 protein results in increased susceptibility to Luteolin] which results in decreased abundance of diosmetin CTD PMID:33727136 CYP1A2 Human dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of CYP1A2 mRNA CTD PMID:19695866 CYP1A2 Human dioxygen increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Oxygen results in increased activity of CYP1A2 protein CTD PMID:10640292 CYP1A2 Human dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of CYP1A2 mRNA CTD PMID:33811995 CYP1A2 Human dioxygen increases response to substance EXP 6480464 CYP1A2 gene mutant form results in increased susceptibility to Oxygen CTD PMID:29180065 CYP1A2 Human dioxygen increases expression ISO Cyp1a2 (Mus musculus) 6480464 Oxygen results in increased expression of CYP1A2 mRNA CTD PMID:25703676 CYP1A2 Human dioxygen multiple interactions EXP 6480464 [CYP1A2 gene mutant form results in increased susceptibility to Oxygen] which results in increased expression more ... CTD PMID:26845733|PMID:29180065|PMID:33811995 CYP1A2 Human dioxygen multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [1-aminobenzotriazole co-treated with Oxygen] results in increased activity of CYP1A2 protein; [[[[Oxygen deficiency co-treated with more ... CTD PMID:10640292|PMID:24657529|PMID:26747958|PMID:26845733 CYP1A2 Human dioxygen increases activity ISO Cyp1a2 (Mus musculus) 6480464 Oxygen results in increased activity of CYP1A2 protein CTD PMID:21745492 CYP1A2 Human dioxygen multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [beta-Naphthoflavone results in increased expression of CYP1A2 protein] inhibits the reaction [CYP1A1 gene mutant form more ... CTD PMID:21745492|PMID:28201809|PMID:29180065|PMID:29432836 CYP1A2 Human dipropyl phthalate decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 di-n-propylphthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 CYP1A2 Human diuron increases expression EXP 6480464 Diuron results in increased expression of CYP1A2 mRNA; Diuron results in increased expression of CYP1A2 more ... CTD PMID:21784029|PMID:22310298 CYP1A2 Human domperidone increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Domperidone CTD PMID:15327587 CYP1A2 Human dopamine decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Dopamine results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human doxorubicin multiple interactions EXP 6480464 Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human doxorubicin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human drometrizole increases expression EXP 6480464 benazol P results in increased expression of CYP1A2 mRNA CTD PMID:36586167 CYP1A2 Human elemental selenium multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased more ... CTD PMID:21424224 CYP1A2 Human Elemicin increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of elemicin CTD PMID:31468958 CYP1A2 Human Elemicin multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of elemicin] which results in increased abundance of elemicin more ... CTD PMID:31468958 CYP1A2 Human ellipticine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 ellipticine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human ellipticine multiple interactions EXP 6480464 ellipticine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human ellipticine increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of ellipticine CTD PMID:22917556 CYP1A2 Human emodin increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of Emodin CTD PMID:27989148 CYP1A2 Human emodin increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Emodin CTD PMID:30672276 CYP1A2 Human emodin multiple interactions EXP 6480464 [CYP1A2 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite CTD PMID:27989148 CYP1A2 Human emodin decreases activity EXP 6480464 Emodin results in decreased activity of CYP1A2 protein CTD PMID:27633141|PMID:33438235 CYP1A2 Human endosulfan increases expression ISO Cyp1a2 (Mus musculus) 6480464 Endosulfan analog results in increased expression of CYP1A2 mRNA; Endosulfan results in increased expression of more ... CTD PMID:29702342 CYP1A2 Human enfuvirtide affects activity EXP 6480464 enfuvirtide affects the activity of CYP1A2 protein CTD PMID:15656696 CYP1A2 Human enilconazole affects expression EXP 6480464 enilconazole affects the expression of CYP1A2 mRNA CTD PMID:32201337 CYP1A2 Human enilconazole multiple interactions EXP 6480464 [clothianidin co-treated with enilconazole] results in increased expression of CYP1A2 mRNA; [enilconazole co-treated with thiacloprid more ... CTD PMID:32201337 CYP1A2 Human enoxacin multiple interactions EXP 6480464 Enoxacin inhibits the reaction [CYP1A2 protein affects the metabolism of Fluvoxamine]; Enoxacin inhibits the reaction more ... CTD PMID:15905806|PMID:7946932 CYP1A2 Human enoxacin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] CTD PMID:8905919 CYP1A2 Human enoxacin affects binding ISO Cyp1a2 (Rattus norvegicus) 6480464 Enoxacin binds to CYP1A2 protein CTD PMID:8905919 CYP1A2 Human enoxacin decreases activity EXP 6480464 Enoxacin results in decreased activity of CYP1A2 protein CTD PMID:15905806 CYP1A2 Human epoxiconazole increases expression ISO Cyp1a2 (Mus musculus) 6480464 epoxiconazole results in increased expression of CYP1A2 mRNA CTD PMID:22334560 CYP1A2 Human Erucin increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 erucin results in increased expression of CYP1A2 protein CTD PMID:20833222 CYP1A2 Human estragole increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of estragole CTD PMID:19920071 CYP1A2 Human estragole increases response to substance EXP 6480464 CYP1A2 protein results in increased susceptibility to estragole CTD PMID:32853702 CYP1A2 Human estragole multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [flumequine co-treated with estragole] results in increased expression of CYP1A2 mRNA CTD PMID:31029721 CYP1A2 Human estragole increases expression ISO Cyp1a2 (Mus musculus) 6480464 estragole results in increased expression of CYP1A2 mRNA CTD PMID:31029721 CYP1A2 Human estrone multiple interactions EXP 6480464 CYP1A2 protein promotes the reaction [Estrone binds to Deoxyguanosine] CTD PMID:21907773 CYP1A2 Human estrone affects binding EXP 6480464 CYP1A2 protein binds to Estrone CTD PMID:27966929 CYP1A2 Human ethambutol decreases activity EXP 6480464 Ethambutol results in decreased activity of CYP1A2 protein CTD PMID:24910189 CYP1A2 Human ethanol increases expression EXP 401976472 ethanol increases expression of CYP1A2 mRNA and protein in cervical cancer cells RGD CYP1A2 Human ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP1A2 mRNA CTD PMID:35301062 CYP1A2 Human ethanol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CYP1A2 mRNA CTD PMID:30517762 CYP1A2 Human ethanol multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated more ... CTD PMID:26747958|PMID:35301062 CYP1A2 Human ethanol increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Ethanol results in increased expression of CYP1A2 mRNA; Ethanol results in increased expression of CYP1A2 more ... CTD PMID:23273579|PMID:26747958|PMID:35301062 CYP1A2 Human ethoxyquin increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Ethoxyquin results in increased expression of CYP1A2 mRNA CTD PMID:19695238 CYP1A2 Human ethylisopropylamiloride decreases activity EXP 6480464 ethylisopropylamiloride results in decreased activity of CYP1A2 protein CTD PMID:15081870 CYP1A2 Human ethylparaben decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 ethyl-p-hydroxybenzoate results in decreased activity of CYP1A2 protein CTD PMID:27432241 CYP1A2 Human etodolac decreases activity EXP 6480464 Etodolac results in decreased activity of CYP1A2 protein CTD PMID:18816299 CYP1A2 Human etoposide increases expression EXP 6480464 Etoposide results in increased expression of CYP1A2 mRNA CTD PMID:31542801 CYP1A2 Human etoricoxib decreases activity EXP 6480464 etoricoxib results in decreased activity of CYP1A2 protein CTD PMID:18816299 CYP1A2 Human eugenol multiple interactions EXP 6480464 [CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol CTD PMID:15576237 CYP1A2 Human farnesol increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Farnesol results in increased activity of CYP1A2 protein CTD PMID:15840382 CYP1A2 Human farnesol multiple interactions EXP 6480464 Farnesol analog inhibits the reaction [Oleic Acid results in decreased expression of CYP1A2 mRNA] CTD PMID:30611723 CYP1A2 Human farrerol decreases activity EXP 6480464 farrerol results in decreased activity of CYP1A2 protein CTD PMID:29753067 CYP1A2 Human felbamate decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 felbamate results in decreased expression of CYP1A2 mRNA CTD PMID:17381134 CYP1A2 Human felodipine increases expression EXP 6480464 Felodipine results in increased expression of CYP1A2 mRNA CTD PMID:27732883 CYP1A2 Human fenarimol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fenarimol co-treated with acephate] affects the expression of CYP1A2 protein; [fenarimol co-treated with vinclozolin co-treated more ... CTD PMID:17686559 CYP1A2 Human fenbendazole decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Fenbendazole results in decreased activity of CYP1A2 protein CTD PMID:22048645 CYP1A2 Human fenitrothion increases expression EXP 6480464 Fenitrothion results in increased expression of CYP1A2 mRNA CTD PMID:22310298 CYP1A2 Human fenitrothion increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Fenitrothion results in increased expression of CYP1A2 mRNA CTD PMID:34802538 CYP1A2 Human fenitrothion multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Curcumin inhibits the reaction [Fenitrothion results in increased expression of CYP1A2 mRNA] CTD PMID:34802538 CYP1A2 Human fenitrothion decreases activity EXP 6480464 Fenitrothion results in decreased activity of CYP1A2 protein CTD PMID:20183062|PMID:22634058 CYP1A2 Human fenofibrate multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP1A2 mRNA CTD PMID:18253720 CYP1A2 Human fenofibrate affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Fenofibrate affects the expression of CYP1A2 mRNA CTD PMID:20801182|PMID:25596134 CYP1A2 Human fenproporex decreases alkylation EXP 6480464 CYP1A2 protein results in decreased alkylation of fenproporex CTD PMID:15294457 CYP1A2 Human fenvalerate increases activity EXP 6480464 fenvalerate results in increased activity of CYP1A2 protein CTD PMID:22310298 CYP1A2 Human ferulic acid decreases activity EXP 6480464 ferulic acid results in decreased activity of CYP1A2 protein CTD PMID:15841493 CYP1A2 Human finasteride decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Finasteride results in decreased expression of CYP1A2 mRNA CTD PMID:24136188 CYP1A2 Human fipronil multiple interactions EXP 6480464 [fipronil co-treated with DEET] results in increased expression of CYP1A2 mRNA CTD PMID:27091632 CYP1A2 Human flavanone decreases activity EXP 6480464 flavanone results in decreased activity of CYP1A2 protein CTD PMID:21053930 CYP1A2 Human flavone multiple interactions EXP 6480464 flavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:17090139 CYP1A2 Human flavone decreases activity EXP 6480464 flavone results in decreased activity of CYP1A2 protein CTD PMID:21053930 CYP1A2 Human flavonol decreases activity EXP 6480464 3-hydroxyflavone results in decreased activity of CYP1A2 protein CTD PMID:21053930|PMID:29753067 CYP1A2 Human fluconazole increases expression ISO Cyp1a2 (Mus musculus) 6480464 Fluconazole results in increased expression of CYP1A2 mRNA CTD PMID:16730040 CYP1A2 Human fludioxonil multiple interactions EXP 6480464 [difenoconazole co-treated with fludioxonil] results in increased expression of CYP1A2 mRNA; [propiconazole co-treated with fludioxonil] more ... CTD PMID:33575850 CYP1A2 Human fludioxonil increases expression EXP 6480464 fludioxonil results in increased expression of CYP1A2 mRNA CTD PMID:33575850 CYP1A2 Human flumequine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [flumequine co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of CYP1A2 mRNA; [flumequine co-treated with estragole] more ... CTD PMID:23681119|PMID:31029721 CYP1A2 Human fluoranthene increases expression EXP 6480464 fluoranthene results in increased expression of CYP1A2 mRNA CTD PMID:12107646|PMID:21784029 CYP1A2 Human fluoranthene multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects more ... CTD PMID:18711122 CYP1A2 Human fluoranthene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with more ... CTD PMID:7750161 CYP1A2 Human fluorene increases activity ISO Cyp1a2 (Mus musculus) 6480464 fluorene results in increased activity of CYP1A2 protein CTD PMID:8001243 CYP1A2 Human fluorene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with more ... CTD PMID:7750161 CYP1A2 Human flutamide increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Flutamide results in increased expression of CYP1A2 mRNA CTD PMID:24136188|PMID:26485406 CYP1A2 Human flutamide increases response to substance EXP 6480464 CYP1A2 protein results in increased susceptibility to Flutamide CTD PMID:28762043 CYP1A2 Human flutamide multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:23397584 CYP1A2 Human flutriafol multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [flutriafol results in increased expression of CYP1A2 mRNA] CTD PMID:34200939 CYP1A2 Human flutriafol increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 flutriafol results in increased expression of CYP1A2 mRNA CTD PMID:34200939 CYP1A2 Human flutriafol increases expression EXP 6480464 flutriafol results in increased expression of CYP1A2 mRNA CTD PMID:34200939 CYP1A2 Human fluvoxamine multiple interactions EXP 6480464 [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased chemical synthesis of more ... CTD PMID:15545309|PMID:15905806|PMID:18809730|PMID:21277363|PMID:21915887|PMID:26599973|PMID:9029748 CYP1A2 Human fluvoxamine increases expression EXP 401976472 fluvoxamine increases expression of CYP1A2 mRNA and protein in cervical cancer cells RGD CYP1A2 Human fluvoxamine decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Fluvoxamine results in decreased activity of CYP1A2 protein CTD PMID:26599973 CYP1A2 Human fluvoxamine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Caffeine CTD PMID:26599973 CYP1A2 Human fluvoxamine increases response to substance EXP 6480464 CYP1A2 protein results in increased susceptibility to Fluvoxamine CTD PMID:18809730 CYP1A2 Human fluvoxamine decreases activity EXP 6480464 Fluvoxamine results in decreased activity of CYP1A2 protein CTD PMID:11763009|PMID:15545309|PMID:15845683|PMID:18816299|PMID:21915887|PMID:26599973 CYP1A2 Human folic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression more ... CTD PMID:29127188 CYP1A2 Human fonofos multiple interactions EXP 6480464 Fonofos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol]; Fonofos inhibits more ... CTD PMID:16790556 CYP1A2 Human fonofos decreases activity EXP 6480464 Fonofos results in decreased activity of CYP1A2 protein CTD PMID:16790556 CYP1A2 Human formononetin decreases activity EXP 6480464 formononetin results in decreased activity of CYP1A2 protein CTD PMID:26278343 CYP1A2 Human formononetin decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 formononetin results in decreased activity of CYP1A2 protein CTD PMID:26278343 CYP1A2 Human Frangulin A multiple interactions EXP 6480464 [frangulin A co-treated with frangulin B] results in decreased activity of CYP1A2 protein CTD PMID:33438235 CYP1A2 Human Frangulin B multiple interactions EXP 6480464 [frangulin A co-treated with frangulin B] results in decreased activity of CYP1A2 protein CTD PMID:33438235 CYP1A2 Human fructose multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA; alpha-Tocopherol inhibits the more ... CTD PMID:26102010 CYP1A2 Human Furafylline multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [furafylline results in decreased activity of CYP1A2 protein] which results in decreased glutathionylation of Duloxetine more ... CTD PMID:18493746|PMID:20669986 CYP1A2 Human Furafylline decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 furafylline results in decreased activity of CYP1A2 protein CTD PMID:12814958|PMID:15879494 CYP1A2 Human Furafylline decreases activity EXP 6480464 furafylline results in decreased activity of CYP1A2 protein CTD PMID:12467917|PMID:12814958|PMID:15155557|PMID:15279827|PMID:15306208|PMID:15333513|PMID:15766918|PMID:15860655|PMID:16035375|PMID:16049126|PMID:19328226|PMID:21336516|PMID:21915887|PMID:23850985|PMID:23898916|PMID:33438235|PMID:8020169|PMID:9202738 CYP1A2 Human Furafylline multiple interactions EXP 6480464 [furafylline results in decreased activity of CYP1A2 protein] which results in decreased susceptibility to 2-amino-9H-pyrido(2,3-b)indole; more ... CTD PMID:10215755|PMID:12569440|PMID:16049126|PMID:18493746|PMID:19053182|PMID:19812348|PMID:21915887|PMID:23850985|PMID:23898916|PMID:31082524|PMID:8020169|PMID:8558417|PMID:9202738|PMID:9305587 CYP1A2 Human Furafylline multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [furafylline results in decreased activity of CYP1A2 protein] inhibits the reaction [aristolochic acid I results more ... CTD PMID:21932800|PMID:22491429 CYP1A2 Human furan decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 furan results in decreased expression of CYP1A2 mRNA CTD PMID:25539665 CYP1A2 Human gadolinium trichloride multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP1A2 protein] CTD PMID:18202523 CYP1A2 Human galangin multiple interactions EXP 6480464 galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:17090139 CYP1A2 Human galangin decreases activity EXP 6480464 galangin results in decreased activity of CYP1A2 protein CTD PMID:20806393|PMID:21053930 CYP1A2 Human gallocatechin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin more ... CTD PMID:25663641 CYP1A2 Human gamma-decalactone decreases activity EXP 6480464 decan-4-olide results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human gamma-hexachlorocyclohexane increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Hexachlorocyclohexane results in increased activity of CYP1A2 protein CTD PMID:12842176|PMID:16641539 CYP1A2 Human gamma-hexachlorocyclohexane multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Hexachlorocyclohexane results in increased expression of and results in increased activity of CYP1A2 protein; Methylcholanthrene more ... CTD PMID:18486174 CYP1A2 Human gamma-hexachlorocyclohexane increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Hexachlorocyclohexane results in increased expression of CYP1A2 mRNA; Hexachlorocyclohexane results in increased expression of CYP1A2 more ... CTD PMID:12842176|PMID:17919674|PMID:17984293|PMID:18486174|PMID:23927878|PMID:25572523 CYP1A2 Human gamma-valerolactone decreases activity EXP 6480464 gamma-valerolactone results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human gemfibrozil decreases activity EXP 6480464 Gemfibrozil results in decreased activity of CYP1A2 protein CTD PMID:26599973 CYP1A2 Human gemfibrozil multiple interactions EXP 6480464 [Gemfibrozil results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Amodiaquine CTD PMID:26599973 CYP1A2 Human genistein increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of Genistein CTD PMID:12814970 CYP1A2 Human genistein decreases activity EXP 6480464 Genistein results in decreased activity of CYP1A2 protein CTD PMID:20806393|PMID:21053930|PMID:29753067 CYP1A2 Human genistein decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Genistein results in decreased expression of CYP1A2 mRNA CTD PMID:24967385 CYP1A2 Human genistein increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Genistein CTD PMID:12814970 CYP1A2 Human genistein increases hydroxylation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased hydroxylation of Genistein CTD PMID:15587933 CYP1A2 Human genkwanin increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of genkwanin CTD PMID:19666078 CYP1A2 Human gentamycin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in more ... CTD PMID:30545405 CYP1A2 Human gestodene multiple interactions EXP 6480464 [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in more ... CTD PMID:16198659|PMID:9305587 CYP1A2 Human Ginkgolide A increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 ginkgolide A results in increased activity of CYP1A2 protein CTD PMID:18421621 CYP1A2 Human Ginkgolide A increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 ginkgolide A results in increased expression of CYP1A2 mRNA CTD PMID:18421621 CYP1A2 Human ginkgolide B multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 ginkgolide B results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:18421621 CYP1A2 Human ginkgolide B increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 ginkgolide B results in increased expression of CYP1A2 mRNA CTD PMID:18421621 CYP1A2 Human Glu-P-1 affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole CTD PMID:2655891 CYP1A2 Human Glu-P-1 multiple interactions EXP 6480464 CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole CTD PMID:28160022 CYP1A2 Human Glu-P-1 increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole CTD PMID:14725854 CYP1A2 Human Glu-P-2 multiple interactions EXP 6480464 CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Glu-P-2 CTD PMID:28160022 CYP1A2 Human Glu-P-2 increases expression EXP 6480464 Glu-P-2 results in increased expression of CYP1A2 mRNA CTD PMID:27644595 CYP1A2 Human Glu-P-2 affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Glu-P-2 CTD PMID:2655891 CYP1A2 Human glucoerucin increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 glucoerucin results in increased expression of CYP1A2 protein CTD PMID:20833222 CYP1A2 Human glucoerucin(1-) increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 glucoerucin results in increased expression of CYP1A2 protein CTD PMID:20833222 CYP1A2 Human glucoraphanin increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 glucoraphanin results in increased expression of CYP1A2 protein CTD PMID:20833222 CYP1A2 Human glucose multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of more ... CTD PMID:31776611 CYP1A2 Human glutathione multiple interactions EXP 6480464 [CYP1A2 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac; more ... CTD PMID:20825217|PMID:24246759|PMID:26091900|PMID:31102647|PMID:32198085 CYP1A2 Human glycochenodeoxycholic acid multiple interactions EXP 6480464 [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with more ... CTD PMID:33819548|PMID:34589561 CYP1A2 Human glycocholic acid multiple interactions EXP 6480464 [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with more ... CTD PMID:33819548|PMID:34589561 CYP1A2 Human glycodeoxycholic acid multiple interactions EXP 6480464 [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with more ... CTD PMID:33819548|PMID:34589561 CYP1A2 Human glycyrrhetinate multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP1A2 protein CTD PMID:21800547 CYP1A2 Human glycyrrhetinic acid multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP1A2 protein CTD PMID:21800547 CYP1A2 Human griseofulvin affects expression ISO Cyp1a2 (Mus musculus) 6480464 Griseofulvin affects the expression of CYP1A2 mRNA CTD PMID:12735108 CYP1A2 Human griseofulvin multiple interactions EXP 6480464 Griseofulvin promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline] CTD PMID:9029748 CYP1A2 Human guanethidine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Guanethidine inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] CTD PMID:16510159 CYP1A2 Human GW 3965 increases expression EXP 6480464 GW 3965 results in increased expression of CYP1A2 mRNA CTD PMID:23041609 CYP1A2 Human halocarban increases expression EXP 6480464 cloflucarban results in increased expression of CYP1A2 mRNA; cloflucarban results in increased expression of CYP1A2 more ... CTD PMID:21784029 CYP1A2 Human hemin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated more ... CTD PMID:22159698|PMID:26747958 CYP1A2 Human heroin decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Heroin results in decreased activity of CYP1A2 protein CTD PMID:35914676 CYP1A2 Human hesperetin decreases activity EXP 6480464 hesperetin results in decreased activity of CYP1A2 protein CTD PMID:29753067 CYP1A2 Human hexachlorobenzene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Hexachlorobenzene results in increased expression of CYP1A2 mRNA; Hexachlorobenzene results in increased expression of CYP1A2 more ... CTD PMID:10696772|PMID:2539049|PMID:2845946|PMID:2856071|PMID:9630449 CYP1A2 Human hexane increases hydroxylation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased hydroxylation of n-hexane CTD PMID:16484137 CYP1A2 Human hexane multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 diallyl trisulfide inhibits the reaction [n-hexane results in increased expression of CYP1A2 protein]; n-hexane results more ... CTD PMID:28115069 CYP1A2 Human huperzine A increases metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased metabolism of huperzine A CTD PMID:12586202 CYP1A2 Human hydralazine multiple interactions EXP 6480464 Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human hydralazine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human hydrocortisone succinate multiple interactions EXP 6480464 [hydrocortisone hemisuccinate co-treated with Dimethyl Sulfoxide] results in increased expression of CYP1A2 CTD PMID:18347083 CYP1A2 Human hydrogen peroxide increases abundance EXP 6480464 CYP1A2 protein results in increased abundance of Hydrogen Peroxide CTD PMID:25061110 CYP1A2 Human hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of CYP1A2 mRNA; Hydrogen Peroxide results in increased expression more ... CTD PMID:36368423 CYP1A2 Human hydrogen peroxide multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Hydrogen Peroxide results in increased expression of CYP1A2 mRNA] CTD PMID:36368423 CYP1A2 Human Hypaconitine increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of hypaconitine CTD PMID:21550385 CYP1A2 Human iberin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 iberin results in decreased activity of [CYP1A2 protein co-treated with CYP1A1 protein] CTD PMID:22664424 CYP1A2 Human ibuprofen decreases expression EXP 6480464 Ibuprofen results in decreased expression of CYP1A2 mRNA CTD PMID:25596134 CYP1A2 Human Icaritin decreases activity EXP 6480464 icaritin results in decreased activity of CYP1A2 protein CTD PMID:29753067 CYP1A2 Human ifosfamide increases expression EXP 6480464 Ifosfamide results in increased expression of CYP1A2 mRNA CTD PMID:25596134 CYP1A2 Human imipramine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Imipramine CTD PMID:15286053 CYP1A2 Human imipramine increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Imipramine CTD PMID:11714871 CYP1A2 Human imipramine multiple interactions EXP 6480464 CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine; Imipramine more ... CTD PMID:11714871|PMID:15922009 CYP1A2 Human imipramine oxide increases abundance EXP 6480464 CYP1A2 protein results in increased abundance of imipramine N-oxide CTD PMID:27320963 CYP1A2 Human imiprothrin increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 imiprothrin results in increased expression of CYP1A2 mRNA CTD PMID:33638779 CYP1A2 Human imiquimod increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of Imiquimod metabolite CTD PMID:31111189 CYP1A2 Human imiquimod multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of Imiquimod] which results in increased chemical synthesis of more ... CTD PMID:31111189 CYP1A2 Human imiquimod multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the reaction [beta-Naphthoflavone results in increased metabolism of Imiquimod] CTD PMID:31111189 CYP1A2 Human imiquimod increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Imiquimod CTD PMID:31111189 CYP1A2 Human imiquimod affects metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the metabolism of Imiquimod CTD PMID:31111189 CYP1A2 Human imperatorin increases expression ISO Cyp1a2 (Mus musculus) 6480464 imperatorin results in increased expression of CYP1A2 protein CTD PMID:18692084 CYP1A2 Human indane decreases activity EXP 6480464 indan results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human Indeno[1,2,3-cd]pyrene increases expression EXP 6480464 indeno(1,2,3-cd)pyrene results in increased expression of CYP1A2 mRNA CTD PMID:17253728 CYP1A2 Human indirubin increases expression EXP 6480464 indirubin results in increased expression of CYP1A2 mRNA CTD PMID:15056799 CYP1A2 Human indole-3-methanol increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 indole-3-carbinol results in increased activity of CYP1A2; indole-3-carbinol results in increased activity of CYP1A2 protein CTD PMID:12147290|PMID:17297389 CYP1A2 Human indole-3-methanol increases expression EXP 6480464 indole-3-carbinol results in increased expression of CYP1A2 mRNA CTD PMID:28357125 CYP1A2 Human indole-3-methanol increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 indole-3-carbinol results in increased expression of CYP1A2; indole-3-carbinol results in increased expression of CYP1A2 protein CTD PMID:22328411|PMID:8384853|PMID:9806166 CYP1A2 Human indole-3-methanol multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA; Acetylcysteine inhibits the reaction more ... CTD PMID:22129741 CYP1A2 Human indole-3-methanol increases expression ISO Cyp1a2 (Mus musculus) 6480464 indole-3-carbinol results in increased expression of CYP1A2 CTD PMID:22328411 CYP1A2 Human indole-3-methanol affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 indole-3-carbinol affects the expression of CYP1A2 mRNA CTD PMID:21396975 CYP1A2 Human indolin-2-one increases expression EXP 6480464 2-oxindole results in increased expression of CYP1A2 protein CTD PMID:36368423 CYP1A2 Human indolin-2-one multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [2-oxindole results in increased expression of CYP1A2 protein]; IFNG more ... CTD PMID:36368423 CYP1A2 Human indometacin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 TLR4 protein affects the reaction [Indomethacin results in decreased activity of CYP1A2 protein] CTD PMID:12927920 CYP1A2 Human indometacin decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Indomethacin results in decreased expression of CYP1A2 mRNA CTD PMID:16771604 CYP1A2 Human indoxyl sulfate increases expression EXP 6480464 Indican results in increased expression of CYP1A2 mRNA CTD PMID:20000589 CYP1A2 Human indoxyl sulfate multiple interactions EXP 6480464 Indican results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:38670245 CYP1A2 Human indoxyl sulfate multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Indican results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:38670245 CYP1A2 Human inulin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CYP1A2 mRNA CTD PMID:36331819 CYP1A2 Human irilone decreases activity EXP 6480464 irilone results in decreased activity of CYP1A2 protein CTD PMID:29753067 CYP1A2 Human iron dextran multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Iron-Dextran Complex inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:9443932 CYP1A2 Human iron dextran decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Iron-Dextran Complex results in decreased activity of CYP1A2 protein CTD PMID:9443932 CYP1A2 Human isocarbophos multiple interactions EXP 6480464 CYP1A2 protein results in increased metabolism of and results in decreased sulfation of and affects more ... CTD PMID:24752505 CYP1A2 Human isoimperatorin increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of isoimperatorin CTD PMID:25500267 CYP1A2 Human isoliquiritigenin multiple interactions EXP 6480464 isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]; isoliquiritigenin inhibits the more ... CTD PMID:25110319 CYP1A2 Human isoliquiritigenin decreases activity EXP 6480464 isoliquiritigenin results in decreased activity of CYP1A2 protein CTD PMID:29753067 CYP1A2 Human isoniazide multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Isoniazid co-treated with Rifampin] results in decreased expression of CYP1A2 mRNA; [Isoniazid co-treated with Rifampin] more ... CTD PMID:32633153 CYP1A2 Human isopimpinellin increases expression ISO Cyp1a2 (Mus musculus) 6480464 isopimpinellin results in increased expression of CYP1A2 protein CTD PMID:18692084 CYP1A2 Human isoprenaline multiple interactions EXP 6480464 Isoproterenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human isoprenaline multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]; Propranolol inhibits the more ... CTD PMID:15710352 CYP1A2 Human isoproturon increases activity EXP 6480464 isoproturon results in increased activity of CYP1A2 protein CTD PMID:22310298 CYP1A2 Human isoproturon decreases activity ISO Cyp1a2 (Mus musculus) 6480464 isoproturon results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human isoproturon increases expression EXP 6480464 isoproturon results in increased expression of CYP1A2 mRNA CTD PMID:22310298 CYP1A2 Human Isosafrole multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 isosafrole inhibits the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] CTD PMID:12062927 CYP1A2 Human Isosafrole decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 isosafrole results in decreased activity of CYP1A2 protein CTD PMID:12062927 CYP1A2 Human Isosafrole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 isosafrole results in increased expression of CYP1A2 mRNA CTD PMID:11285323 CYP1A2 Human Isosafrole increases expression ISO Cyp1a2 (Mus musculus) 6480464 isosafrole results in increased expression of CYP1A2 mRNA CTD PMID:8722114 CYP1A2 Human Isoxanthohumol increases expression EXP 6480464 isoxanthohumol results in increased expression of CYP1A2 mRNA CTD PMID:15672752 CYP1A2 Human Isradipine increases expression EXP 6480464 Isradipine results in increased expression of CYP1A2 mRNA CTD PMID:27732883 CYP1A2 Human ivermectin increases expression ISO Cyp1a2 (Mus musculus) 6480464 Ivermectin results in increased expression of CYP1A2 mRNA CTD PMID:24998875 CYP1A2 Human kaempferol increases expression EXP 6480464 kaempferol results in increased expression of CYP1A2 mRNA CTD PMID:19034627 CYP1A2 Human kaempferol decreases activity EXP 6480464 kaempferol results in decreased activity of CYP1A2 protein CTD PMID:20806393|PMID:21053930|PMID:29753067 CYP1A2 Human kaempferol multiple interactions EXP 6480464 kaempferol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:21256954 CYP1A2 Human kaempferol increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 kaempferol results in increased expression of CYP1A2 mRNA CTD PMID:18421621 CYP1A2 Human kaempferol multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 kaempferol results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:18421621 CYP1A2 Human ketoconazole multiple interactions EXP 6480464 Ketoconazole affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with more ... CTD PMID:24120545|PMID:9305587 CYP1A2 Human ketoconazole decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Ketoconazole results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of CYP1A2 mRNA; Ketoconazole results in increased expression of CYP1A2 more ... CTD PMID:25000292 CYP1A2 Human ketoconazole decreases activity EXP 6480464 Ketoconazole results in decreased activity of CYP1A2 protein CTD PMID:15618748|PMID:15916432 CYP1A2 Human ketoconazole decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Ketoconazole results in decreased activity of CYP1A2 protein CTD PMID:12814958|PMID:15879494 CYP1A2 Human ketoconazole multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Ketoconazole inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] CTD PMID:19858067 CYP1A2 Human ketoconazole multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Ketoconazole inhibits the reaction [CYP1A2 protein results in increased oxidation of Uroporphyrinogens] CTD PMID:1567206 CYP1A2 Human L-ascorbic acid increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Ascorbic Acid deficiency results in increased expression of CYP1A2 mRNA; Ascorbic Acid deficiency results in more ... CTD PMID:8269614 CYP1A2 Human L-methionine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [3,4,5,3',4'-pentachlorobiphenyl co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of CYP1A2 more ... CTD PMID:27712037|PMID:28163111|PMID:28973532|PMID:29127188 CYP1A2 Human L-methionine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Choline deficiency co-treated with Methionine deficiency] results in decreased activity of CYP1A2 protein; [Choline deficiency more ... CTD PMID:38663832 CYP1A2 Human lansoprazole increases expression EXP 6480464 Lansoprazole results in increased expression of CYP1A2 mRNA; Lansoprazole results in increased expression of CYP1A2 more ... CTD PMID:12623754|PMID:8169844|PMID:9744552 CYP1A2 Human lansoprazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Lansoprazole results in increased expression of CYP1A2 mRNA; Lansoprazole results in increased expression of CYP1A2 more ... CTD PMID:14550749|PMID:25626140|PMID:9152597 CYP1A2 Human laquinimod increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 laquinimod analog results in increased expression of CYP1A2 mRNA CTD PMID:28433708 CYP1A2 Human lead nitrate decreases activity EXP 6480464 lead nitrate results in decreased activity of CYP1A2 protein CTD PMID:11162773 CYP1A2 Human lead nitrate multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]; lead nitrate more ... CTD PMID:8902619 CYP1A2 Human lead(0) affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Lead affects the expression of CYP1A2 mRNA CTD PMID:23631153 CYP1A2 Human lefetamine decreases alkylation EXP 6480464 CYP1A2 protein results in decreased alkylation of lephetamine CTD PMID:26276083 CYP1A2 Human leflunomide increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 leflunomide results in increased expression of CYP1A2 mRNA CTD PMID:24136188 CYP1A2 Human leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CYP1A2 mRNA CTD PMID:28988120 CYP1A2 Human lentinan decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Lentinan results in decreased expression of CYP1A2 CTD PMID:15630237 CYP1A2 Human Licochalcone A decreases activity EXP 6480464 licochalcone A results in decreased activity of CYP1A2 protein CTD PMID:26100226 CYP1A2 Human lidocaine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Lidocaine CTD PMID:15447735 CYP1A2 Human linoleic acid decreases activity EXP 6480464 Linoleic Acid results in decreased activity of CYP1A2 protein CTD PMID:16978661 CYP1A2 Human linuron decreases response to substance EXP 6480464 CYP1A2 protein results in decreased susceptibility to Linuron CTD PMID:29573710 CYP1A2 Human lipoic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A1 protein co-treated with CYP1A2 protein] affects the reaction [[Thioctic Acid results in decreased activity more ... CTD PMID:21932800 CYP1A2 Human lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated more ... CTD PMID:24120545 CYP1A2 Human lipopolysaccharide multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Lipopolysaccharides inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:22466549 CYP1A2 Human lipopolysaccharide decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Lipopolysaccharides results in decreased activity of CYP1A2 protein CTD PMID:15542068|PMID:15710352 CYP1A2 Human lipopolysaccharide multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]; Colforsin inhibits the more ... CTD PMID:15542068|PMID:15710352 CYP1A2 Human lithocholic acid decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Lithocholic Acid results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human lithocholic acid increases metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased metabolism of Lithocholic Acid CTD PMID:18039809 CYP1A2 Human lithocholic acid multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [CYP1A2 protein results in increased metabolism of Lithocholic Acid] which results in increased chemical synthesis more ... CTD PMID:18039809 CYP1A2 Human loxapine increases metabolic processing EXP 6480464 CYP1A2 results in increased metabolism of Loxapine CTD PMID:21826677 CYP1A2 Human luteolin decreases activity EXP 6480464 Luteolin results in decreased activity of CYP1A2 protein CTD PMID:29753067 CYP1A2 Human luteolin decreases expression EXP 6480464 Luteolin results in decreased expression of CYP1A2 protein CTD PMID:33727136 CYP1A2 Human luteolin multiple interactions EXP 6480464 [CYP1A2 protein results in increased susceptibility to Luteolin] which results in decreased abundance of diosmetin; more ... CTD PMID:33727136 CYP1A2 Human luteolin increases response to substance EXP 6480464 CYP1A2 protein results in increased susceptibility to Luteolin CTD PMID:33727136 CYP1A2 Human Luteolin 7-methyl ether decreases activity EXP 6480464 hydroxygenkwanin results in decreased activity of CYP1A2 protein CTD PMID:34843882 CYP1A2 Human Luteolin 7-methyl ether decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 hydroxygenkwanin results in decreased activity of CYP1A2 protein CTD PMID:34843882 CYP1A2 Human lycopene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Lycopene co-treated with Atrazine] results in increased expression of CYP1A2 mRNA; Lycopene inhibits the reaction more ... CTD PMID:26775023|PMID:34670089|PMID:36216167|PMID:36403809 CYP1A2 Human lycopene increases expression ISO Cyp1a2 (Mus musculus) 6480464 Lycopene results in increased expression of CYP1A2 mRNA CTD PMID:36216167 CYP1A2 Human m-xylene multiple interactions EXP 6480464 furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-xylene] CTD PMID:8558417 CYP1A2 Human m-xylene increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of 3-xylene CTD PMID:8558417 CYP1A2 Human m-xylene decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 3-xylene results in decreased activity of CYP1A2 protein CTD PMID:8598570 CYP1A2 Human Magnolol decreases activity ISO Cyp1a2 (Mus musculus) 6480464 magnolol results in decreased activity of CYP1A2 protein CTD PMID:19140158 CYP1A2 Human malathion affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Malathion CTD PMID:15557345 CYP1A2 Human malathion increases expression EXP 6480464 Malathion results in increased expression of CYP1A2 mRNA CTD PMID:22310298 CYP1A2 Human maneb multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of more ... CTD PMID:23159886 CYP1A2 Human mangiferin decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 mangiferin results in decreased activity of CYP1A2 protein CTD PMID:18053976 CYP1A2 Human mangiferin decreases activity EXP 6480464 mangiferin results in decreased activity of CYP1A2 protein CTD PMID:22815239 CYP1A2 Human mangiferin increases expression EXP 6480464 mangiferin results in increased expression of CYP1A2 mRNA CTD PMID:22815239 CYP1A2 Human mebendazole increases expression EXP 6480464 Mebendazole results in increased expression of CYP1A2 protein CTD PMID:12841937 CYP1A2 Human mebendazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Mebendazole results in increased expression of CYP1A2 protein CTD PMID:12841937 CYP1A2 Human Meclizine multiple interactions EXP 6480464 Meclizine inhibits the reaction [[Phenobarbital results in increased activity of NR1I3 protein] which results in more ... CTD PMID:15272053 CYP1A2 Human Meclizine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Meclizine binds to and results in increased activity of NR1I3 protein] which results in increased more ... CTD PMID:15272053 CYP1A2 Human mefenamic acid decreases activity EXP 6480464 Mefenamic Acid results in decreased activity of CYP1A2 protein CTD PMID:18816299 CYP1A2 Human mefenamic acid multiple interactions EXP 6480464 SOD1 protein inhibits the reaction [CYP1A2 protein results in increased oxidation of Mefenamic Acid] CTD PMID:33259822 CYP1A2 Human mefenamic acid increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of Mefenamic Acid CTD PMID:33259822 CYP1A2 Human mefenamic acid increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Mefenamic Acid CTD PMID:25372302 CYP1A2 Human mefenamic acid increases glutathionylation EXP 6480464 CYP1A2 protein results in increased glutathionylation of Mefenamic Acid analog CTD PMID:25372302 CYP1A2 Human MeIQ multiple interactions EXP 6480464 [CYP1A2 protein co-treated with POR protein co-treated with OAT protein] results in increased susceptibility to more ... CTD PMID:10503888|PMID:10775323|PMID:28160022|PMID:9581821 CYP1A2 Human MeIQ multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] which more ... CTD PMID:11585058 CYP1A2 Human MeIQ multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 2-amino-3,4-dimethylimidazo(4,5-f)quinoline inhibits the reaction [CYP1A2 protein results in increased oxidation of Uroporphyrinogens] CTD PMID:1567206 CYP1A2 Human MeIQ decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 2-amino-3,4-dimethylimidazo(4,5-f)quinoline results in decreased activity of CYP1A2 protein CTD PMID:1617633 CYP1A2 Human MeIQ affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2-amino-3,4-dimethylimidazo(4,5-f)quinoline affects the expression of CYP1A2 protein CTD PMID:1617633 CYP1A2 Human MeIQ increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline CTD PMID:14725854 CYP1A2 Human MeIQ increases activity EXP 6480464 CYP1A2 results in increased activity of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline CTD PMID:10775323|PMID:10861951|PMID:11166912|PMID:2334931 CYP1A2 Human MeIQ affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline CTD PMID:2655891 CYP1A2 Human MeIQ increases metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased metabolism of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline CTD PMID:1617633 CYP1A2 Human MeIQ affects binding EXP 6480464 CYP1A2 protein binds to 2-amino-3,4-dimethylimidazo(4,5-f)quinoline CTD PMID:9334905 CYP1A2 Human MeIQ increases metabolic processing EXP 6480464 CYP1A2 protein mutant form results in increased metabolism of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline; CYP1A2 results in increased metabolism more ... CTD PMID:14744142 CYP1A2 Human MeIQx multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [flumequine co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of CYP1A2 mRNA; [Phenobarbital co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] more ... CTD PMID:23681119 CYP1A2 Human MeIQx increases expression EXP 6480464 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA CTD PMID:20307560|PMID:20816883|PMID:22138251|PMID:23810796|PMID:27644595 CYP1A2 Human MeIQx affects oxidation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 affects the oxidation of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline CTD PMID:10503887 CYP1A2 Human MeIQx increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline; CYP1A2 results in increased oxidation of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline CTD PMID:10503887|PMID:20192249|PMID:22118226 CYP1A2 Human MeIQx multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline promotes the reaction [Carbon Tetrachloride results in decreased expression of CYP1A2 protein]; [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated more ... CTD PMID:12079509|PMID:20448087|PMID:20930465 CYP1A2 Human MeIQx increases activity EXP 6480464 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased activity of CYP1A2 protein; CYP1A2 results in increased activity of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline CTD PMID:20307560|PMID:2334931 CYP1A2 Human MeIQx affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline CTD PMID:2655891 CYP1A2 Human MeIQx decreases activity EXP 6480464 CYP1A2 protein results in decreased activity of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline CTD PMID:20192249 CYP1A2 Human MeIQx increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA; 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 more ... CTD PMID:12079509|PMID:14965361|PMID:20448087 CYP1A2 Human MeIQx multiple interactions EXP 6480464 [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of CYP1A2 mRNA; [CYP1A2 protein co-treated with more ... CTD PMID:10503888|PMID:20192249|PMID:20307560|PMID:20816883|PMID:22138251|PMID:28160022|PMID:9202738|PMID:9581821 CYP1A2 Human MeIQx increases expression ISO Cyp1a2 (Mus musculus) 6480464 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA CTD PMID:23681119 CYP1A2 Human melatonin decreases methylation EXP 6480464 CYP1A2 protein results in decreased methylation of Melatonin CTD PMID:15616152 CYP1A2 Human melatonin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [ABCB6 gene mutant form results in decreased expression of CYP1A2 mRNA] inhibits the reaction [CYP1A2 more ... CTD PMID:25623066 CYP1A2 Human melatonin increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of Melatonin CTD PMID:25623066 CYP1A2 Human melatonin increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Melatonin CTD PMID:15616152|PMID:22634058 CYP1A2 Human melatonin affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Melatonin CTD PMID:15626586|PMID:15824912 CYP1A2 Human melatonin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of CYP1A2 mRNA CTD PMID:20033131 CYP1A2 Human melatonin decreases activity EXP 6480464 Melatonin results in decreased activity of CYP1A2 protein CTD PMID:19919601 CYP1A2 Human melatonin increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Melatonin CTD PMID:17565714 CYP1A2 Human melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene] CTD PMID:19919601 CYP1A2 Human meloxicam multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Meloxicam] which more ... CTD PMID:33253783 CYP1A2 Human melphalan multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human melphalan multiple interactions EXP 6480464 Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human menadione multiple interactions EXP 6480464 Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human menadione increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Vitamin K 3 results in increased expression of CYP1A2 mRNA CTD PMID:15603920 CYP1A2 Human menadione increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Vitamin K 3 results in increased activity of CYP1A2 protein CTD PMID:15603920 CYP1A2 Human menadione multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human mercury atom multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Mercury co-treated with methylmercuric chloride] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 more ... CTD PMID:22579925|PMID:23231920|PMID:36245390 CYP1A2 Human mercury atom increases activity ISO Cyp1a2 (Mus musculus) 6480464 Mercury results in increased activity of CYP1A2 protein CTD PMID:22579925 CYP1A2 Human mercury dichloride decreases activity EXP 6480464 Mercuric Chloride results in decreased activity of CYP1A2 protein CTD PMID:11162773 CYP1A2 Human mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of CYP1A2 protein CTD PMID:37172713 CYP1A2 Human mercury dichloride decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Mercuric Chloride results in decreased expression of CYP1A2 protein CTD PMID:37172713 CYP1A2 Human mercury(0) multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Mercury co-treated with methylmercuric chloride] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 more ... CTD PMID:22579925|PMID:23231920|PMID:36245390 CYP1A2 Human mercury(0) increases activity ISO Cyp1a2 (Mus musculus) 6480464 Mercury results in increased activity of CYP1A2 protein CTD PMID:22579925 CYP1A2 Human metformin increases expression EXP 6480464 Metformin results in increased expression of CYP1A2 mRNA CTD PMID:19022234 CYP1A2 Human metformin decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Metformin results in decreased expression of CYP1A2 mRNA CTD PMID:25596134 CYP1A2 Human methamphetamine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Methamphetamine metabolite CTD PMID:16038959 CYP1A2 Human methidathion increases expression ISO Cyp1a2 (Mus musculus) 6480464 methidathion results in increased expression of CYP1A2 mRNA CTD PMID:34813904 CYP1A2 Human methotrexate multiple interactions EXP 6480464 Methotrexate inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human methotrexate decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Methotrexate results in decreased expression of CYP1A2 mRNA CTD PMID:15120968 CYP1A2 Human methoxsalen decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Methoxsalen results in decreased activity of CYP1A2 protein CTD PMID:12814958|PMID:15879494 CYP1A2 Human methoxsalen decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Methoxsalen results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human methoxsalen decreases activity EXP 6480464 Methoxsalen results in decreased activity of CYP1A2 protein CTD PMID:8819299 CYP1A2 Human methoxychlor multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 ESR1 protein promotes the reaction [Methoxychlor results in increased expression of CYP1A2 mRNA] CTD PMID:21252393 CYP1A2 Human methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of CYP1A2 mRNA CTD PMID:21924250 CYP1A2 Human methoxychlor decreases methylation EXP 6480464 CYP1A2 protein results in decreased methylation of Methoxychlor CTD PMID:12167570|PMID:12433799|PMID:9733665 CYP1A2 Human methoxychlor multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Methoxychlor results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:12919727 CYP1A2 Human methoxychlor increases expression ISO Cyp1a2 (Mus musculus) 6480464 Methoxychlor results in increased expression of CYP1A2 mRNA CTD PMID:21252393 CYP1A2 Human methoxychlor increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Methoxychlor CTD PMID:9047321 CYP1A2 Human methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate decreases activity EXP 6480464 Nisoldipine results in decreased activity of CYP1A2 protein CTD PMID:10805063 CYP1A2 Human methylarsonic acid increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 monomethylarsonic acid results in increased expression of CYP1A2 mRNA CTD PMID:17481689 CYP1A2 Human methylglyoxal multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Meloxicam] which more ... CTD PMID:33253783 CYP1A2 Human methylmercury chloride multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of more ... CTD PMID:30744511 CYP1A2 Human methylmercury chloride multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Mercury co-treated with methylmercuric chloride] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 more ... CTD PMID:36245390 CYP1A2 Human metolachlor increases activity EXP 6480464 metolachlor results in increased activity of CYP1A2 protein CTD PMID:10813365 CYP1A2 Human metronidazole multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in more ... CTD PMID:30545405 CYP1A2 Human miconazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Miconazole results in increased expression of CYP1A2 mRNA CTD PMID:22262564 CYP1A2 Human microcystin-LR increases expression ISO Cyp1a2 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of CYP1A2 mRNA CTD PMID:17383702 CYP1A2 Human mifepristone multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 more ... CTD PMID:17690134 CYP1A2 Human mifepristone multiple interactions EXP 6480464 [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein]; more ... CTD PMID:19022236 CYP1A2 Human mitomycin C decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Mitomycin results in decreased activity of CYP1A2 protein CTD PMID:15696929 CYP1A2 Human Mitragynine increases activity EXP 6480464 mitragynine results in increased activity of CYP1A2 protein CTD PMID:23274770 CYP1A2 Human Mitragynine increases expression EXP 6480464 mitragynine results in increased expression of CYP1A2 mRNA; mitragynine results in increased expression of CYP1A2 more ... CTD PMID:23274770 CYP1A2 Human Monobutylphthalate decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 monobutyl phthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 CYP1A2 Human monocrotophos increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Monocrotophos results in increased expression of CYP1A2 protein CTD PMID:21445290 CYP1A2 Human monosodium L-glutamate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin more ... CTD PMID:25663641 CYP1A2 Human morphine decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Morphine results in decreased activity of CYP1A2 protein CTD PMID:35914676 CYP1A2 Human musk xylene increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 musk xylene results in increased activity of CYP1A2 protein CTD PMID:10630706 CYP1A2 Human musk xylene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 musk xylene results in increased expression of CYP1A2 protein CTD PMID:10630706 CYP1A2 Human musk xylene increases expression ISO Cyp1a2 (Mus musculus) 6480464 musk xylene metabolite results in increased expression of CYP1A2 mRNA; musk xylene results in increased more ... CTD PMID:9397191 CYP1A2 Human mycophenolic acid multiple interactions EXP 6480464 Mycophenolic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:25929522 CYP1A2 Human myricetin decreases activity EXP 6480464 myricetin results in decreased activity of CYP1A2 protein CTD PMID:29753067 CYP1A2 Human myristicin affects oxidation EXP 6480464 CYP1A2 protein affects the oxidation of myristicin CTD PMID:12523956 CYP1A2 Human myristicin decreases activity EXP 6480464 myristicin results in decreased activity of CYP1A2 protein CTD PMID:26091900 CYP1A2 Human myristicin multiple interactions EXP 6480464 Glutathione inhibits the reaction [myristicin results in decreased activity of CYP1A2 protein] CTD PMID:26091900 CYP1A2 Human N'-(2,4-dimethylphenyl)-N-methylformamidine increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 U 40481 results in increased expression of CYP1A2 protein CTD PMID:31029719 CYP1A2 Human N,N-diethyl-m-toluamide increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of DEET CTD PMID:11854147 CYP1A2 Human N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [fipronil co-treated with DEET] results in increased expression of CYP1A2 mRNA CTD PMID:27091632 CYP1A2 Human N,N-diethyl-m-toluamide increases expression EXP 6480464 DEET results in increased expression of CYP1A2 mRNA CTD PMID:19326769|PMID:27091632 CYP1A2 Human N,N-diisopropyltryptamine multiple interactions EXP 6480464 [N,N-diisopropyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of more ... CTD PMID:26599973 CYP1A2 Human N,N-diisopropyltryptamine decreases activity EXP 6480464 N,N-diisopropyltryptamine analog results in decreased activity of CYP1A2 protein CTD PMID:26599973 CYP1A2 Human N,N-dimethyltryptamine increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of N,N-Dimethyltryptamine CTD PMID:27320963 CYP1A2 Human N-[3-(aminomethyl)benzyl]acetamidine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] CTD PMID:15542068 CYP1A2 Human N-acetyl-1,4-benzoquinone imine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased chemical synthesis of and results in increased abundance of N-acetyl-4-benzoquinoneimine CTD PMID:19679878 CYP1A2 Human N-acetyl-1,4-benzoquinone imine increases abundance EXP 6480464 CYP1A2 protein results in increased abundance of N-acetyl-4-benzoquinoneimine CTD PMID:24661219 CYP1A2 Human N-acetyl-L-cysteine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased more ... CTD PMID:21424224|PMID:22129741|PMID:23159886 CYP1A2 Human N-acetyl-L-cysteine multiple interactions EXP 6480464 [CYP1A2 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite; Acetylcysteine inhibits the more ... CTD PMID:27989148|PMID:34200939 CYP1A2 Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO Cyp1a2 (Rattus norvegicus) 401794136 MG132 pretreatment increases expression of protein in liver of intestinal ischemia/reperfusion rats RGD CYP1A2 Human N-desmethylclozapine multiple interactions EXP 6480464 [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of norclozapine; more ... CTD PMID:11151749|PMID:18809730 CYP1A2 Human N-desmethylclozapine increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of norclozapine CTD PMID:18809730 CYP1A2 Human N-desmethylclozapine increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of norclozapine CTD PMID:12969762 CYP1A2 Human N-Desmethyltamoxifen increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of N-desmethyltamoxifen CTD PMID:29285606 CYP1A2 Human N-Desmethyltamoxifen multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of N-desmethyltamoxifen] which results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene CTD PMID:29285606 CYP1A2 Human N-hydroxy-PhIP multiple interactions EXP 6480464 [[CYP1A2 protein co-treated with CYP1A1 protein] results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in more ... CTD PMID:16167840|PMID:17279779|PMID:20192249 CYP1A2 Human N-hydroxy-PhIP multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased abundance of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine CTD PMID:1943715 CYP1A2 Human N-nitrosodiethylamine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] which results in increased more ... CTD PMID:20118626 CYP1A2 Human N-nitrosodiethylamine decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Diethylnitrosamine results in decreased expression of CYP1A2 mRNA CTD PMID:19638242|PMID:20360939|PMID:23494807|PMID:27565560 CYP1A2 Human N-nitrosodiethylamine decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of CYP1A2 mRNA CTD PMID:24535843 CYP1A2 Human N-nitrosodiethylamine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA; [Diethylnitrosamine co-treated with caffeic more ... CTD PMID:18164116|PMID:18253720|PMID:18754104|PMID:20033131|PMID:20045035|PMID:20360939|PMID:22129741|PMID:22687989|PMID:23494807|PMID:27565560|PMID:28943392 CYP1A2 Human N-nitrosodimethylamine decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in decreased expression of CYP1A2 mRNA; Dimethylnitrosamine results in decreased expression of CYP1A2 more ... CTD PMID:16997515|PMID:17072980 CYP1A2 Human NADP zwitterion multiple interactions EXP 6480464 [CYP1A2 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results more ... CTD PMID:11714871|PMID:20825217|PMID:24120545|PMID:33728909|PMID:7946932 CYP1A2 Human NADP(+) multiple interactions EXP 6480464 [CYP1A2 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results more ... CTD PMID:11714871|PMID:20825217|PMID:24120545|PMID:33728909|PMID:7946932 CYP1A2 Human naphthalene multiple interactions EXP 6480464 naphthalene inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol]; naphthalene inhibits more ... CTD PMID:16790556 CYP1A2 Human naphthalene decreases activity EXP 6480464 naphthalene analog results in decreased activity of CYP1A2 protein; naphthalene results in decreased activity of more ... CTD PMID:15916432|PMID:16790556 CYP1A2 Human naringin decreases activity EXP 6480464 naringin results in decreased activity of CYP1A2 protein CTD PMID:21053930 CYP1A2 Human NCX-4040 decreases activity EXP 6480464 NCX 4040 results in decreased activity of CYP1A2 protein CTD PMID:19542225 CYP1A2 Human NCX-4040 multiple interactions EXP 6480464 NCX 4040 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:19542225 CYP1A2 Human nefazodone increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 nefazodone results in increased expression of CYP1A2 mRNA CTD PMID:24136188 CYP1A2 Human nefazodone multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... CTD PMID:33819548 CYP1A2 Human neomycin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in more ... CTD PMID:30545405 CYP1A2 Human nicardipine multiple interactions EXP 6480464 Methylcholanthrene promotes the reaction [Nicardipine results in increased expression of CYP1A2 mRNA]; Nicardipine promotes the more ... CTD PMID:20067464 CYP1A2 Human nicardipine increases expression EXP 6480464 Nicardipine results in increased expression of CYP1A2 mRNA CTD PMID:20067464 CYP1A2 Human nicardipine decreases activity EXP 6480464 Nicardipine results in decreased activity of CYP1A2 protein CTD PMID:15863898 CYP1A2 Human nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of CYP1A2 mRNA CTD PMID:24768652 CYP1A2 Human nickel dichloride decreases expression EXP 6480464 nickel chloride results in decreased expression of CYP1A2 protein CTD PMID:21784029 CYP1A2 Human niclosamide increases expression EXP 6480464 Niclosamide results in increased expression of CYP1A2 mRNA CTD PMID:28284560 CYP1A2 Human niclosamide decreases activity EXP 6480464 Niclosamide results in decreased activity of CYP1A2 protein CTD PMID:11124226 CYP1A2 Human nicotine decreases activity EXP 6480464 Nicotine results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human nicotine decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Nicotine results in decreased expression of CYP1A2 mRNA CTD PMID:26463278 CYP1A2 Human nicotine increases expression EXP 6480464 Nicotine results in increased expression of CYP1A2 protein CTD PMID:11849738 CYP1A2 Human nifedipine decreases activity EXP 6480464 Nifedipine results in decreased activity of CYP1A2 protein CTD PMID:10805063 CYP1A2 Human nifedipine decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Nifedipine results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human nifedipine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Nifedipine inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] CTD PMID:19858067 CYP1A2 Human nimesulide decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 nimesulide results in decreased expression of CYP1A2 mRNA CTD PMID:24136188 CYP1A2 Human nimesulide increases glutathionylation EXP 6480464 CYP1A2 protein results in increased glutathionylation of nimesulide CTD PMID:26524229 CYP1A2 Human nisoldipine decreases activity EXP 6480464 Nisoldipine results in decreased activity of CYP1A2 protein CTD PMID:10805063 CYP1A2 Human nitroaniline increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 nitroaniline analog results in increased expression of CYP1A2 mRNA; nitroaniline analog results in increased expression more ... CTD PMID:9545601 CYP1A2 Human nitroaniline increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 nitroaniline analog results in increased activity of CYP1A2 protein CTD PMID:9545601 CYP1A2 Human nitrofurantoin multiple interactions EXP 6480464 Nitrofurantoin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human nitroglycerin affects expression ISO Cyp1a2 (Rattus norvegicus) 401900296 Vitamin E inhibits the reaction [nitroglycerine decreases Cyp1a2 protein expression in rat heart] RGD CYP1A2 Human nitroglycerin decreases expression ISO Cyp1a2 (Rattus norvegicus) 401900656 nitroglycerin decreased expression of Cyp1a2 protein in thoracic aorta of rats RGD CYP1A2 Human nobiletin increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of nobiletin CTD PMID:22743247 CYP1A2 Human Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of CYP1A2 mRNA; nonylphenol results in increased expression of CYP1A2 more ... CTD PMID:34974051 CYP1A2 Human norfloxacin affects binding ISO Cyp1a2 (Rattus norvegicus) 6480464 Norfloxacin binds to CYP1A2 protein CTD PMID:8905919 CYP1A2 Human norfloxacin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Norfloxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] CTD PMID:8905919 CYP1A2 Human norgestimate multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP1A2 protein CTD PMID:16291717 CYP1A2 Human nortriptyline increases metabolic processing EXP 6480464 Nortriptyline results in increased metabolism of CYP1A2 protein CTD PMID:18359012 CYP1A2 Human notoginsenoside R1 decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 notoginsenoside R1 results in decreased activity of CYP1A2 protein CTD PMID:25834921 CYP1A2 Human Notopterol multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of notopterol] promotes the reaction [Glutathione binds to notopterol] CTD PMID:32198085 CYP1A2 Human Notopterol increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of notopterol CTD PMID:32198085 CYP1A2 Human o-anisidine increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2-anisidine results in increased expression of CYP1A2 CTD PMID:11409192 CYP1A2 Human o-anisidine increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of 2-anisidine CTD PMID:15828049 CYP1A2 Human O-methyleugenol increases expression EXP 6480464 methyleugenol results in increased expression of CYP1A2 mRNA CTD PMID:32234424 CYP1A2 Human obeticholic acid multiple interactions EXP 6480464 obeticholic acid inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of Acetaminophen]; obeticholic more ... CTD PMID:27939613 CYP1A2 Human obeticholic acid decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 obeticholic acid results in decreased expression of CYP1A2 mRNA CTD PMID:35267068 CYP1A2 Human obeticholic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Dietary Fats co-treated with obeticholic acid] results in decreased expression of CYP1A2 mRNA; [Dietary Fats more ... CTD PMID:35267068 CYP1A2 Human obeticholic acid decreases expression EXP 6480464 obeticholic acid results in decreased expression of CYP1A2 mRNA CTD PMID:27939613 CYP1A2 Human obeticholic acid decreases activity EXP 6480464 obeticholic acid results in decreased activity of CYP1A2 protein CTD PMID:27939613 CYP1A2 Human ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of CYP1A2 mRNA; ochratoxin A results in increased expression more ... CTD PMID:21834667|PMID:30291945 CYP1A2 Human ochratoxin A increases expression ISO Cyp1a2 (Mus musculus) 6480464 ochratoxin A results in increased expression of CYP1A2 mRNA; ochratoxin A results in increased expression more ... CTD PMID:30291945 CYP1A2 Human ochratoxin A increases response to substance EXP 6480464 CYP1A2 protein results in increased susceptibility to ochratoxin A CTD PMID:11189750|PMID:21781659|PMID:8542584 CYP1A2 Human Octachlorostyrene increases activity ISO Cyp1a2 (Mus musculus) 6480464 octachlorostyrene results in increased activity of CYP1A2 protein CTD PMID:19525444 CYP1A2 Human Octachlorostyrene increases expression ISO Cyp1a2 (Mus musculus) 6480464 octachlorostyrene results in increased expression of CYP1A2 mRNA CTD PMID:19525444 CYP1A2 Human octamethylcyclotetrasiloxane multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 octamethylcyclotetrasiloxane results in decreased expression of and results in increased activity of CYP1A2 protein CTD PMID:36100151 CYP1A2 Human ofloxacin multiple interactions EXP 6480464 [Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] CTD PMID:11408986 CYP1A2 Human okadaic acid multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Okadaic Acid CTD PMID:26374342 CYP1A2 Human okadaic acid decreases expression EXP 6480464 Okadaic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:38832940 CYP1A2 Human okadaic acid multiple interactions EXP 6480464 CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Okadaic Acid CTD PMID:26374342 CYP1A2 Human okanin decreases activity EXP 6480464 okanin results in decreased activity of CYP1A2 protein CTD PMID:29753067 CYP1A2 Human olanzapine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of olanzapine CTD PMID:15545309|PMID:15883149 CYP1A2 Human olanzapine multiple interactions EXP 6480464 Fluvoxamine inhibits the reaction [CYP1A2 protein affects the metabolism of olanzapine] CTD PMID:15545309 CYP1A2 Human oleanolic acid multiple interactions EXP 6480464 Oleanolic Acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] CTD PMID:15043991 CYP1A2 Human oleanolic acid decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Oleanolic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:23948738 CYP1A2 Human oleanolic acid decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Oleanolic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:18706400 CYP1A2 Human oleanolic acid decreases activity EXP 6480464 Oleanolic Acid results in decreased activity of CYP1A2 protein CTD PMID:15043991 CYP1A2 Human oleic acid decreases expression EXP 6480464 Oleic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:30611723 CYP1A2 Human oleic acid multiple interactions EXP 6480464 Farnesol analog inhibits the reaction [Oleic Acid results in decreased expression of CYP1A2 mRNA] CTD PMID:30611723 CYP1A2 Human Olivacine multiple interactions EXP 6480464 olivacine analog results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:14709624 CYP1A2 Human Olivacine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of olivacine analog CTD PMID:14709624 CYP1A2 Human oltipraz increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 oltipraz results in increased expression of CYP1A2 mRNA CTD PMID:8625305 CYP1A2 Human oltipraz increases expression ISO Cyp1a2 (Mus musculus) 6480464 oltipraz results in increased expression of CYP1A2 mRNA CTD PMID:22496397 CYP1A2 Human oltipraz multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 NFE2L2 protein affects the reaction [oltipraz results in increased expression of CYP1A2 mRNA] CTD PMID:22496397 CYP1A2 Human oltipraz increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 oltipraz results in increased activity of CYP1A2 protein CTD PMID:8625305 CYP1A2 Human oltipraz multiple interactions EXP 6480464 oltipraz inhibits the reaction [CYP1A2 results in increased activity of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline] CTD PMID:10775323 CYP1A2 Human oltipraz affects metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein affects the metabolism of oltipraz CTD PMID:15831204|PMID:15920769 CYP1A2 Human oltipraz decreases activity EXP 6480464 oltipraz metabolite results in decreased activity of CYP1A2 protein; oltipraz results in decreased activity of more ... CTD PMID:10775323 CYP1A2 Human omeprazole increases activity EXP 6480464 Omeprazole results in increased activity of CYP1A2 promoter; Omeprazole results in increased activity of CYP1A2 more ... CTD PMID:18502397|PMID:19118567|PMID:19230594|PMID:23274770|PMID:30044681|PMID:36288780 CYP1A2 Human omeprazole decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Omeprazole results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human omeprazole multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA CTD PMID:22687989 CYP1A2 Human omeprazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP1A2 mRNA; Omeprazole results in increased expression of CYP1A2 more ... CTD PMID:12040753|PMID:12623754|PMID:12841937|PMID:15681896|PMID:15802389|PMID:17954527|PMID:18332078|PMID:19118567|PMID:19230594|PMID:20171196|PMID:21784029|PMID:21924250|PMID:22524704|PMID:23274770|PMID:23850985|PMID:24752503|PMID:26204831|PMID:27794450|PMID:30044681|PMID:36288780|PMID:9744552 CYP1A2 Human omeprazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Omeprazole results in increased expression of CYP1A2 mRNA; Omeprazole results in increased expression of CYP1A2 more ... CTD PMID:19118567|PMID:25626140|PMID:9152597 CYP1A2 Human omeprazole multiple interactions EXP 6480464 [Omeprazole results in increased expression of CYP1A2 protein] which results in decreased alkylation of Phenacetin; more ... CTD PMID:15802389|PMID:20171196|PMID:22524704|PMID:31863871 CYP1A2 Human omeprazole decreases activity EXP 6480464 Omeprazole results in decreased activity of CYP1A2 protein CTD PMID:16035375 CYP1A2 Human Ondansetron affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Ondansetron CTD PMID:15286053 CYP1A2 Human organophosphorus compound multiple interactions EXP 6480464 Organophosphorus Compounds inhibits the reaction [CYP1A2 protein results in decreased methylation of and results in more ... CTD PMID:15922009 CYP1A2 Human organoselenium compound multiple interactions EXP 6480464 Organoselenium Compounds binds to and results in decreased activity of CYP1A2 protein CTD PMID:21732699 CYP1A2 Human orphenadrine multiple interactions EXP 6480464 Orphenadrine inhibits the reaction [CYP1A2 protein results in decreased ethylation of 7-ethoxy-4-trifluoromethylcoumarin]; Orphenadrine inhibits the more ... CTD PMID:9241656 CYP1A2 Human orphenadrine decreases activity EXP 6480464 Orphenadrine results in decreased activity of CYP1A2 protein CTD PMID:9241656 CYP1A2 Human orphenadrine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Orphenadrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human ortho-Aminoazotoluene increases activity ISO Cyp1a2 (Mus musculus) 6480464 o-Aminoazotoluene results in increased activity of CYP1A2 protein CTD PMID:15863256 CYP1A2 Human ortho-Aminoazotoluene increases expression ISO Cyp1a2 (Mus musculus) 6480464 o-Aminoazotoluene results in increased expression of CYP1A2 mRNA CTD PMID:10887293|PMID:14562683 CYP1A2 Human osthole increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of osthol CTD PMID:39793773 CYP1A2 Human Oxadiazon increases expression ISO Cyp1a2 (Mus musculus) 6480464 oxadiazon results in increased expression of CYP1A2 mRNA CTD PMID:26710982 CYP1A2 Human oxfendazole multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA; [Diethylnitrosamine more ... CTD PMID:18754104|PMID:20033131 CYP1A2 Human oxolane multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 NR1I2 protein affects the reaction [tetrahydrofuran results in increased expression of CYP1A2 mRNA]; NR1I3 protein more ... CTD PMID:28495613 CYP1A2 Human oxolane increases expression ISO Cyp1a2 (Mus musculus) 6480464 tetrahydrofuran results in increased expression of CYP1A2 mRNA CTD PMID:28495613 CYP1A2 Human ozone multiple interactions EXP 6480464 AHR protein affects the reaction [Ozone results in increased expression of CYP1A2 mRNA]; AHR protein more ... CTD PMID:19536146 CYP1A2 Human ozone decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Ozone results in decreased expression of CYP1A2 mRNA CTD PMID:16183385 CYP1A2 Human ozone increases expression EXP 6480464 Ozone results in increased expression of CYP1A2 mRNA; Ozone results in increased expression of CYP1A2 more ... CTD PMID:19536146 CYP1A2 Human p-cresol increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of 4-cresol CTD PMID:16174805 CYP1A2 Human paclitaxel increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Paclitaxel results in increased expression of CYP1A2 mRNA CTD PMID:15585946 CYP1A2 Human paclitaxel decreases activity EXP 6480464 Paclitaxel results in decreased activity of CYP1A2 protein CTD PMID:19909766 CYP1A2 Human pantoprazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 pantoprazole results in increased expression of CYP1A2 mRNA; pantoprazole results in increased expression of CYP1A2 more ... CTD PMID:25626140|PMID:9152597 CYP1A2 Human papaverine multiple interactions EXP 6480464 Papaverine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human paracetamol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYP1A2 mRNA; [CYP1A2 protein results in increased more ... CTD PMID:11376689|PMID:12958197|PMID:14978233|PMID:16141365|PMID:16729303|PMID:17585979|PMID:19002106|PMID:19679878|PMID:30503582|PMID:33887374|PMID:34546377 CYP1A2 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CYP1A2 mRNA CTD PMID:33811995 CYP1A2 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CYP1A2 mRNA CTD PMID:32112222 CYP1A2 Human paracetamol increases chemical synthesis ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased chemical synthesis of Acetaminophen CTD PMID:28438436 CYP1A2 Human paracetamol increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of Acetaminophen CTD PMID:12401345|PMID:15155557|PMID:21915887|PMID:23850985|PMID:27939613|PMID:31706005 CYP1A2 Human paracetamol decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of CYP1A2 mRNA CTD PMID:12969438|PMID:21807079 CYP1A2 Human paracetamol affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Acetaminophen affects the expression of CYP1A2 mRNA CTD PMID:11245408|PMID:17366322 CYP1A2 Human paracetamol increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of CYP1A2 protein CTD PMID:18798224 CYP1A2 Human paracetamol multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of more ... CTD PMID:12969438|PMID:18493746|PMID:18798224|PMID:28438436 CYP1A2 Human paracetamol increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of Acetaminophen CTD PMID:10977129|PMID:19002106 CYP1A2 Human paracetamol increases abundance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased abundance of Acetaminophen CTD PMID:10445756 CYP1A2 Human paracetamol increases expression ISO Cyp1a2 (Mus musculus) 6480464 Acetaminophen results in increased expression of CYP1A2 mRNA; Acetaminophen results in increased expression of CYP1A2 more ... CTD PMID:12958197|PMID:14978233|PMID:16141365|PMID:19002106 CYP1A2 Human paracetamol affects expression ISO Cyp1a2 (Mus musculus) 6480464 Acetaminophen affects the expression of CYP1A2 mRNA CTD PMID:17562736 CYP1A2 Human paracetamol multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of more ... CTD PMID:19135037|PMID:21915887|PMID:27939613|PMID:28762043|PMID:31706005|PMID:33811995|PMID:35366062|PMID:35748891 CYP1A2 Human paracetamol increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of Acetaminophen CTD PMID:10811468 CYP1A2 Human paracetamol increases metabolic processing EXP 6480464 CYP1A2 results in increased metabolism of Acetaminophen CTD PMID:20566340 CYP1A2 Human paracetamol increases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased susceptibility to Acetaminophen CTD PMID:16141365|PMID:16557553|PMID:19679878 CYP1A2 Human paracetamol decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Acetaminophen results in decreased expression of CYP1A2 mRNA; Acetaminophen results in decreased expression of CYP1A2 more ... CTD PMID:15576447|PMID:16611625|PMID:21329376 CYP1A2 Human paraquat increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Paraquat results in increased activity of CYP1A2 protein CTD PMID:20888808 CYP1A2 Human paraquat increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Paraquat results in increased expression of CYP1A2 mRNA; Paraquat results in increased expression of CYP1A2 more ... CTD PMID:20888808|PMID:23159886 CYP1A2 Human paraquat multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of more ... CTD PMID:23159886 CYP1A2 Human parathion affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Parathion CTD PMID:12669189|PMID:15557345|PMID:17079358 CYP1A2 Human parathion increases expression EXP 6480464 Parathion results in increased expression of CYP1A2 mRNA CTD PMID:26196221 CYP1A2 Human PCB138 decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 2,2',3',4,4',5-hexachlorobiphenyl CTD PMID:21571617 CYP1A2 Human PCB138 multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 2,2',3',4,4',5-hexachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]; [3,4,3',4'-tetrachlorobiphenyl co-treated with more ... CTD PMID:20961953 CYP1A2 Human pedalitin decreases activity EXP 6480464 pedalitin results in decreased activity of CYP1A2 protein CTD PMID:29753067 CYP1A2 Human pelargonidin increases expression EXP 6480464 pelargonidin results in increased expression of CYP1A2 mRNA CTD PMID:23419638 CYP1A2 Human pentachlorobenzene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 pentachlorobenzene results in increased expression of CYP1A2 protein CTD PMID:10696772 CYP1A2 Human pentachlorophenol increases expression ISO Cyp1a2 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of CYP1A2 mRNA CTD PMID:23892564 CYP1A2 Human pentobarbital increases expression ISO Cyp1a2 (Mus musculus) 6480464 Pentobarbital results in increased expression of CYP1A2 mRNA CTD PMID:10064569 CYP1A2 Human Pentoxifylline decreases activity EXP 6480464 Pentoxifylline results in decreased activity of CYP1A2 protein CTD PMID:11465391 CYP1A2 Human perampanel increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of perampanel CTD PMID:35200000 CYP1A2 Human perfluorooctane-1-sulfonic acid decreases activity EXP 6480464 perfluorooctane sulfonic acid results in decreased activity of CYP1A2 protein CTD PMID:31809754 CYP1A2 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP1A2 mRNA; [perfluorooctane sulfonic more ... CTD PMID:36331819 CYP1A2 Human perfluorooctane-1-sulfonic acid affects expression EXP 6480464 perfluorooctane sulfonic acid affects the expression of CYP1A2 mRNA CTD PMID:31809754 CYP1A2 Human perfluorooctane-1-sulfonic acid increases expression ISO Cyp1a2 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of CYP1A2 mRNA CTD PMID:20936131 CYP1A2 Human perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 perfluorooctane sulfonic acid inhibits the reaction [CYP1A2 protein results in increased oxidation of Oxazines] CTD PMID:21964418 CYP1A2 Human perfluorooctanoic acid affects expression ISO Cyp1a2 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of CYP1A2 mRNA CTD PMID:18281256 CYP1A2 Human perfluorooctanoic acid affects expression EXP 6480464 perfluorooctanoic acid affects the expression of CYP1A2 mRNA CTD PMID:31809754 CYP1A2 Human perfluorooctanoic acid decreases activity EXP 6480464 perfluorooctanoic acid results in decreased activity of CYP1A2 protein CTD PMID:31809754 CYP1A2 Human perfluorooctanoic acid decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in decreased expression of CYP1A2 mRNA; perfluorooctanoic acid results in decreased expression more ... CTD PMID:16221955|PMID:19162173|PMID:34958885 CYP1A2 Human perfluorooctanoic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 PPARA promotes the reaction [perfluorooctanoic acid results in increased expression of CYP1A2 mRNA] CTD PMID:20118188 CYP1A2 Human perfluorooctanoic acid decreases expression ISO Cyp1a2 (Mus musculus) 6480464 perfluorooctanoic acid results in decreased expression of CYP1A2 mRNA CTD PMID:20118188 CYP1A2 Human perhexiline multiple interactions EXP 6480464 CYP1A2 protein results in increased hydroxylation of [perhexiline maleate results in increased abundance of Perhexiline]; more ... CTD PMID:18493746|PMID:36083301 CYP1A2 Human Perhexiline maleate multiple interactions EXP 6480464 CYP1A2 protein results in increased hydroxylation of [perhexiline maleate results in increased abundance of Perhexiline]; more ... CTD PMID:36083301 CYP1A2 Human permethrin increases expression EXP 6480464 Permethrin results in increased expression of CYP1A2 mRNA; Permethrin results in increased expression of CYP1A2 more ... CTD PMID:21784029 CYP1A2 Human Pf-06840003 multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 PF-06840003 inhibits the reaction [[amyloid beta-protein (1-42) binds to MAPT protein] which results in increased more ... CTD PMID:39172838 CYP1A2 Human Pf-06840003 multiple interactions EXP 6480464 PF-06840003 inhibits the reaction [MAPT protein mutant form results in increased expression of CYP1A2 mRNA] CTD PMID:39172838 CYP1A2 Human phenacetin multiple interactions EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [CYP1A2 protein results in decreased ethylation of Phenacetin]; 2-aminofluorene inhibits the more ... CTD PMID:11465391|PMID:11751525|PMID:14570767|PMID:15043991|PMID:16049126|PMID:19053182|PMID:19135037|PMID:21915887|PMID:22524704|PMID:23850985|PMID:26599973|PMID:27939613|PMID:28119166|PMID:29445054|PMID:31706005|PMID:35366062|PMID:35748891|PMID:8020169 CYP1A2 Human phenacetin increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Phenacetin CTD PMID:12401345|PMID:12467917|PMID:15043991|PMID:15155557|PMID:15370959|PMID:16049126|PMID:16124035|PMID:17267297|PMID:17418993|PMID:17702393|PMID:19135037|PMID:21915887|PMID:23850985|PMID:27939613|PMID:28119166|PMID:28762043|PMID:31706005|PMID:35366062|PMID:35748891 CYP1A2 Human phenacetin affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Phenacetin CTD PMID:11751525|PMID:15801540|PMID:3577206 CYP1A2 Human phenacetin increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of Phenacetin; CYP1A2 protein results in increased oxidation of more ... CTD PMID:10985777|PMID:11284709|PMID:18032064|PMID:19053182|PMID:9195021 CYP1A2 Human phenacetin decreases ethylation EXP 6480464 CYP1A2 protein results in decreased ethylation of Phenacetin CTD PMID:11303964|PMID:12433797|PMID:14563787|PMID:14725854|PMID:15618748|PMID:8020169 CYP1A2 Human phenacetin affects metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein affects the metabolism of Phenacetin CTD PMID:15231049|PMID:15801540|PMID:15879494 CYP1A2 Human phenacetin increases metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased metabolism of Phenacetin CTD PMID:12222751|PMID:17651725|PMID:28438436|PMID:8905919 CYP1A2 Human phenacetin decreases ethylation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in decreased ethylation of Phenacetin CTD PMID:11911841|PMID:12064368 CYP1A2 Human phenacetin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of more ... CTD PMID:28438436|PMID:8905919 CYP1A2 Human phenacetin increases expression ISO Cyp1a2 (Mus musculus) 6480464 Phenacetin results in increased expression of CYP1A2 protein CTD PMID:15742976 CYP1A2 Human phenacetin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of more ... CTD PMID:1567206|PMID:30503582 CYP1A2 Human phenacetin increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of Phenacetin CTD PMID:10445756|PMID:30503582 CYP1A2 Human phenacetin affects metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the metabolism of Phenacetin CTD PMID:15742976 CYP1A2 Human phenacetin increases activity EXP 6480464 Phenacetin results in increased activity of CYP1A2 protein CTD PMID:15802386 CYP1A2 Human phenanthrene increases activity ISO Cyp1a2 (Mus musculus) 6480464 phenanthrene results in increased activity of CYP1A2 protein CTD PMID:8001243 CYP1A2 Human phenanthrene increases expression ISO Cyp1a2 (Mus musculus) 6480464 phenanthrene results in increased expression of CYP1A2 mRNA; phenanthrene results in increased expression of CYP1A2 more ... CTD PMID:31181217 CYP1A2 Human phenanthrene increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of phenanthrene CTD PMID:27137136 CYP1A2 Human phenanthrene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with more ... CTD PMID:19766613|PMID:7750161 CYP1A2 Human phenanthrene multiple interactions EXP 6480464 [CYP1A2 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol; more ... CTD PMID:19766613|PMID:27137136 CYP1A2 Human phenethyl caffeate multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP1A2 mRNA CTD PMID:20360939 CYP1A2 Human phenethyl caffeate decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 caffeic acid phenethyl ester results in decreased expression of CYP1A2 protein CTD PMID:22291063 CYP1A2 Human phenethyl isothiocyanate decreases activity EXP 6480464 phenethyl isothiocyanate results in decreased activity of CYP1A2 mRNA CTD PMID:20442190 CYP1A2 Human phenethyl isothiocyanate increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 phenethyl isothiocyanate results in increased expression of CYP1A2 mRNA CTD PMID:22664424 CYP1A2 Human phenethyl isothiocyanate multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 phenethyl isothiocyanate results in increased activity of [CYP1A1 protein co-treated with CYP1A2 protein] CTD PMID:22664424 CYP1A2 Human phenethyl isothiocyanate decreases expression EXP 6480464 phenethyl isothiocyanate results in decreased expression of CYP1A2 protein CTD PMID:20025923 CYP1A2 Human phenethyl isothiocyanate decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 phenethyl isothiocyanate results in decreased expression of CYP1A2 protein CTD PMID:20025923 CYP1A2 Human phenethyl isothiocyanate increases expression EXP 6480464 phenethyl isothiocyanate results in increased expression of CYP1A2 mRNA CTD PMID:15672752|PMID:20442190 CYP1A2 Human phenobarbital increases activity ISO Cyp1a2 (Mus musculus) 6480464 Phenobarbital results in increased activity of CYP1A2 protein CTD PMID:10064569 CYP1A2 Human phenobarbital increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Phenobarbital results in increased expression of CYP1A2 mRNA CTD PMID:20226384|PMID:23273579|PMID:24449422|PMID:8849338 CYP1A2 Human phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP1A2 mRNA; Phenobarbital results in increased expression of CYP1A2 more ... CTD PMID:19118567|PMID:22258563|PMID:22310298|PMID:28541575 CYP1A2 Human phenobarbital decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Phenobarbital results in decreased expression of CYP1A2 mRNA; Phenobarbital results in decreased expression of CYP1A2 more ... CTD PMID:11328961|PMID:15596064|PMID:17381134|PMID:20607812|PMID:24090815|PMID:30842367 CYP1A2 Human phenobarbital affects expression ISO Cyp1a2 (Mus musculus) 6480464 Phenobarbital affects the expression of CYP1A2 mRNA CTD PMID:23091169 CYP1A2 Human phenobarbital decreases activity EXP 6480464 Phenobarbital results in decreased activity of CYP1A2 protein CTD PMID:19909766 CYP1A2 Human phenobarbital increases activity EXP 6480464 Phenobarbital results in increased activity of CYP1A2 protein CTD PMID:19118567 CYP1A2 Human phenobarbital increases expression ISO Cyp1a2 (Mus musculus) 6480464 Phenobarbital results in increased expression of CYP1A2 mRNA; Phenobarbital results in increased expression of CYP1A2 more ... CTD PMID:10064569|PMID:16109766|PMID:17962186|PMID:18692084|PMID:20403969|PMID:23681119|PMID:28218408|PMID:28541575|PMID:30503582|PMID:32320717|PMID:9397191 CYP1A2 Human phenobarbital multiple interactions EXP 6480464 [Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 more ... CTD PMID:15272053 CYP1A2 Human phenobarbital multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Phenobarbital co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 protein; Choline deficiency promotes the more ... CTD PMID:18486174|PMID:18798224|PMID:30842367 CYP1A2 Human phenobarbital multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Phenobarbital co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of CYP1A2 mRNA; ciprofibrate inhibits the reaction more ... CTD PMID:16109766|PMID:17962186|PMID:23681119|PMID:28218408 CYP1A2 Human phenol affects response to substance EXP 6480464 CYP1A2 protein affects the susceptibility to Phenol CTD PMID:8242868 CYP1A2 Human phenthoate increases expression EXP 6480464 phenthoate results in increased expression of CYP1A2 mRNA CTD PMID:22310298 CYP1A2 Human phenylephrine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Phenylephrine promotes the more ... CTD PMID:16510159 CYP1A2 Human phenytoin multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:23397584 CYP1A2 Human PhIP increases activity EXP 6480464 CYP1A2 protein polymorphism results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine; CYP1A2 protein results in increased activity more ... CTD PMID:12949046|PMID:15110095|PMID:2334931 CYP1A2 Human PhIP affects metabolic processing EXP 6480464 CYP1A2 gene SNP affects the metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine CTD PMID:22131055 CYP1A2 Human PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA CTD PMID:20307560|PMID:20816883|PMID:22138251|PMID:23810796|PMID:29362861|PMID:31515600|PMID:31542801 CYP1A2 Human PhIP increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine CTD PMID:14725854|PMID:15944213|PMID:8020169 CYP1A2 Human PhIP increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine CTD PMID:17279779 CYP1A2 Human PhIP increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine CTD PMID:15598703 CYP1A2 Human PhIP increases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased susceptibility to 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine CTD PMID:1943715 CYP1A2 Human PhIP increases hydroxylation ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine CTD PMID:16167840 CYP1A2 Human PhIP affects response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine CTD PMID:2023932 CYP1A2 Human PhIP increases oxidation EXP 6480464 CYP1A2 results in increased oxidation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine CTD PMID:10503887 CYP1A2 Human PhIP multiple interactions EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [CYP1A2 protein results in decreased ethylation of Phenacetin]; [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with more ... CTD PMID:10503888|PMID:15310245|PMID:16167840|PMID:17279779|PMID:1913651|PMID:20192249|PMID:20307560|PMID:20816883|PMID:28160022|PMID:8020169|PMID:8625468|PMID:9202738|PMID:9581821 CYP1A2 Human PhIP multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [1-Naphthylisothiocyanate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in decreased expression of CYP1A2 protein; [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with 1-Naphthylisothiocyanate] more ... CTD PMID:12706856|PMID:15598703|PMID:1913651|PMID:8902619 CYP1A2 Human PhIP affects oxidation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 affects the oxidation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine CTD PMID:10503887 CYP1A2 Human PhIP increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA; 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 more ... CTD PMID:12706856|PMID:15598703|PMID:33945839|PMID:8902619 CYP1A2 Human PhIP increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine CTD PMID:17279779 CYP1A2 Human PhIP multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in increased mutagenesis of APRT gene; [CYP1A2 protein results more ... CTD PMID:16167840|PMID:1943715|PMID:2023932 CYP1A2 Human phlorizin decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Phlorhizin results in decreased expression of CYP1A2 mRNA CTD PMID:22538082 CYP1A2 Human phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 Tetradecanoylphorbol Acetate promotes the reaction [FOS protein binds to CYP1A2 enhancer]; Tetradecanoylphorbol Acetate promotes the more ... CTD PMID:10620351 CYP1A2 Human phorbol 13-acetate 12-myristate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:1313028 CYP1A2 Human phorone increases expression ISO Cyp1a2 (Mus musculus) 6480464 phorone results in increased expression of CYP1A2 mRNA CTD PMID:24494203 CYP1A2 Human phosphatidylcholine affects activity EXP 6480464 Phosphatidylcholines affects the activity of CYP1A2 protein CTD PMID:15966743 CYP1A2 Human phosphatidylethanolamine multiple interactions EXP 6480464 phosphatidylethanolamine results in increased stability of and results in increased activity of CYP1A2 protein CTD PMID:15966743 CYP1A2 Human physcion decreases activity EXP 6480464 physcione results in decreased activity of CYP1A2 protein CTD PMID:27633141|PMID:33438235 CYP1A2 Human pifithrin-alpha hydrobromide increases expression EXP 6480464 pifithrin results in increased expression of CYP1A2 mRNA; pifithrin results in increased expression of CYP1A2 more ... CTD PMID:16258175 CYP1A2 Human pifithrin-alpha hydrobromide decreases activity EXP 6480464 pifithrin results in decreased activity of CYP1A2 protein CTD PMID:16258175 CYP1A2 Human pimobendan decreases methylation EXP 6480464 CYP1A2 protein results in decreased methylation of pimobendan CTD PMID:10611143 CYP1A2 Human pinocembrin decreases activity EXP 6480464 pinocembrin results in decreased activity of CYP1A2 protein CTD PMID:29753067 CYP1A2 Human Pipermethystine increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 pipermethystine results in increased expression of CYP1A2 protein CTD PMID:17329236 CYP1A2 Human piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of CYP1A2 mRNA; Piperonyl Butoxide results in increased expression more ... CTD PMID:21784029 CYP1A2 Human piperonyl butoxide increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Piperonyl Butoxide results in increased expression of CYP1A2 mRNA CTD PMID:18544911|PMID:20735435 CYP1A2 Human piperonyl butoxide increases expression ISO Cyp1a2 (Mus musculus) 6480464 Piperonyl Butoxide results in increased expression of CYP1A2 mRNA; Piperonyl Butoxide results in increased expression more ... CTD PMID:30572783|PMID:32320717|PMID:8722114|PMID:9233375 CYP1A2 Human piperonyl butoxide multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of CYP1A2 mRNA] CTD PMID:18544911 CYP1A2 Human pirinixic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of CYP1A2 mRNA; pirinixic acid inhibits more ... CTD PMID:17962186|PMID:18467677|PMID:20059764|PMID:20813756 CYP1A2 Human pirinixic acid decreases expression ISO Cyp1a2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of CYP1A2 mRNA CTD PMID:17962186|PMID:18467677|PMID:20059764|PMID:20813756|PMID:23811191|PMID:28541575 CYP1A2 Human pirinixic acid decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 pirinixic acid results in decreased expression of CYP1A2 mRNA CTD PMID:19162173 CYP1A2 Human pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 CYP1A2 Human poly(styrene) multiple interactions EXP 6480464 styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP1A2 protein] CTD PMID:19909766 CYP1A2 Human poly(styrene) affects activity EXP 6480464 styrofoam analog affects the activity of CYP1A2 protein CTD PMID:19909766 CYP1A2 Human potassium dichromate increases expression ISO Cyp1a2 (Mus musculus) 6480464 Potassium Dichromate results in increased expression of CYP1A2 mRNA CTD PMID:23608068 CYP1A2 Human pravastatin decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Pravastatin results in decreased expression of CYP1A2 mRNA CTD PMID:27225895 CYP1A2 Human pravastatin decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Pravastatin results in decreased expression of CYP1A2 mRNA CTD PMID:27225895 CYP1A2 Human prazosin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 more ... CTD PMID:16510159 CYP1A2 Human pregnenolone 16alpha-carbonitrile decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP1A2 mRNA CTD PMID:15596064|PMID:19162173|PMID:29548889 CYP1A2 Human pregnenolone 16alpha-carbonitrile multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 NR1I2 gene mutant form inhibits the reaction [Pregnenolone Carbonitrile results in decreased expression of CYP1A2 more ... CTD PMID:29548889 CYP1A2 Human pregnenolone 16alpha-carbonitrile increases expression ISO Cyp1a2 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of CYP1A2 mRNA CTD PMID:27413110|PMID:31388680 CYP1A2 Human pregnenolone 16alpha-carbonitrile multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Pregnenolone Carbonitrile inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] CTD PMID:28428138 CYP1A2 Human primaquine increases activity EXP 6480464 Primaquine results in increased activity of CYP1A2 promoter CTD PMID:18502397 CYP1A2 Human primaquine increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Primaquine CTD PMID:19616568 CYP1A2 Human primaquine multiple interactions EXP 6480464 [CYP1A2 protein results in increased expression of HBG2 protein] which affects the susceptibility to Primaquine CTD PMID:19616568 CYP1A2 Human primaquine increases expression EXP 6480464 Primaquine results in increased expression of CYP1A2 mRNA CTD PMID:12451431|PMID:12623754|PMID:17954527 CYP1A2 Human primaquine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Primaquine CTD PMID:12920490 CYP1A2 Human prochloraz increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 prochloraz results in increased expression of CYP1A2 mRNA; prochloraz results in increased expression of CYP1A2 more ... CTD PMID:25182419|PMID:33150952 CYP1A2 Human prochloraz increases expression EXP 6480464 prochloraz results in increased expression of CYP1A2 mRNA; prochloraz results in increased expression of CYP1A2 more ... CTD PMID:21784029|PMID:33150952 CYP1A2 Human profenofos increases expression EXP 6480464 profenofos results in increased expression of CYP1A2 mRNA CTD PMID:22310298 CYP1A2 Human profenofos decreases activity EXP 6480464 profenofos results in decreased activity of CYP1A2 protein CTD PMID:20183062 CYP1A2 Human propachlor increases activity EXP 6480464 propachlor results in increased activity of CYP1A2 protein CTD PMID:10813365 CYP1A2 Human propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP1A2 mRNA CTD PMID:19409404|PMID:30293151|PMID:30458266|PMID:33575850 CYP1A2 Human propiconazole multiple interactions EXP 6480464 [propiconazole co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A2 mRNA; [propiconazole co-treated with fludioxonil] more ... CTD PMID:30293151|PMID:30458266|PMID:33575850 CYP1A2 Human propiconazole increases activity EXP 6480464 propiconazole results in increased activity of CYP1A2 protein CTD PMID:30458266 CYP1A2 Human propiconazole increases expression ISO Cyp1a2 (Mus musculus) 6480464 propiconazole results in increased expression of CYP1A2 mRNA CTD PMID:16730040|PMID:19010342|PMID:22334560 CYP1A2 Human propiconazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 propiconazole results in increased expression of CYP1A2 mRNA; propiconazole results in increased expression of CYP1A2 more ... CTD PMID:15603923|PMID:16643972|PMID:30293151|PMID:7986207 CYP1A2 Human propiconazole increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 propiconazole results in increased activity of CYP1A2 protein CTD PMID:30293151|PMID:3190755 CYP1A2 Human propranolol affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Propranolol CTD PMID:15286053 CYP1A2 Human propranolol increases expression ISO Cyp1a2 (Mus musculus) 6480464 Propranolol results in increased expression of CYP1A2 protein CTD PMID:15618653 CYP1A2 Human propranolol multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 more ... CTD PMID:15710352 CYP1A2 Human propylparaben decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 propylparaben results in decreased activity of CYP1A2 protein CTD PMID:27432241 CYP1A2 Human protopine increases expression EXP 6480464 protopine results in increased expression of CYP1A2 mRNA CTD PMID:21419197 CYP1A2 Human pterostilbene decreases activity ISO Cyp1a2 (Mus musculus) 6480464 pterostilbene results in decreased activity of CYP1A2 protein CTD PMID:16684708 CYP1A2 Human pterostilbene decreases activity EXP 6480464 pterostilbene results in decreased activity of CYP1A2 protein CTD PMID:30394306 CYP1A2 Human pyrazinecarboxamide increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Pyrazinamide results in increased expression of CYP1A2 mRNA CTD PMID:22431067 CYP1A2 Human pyrene increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of pyrene CTD PMID:15016593 CYP1A2 Human pyrene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 pyrene results in increased expression of CYP1A2 mRNA CTD PMID:30240548 CYP1A2 Human pyrene increases expression ISO Cyp1a2 (Mus musculus) 6480464 pyrene results in increased expression of CYP1A2 mRNA; pyrene results in increased expression of CYP1A2 more ... CTD PMID:17618724|PMID:26160115 CYP1A2 Human pyrene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with more ... CTD PMID:17618724|PMID:7750161 CYP1A2 Human pyridine increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 pyridine results in increased expression of CYP1A2 mRNA; pyridine results in increased expression of CYP1A2 more ... CTD PMID:10413312|PMID:10463385|PMID:1857340|PMID:7493548 CYP1A2 Human pyridine increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 pyridine results in increased activity of CYP1A2 protein CTD PMID:10413312|PMID:10463385|PMID:1857340 CYP1A2 Human pyrogallol increases expression ISO Cyp1a2 (Mus musculus) 6480464 Pyrogallol results in increased expression of CYP1A2 mRNA CTD PMID:18789925 CYP1A2 Human pyrogallol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 resveratrol inhibits the reaction [Pyrogallol results in increased activity of CYP1A2 protein]; resveratrol inhibits the more ... CTD PMID:18789925 CYP1A2 Human pyrogallol increases activity ISO Cyp1a2 (Mus musculus) 6480464 Pyrogallol results in increased activity of CYP1A2 protein CTD PMID:18789925 CYP1A2 Human pyrrolidines affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Pyrrolidines CTD PMID:21053377 CYP1A2 Human quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with more ... CTD PMID:10620351|PMID:16544949|PMID:16970932|PMID:21256954|PMID:24120545 CYP1A2 Human quercetin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Quercetin co-treated with Oxygen] results in increased expression of CYP1A2 mRNA CTD PMID:29432836 CYP1A2 Human quercetin decreases activity EXP 6480464 Quercetin results in decreased activity of CYP1A2 protein CTD PMID:12949046|PMID:15916432|PMID:19215233|PMID:29753067 CYP1A2 Human quercetin decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Quercetin results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human quercetin increases expression EXP 6480464 Quercetin results in increased expression of CYP1A2 mRNA CTD PMID:19034627|PMID:21256954 CYP1A2 Human quercetin affects activity EXP 6480464 Quercetin affects the activity of CYP1A2 protein CTD PMID:21053930 CYP1A2 Human quercetin increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Quercetin results in increased expression of CYP1A2 mRNA CTD PMID:18421621 CYP1A2 Human quercetin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Quercetin inhibits the reaction [CYP1A2 results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline]; Quercetin results in increased more ... CTD PMID:11752233|PMID:18421621 CYP1A2 Human quercetin 3-O-beta-D-glucofuranoside multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA CTD PMID:20033131 CYP1A2 Human quercetin 3-O-beta-D-glucopyranoside multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA CTD PMID:20033131 CYP1A2 Human quinaldine decreases activity EXP 6480464 2-methylquinoline results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human quinidine multiple interactions EXP 6480464 Quinidine affects the reaction [CYP1A2 protein results in increased oxidation of 4-amino-2-phenoxymethanesulfonanilide] CTD PMID:19053182 CYP1A2 Human quinidine decreases activity EXP 6480464 Quinidine results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human quinine increases expression EXP 6480464 Quinine results in increased expression of CYP1A2 mRNA CTD PMID:12451431 CYP1A2 Human quinizarin decreases activity EXP 6480464 1,4-dihydroxyanthraquinone results in decreased activity of CYP1A2 protein CTD PMID:33438235 CYP1A2 Human quinoline decreases activity EXP 6480464 quinoline analog results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human rabeprazole increases expression EXP 6480464 Rabeprazole results in increased expression of CYP1A2 mRNA CTD PMID:12623754 CYP1A2 Human rabeprazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Rabeprazole results in increased expression of CYP1A2 mRNA CTD PMID:25626140 CYP1A2 Human reactive oxygen species multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] which results in increased more ... CTD PMID:20118626 CYP1A2 Human reserpine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression more ... CTD PMID:16510159 CYP1A2 Human resveratrol multiple interactions EXP 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP1A2 mRNA; Imipramine inhibits the more ... CTD PMID:10496959|PMID:11714871|PMID:16544949|PMID:17959153|PMID:19376845|PMID:20716633|PMID:21262253|PMID:23557933|PMID:29209748 CYP1A2 Human resveratrol multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [resveratrol co-treated with Streptozocin] results in decreased expression of CYP1A2 mRNA CTD PMID:25905778 CYP1A2 Human resveratrol decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 resveratrol results in decreased expression of CYP1A2 mRNA CTD PMID:25905778 CYP1A2 Human resveratrol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]; resveratrol inhibits the more ... CTD PMID:18789925|PMID:26204831 CYP1A2 Human resveratrol decreases activity EXP 6480464 Resveratrol results in decreased activity of CYP1A2 protein CTD PMID:11714871|PMID:30394306 CYP1A2 Human resveratrol decreases activity ISO Cyp1a2 (Mus musculus) 6480464 resveratrol analog results in decreased activity of CYP1A2 protein; resveratrol results in decreased activity of more ... CTD PMID:16684708|PMID:18420780|PMID:25956474 CYP1A2 Human resveratrol affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of resveratrol CTD PMID:15276085 CYP1A2 Human Retrorsine increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 retrorsine results in increased expression of CYP1A2 CTD PMID:24799337 CYP1A2 Human Rhein decreases activity EXP 6480464 rhein results in decreased activity of CYP1A2 protein CTD PMID:27633141|PMID:33438235 CYP1A2 Human rifampicin multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of CYP1A2 mRNA; Rifampin inhibits the reaction more ... CTD PMID:18493746|PMID:29162470 CYP1A2 Human rifampicin increases expression ISO Cyp1a2 (Mus musculus) 6480464 Rifampin results in increased expression of CYP1A2 mRNA CTD PMID:30503582 CYP1A2 Human rifampicin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in more ... CTD PMID:25835148|PMID:32633153 CYP1A2 Human rifampicin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human rifampicin increases expression EXP 6480464 Rifampin results in increased expression of CYP1A2 mRNA; Rifampin results in increased expression of CYP1A2 more ... CTD PMID:15977188|PMID:17590308 CYP1A2 Human ritonavir increases expression EXP 6480464 Ritonavir results in increased expression of CYP1A2 mRNA CTD PMID:11918509 CYP1A2 Human ritonavir decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Ritonavir results in decreased expression of CYP1A2 mRNA CTD PMID:17719200 CYP1A2 Human rofecoxib multiple interactions EXP 6480464 rofecoxib inhibits the reaction [CYP1A2 protein results in increased metabolism of Caffeine]; rofecoxib inhibits the more ... CTD PMID:15834531|PMID:16934051 CYP1A2 Human rofecoxib decreases activity EXP 6480464 rofecoxib results in decreased activity of CYP1A2 protein CTD PMID:18816299 CYP1A2 Human rubiadin decreases activity EXP 6480464 rubiadin results in decreased activity of CYP1A2 protein CTD PMID:33438235 CYP1A2 Human Rutecarpine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 rutecarpine promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline] CTD PMID:15720787 CYP1A2 Human Rutecarpine increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 rutecarpine results in increased activity of CYP1A2 protein CTD PMID:15720787 CYP1A2 Human Rutecarpine multiple interactions EXP 6480464 rutecarpine analog binds to and results in decreased activity of CYP1A2 protein; rutecarpine binds to more ... CTD PMID:12852960 CYP1A2 Human safrole increases expression ISO Cyp1a2 (Mus musculus) 6480464 Safrole results in increased expression of CYP1A2 mRNA CTD PMID:8722114 CYP1A2 Human safrole decreases activity EXP 6480464 Safrole results in decreased activity of CYP1A2 protein CTD PMID:15778010 CYP1A2 Human salicylamide multiple interactions EXP 6480464 salicylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:14729655 CYP1A2 Human Salinomycin increases expression EXP 6480464 salinomycin results in increased expression of CYP1A2 mRNA CTD PMID:34806536 CYP1A2 Human sanguinarine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 sanguinarine inhibits the reaction [Methylcholanthrene results in increased expression of and results in increased activity more ... CTD PMID:19788401 CYP1A2 Human saracatinib increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of saracatinib CTD PMID:27769111 CYP1A2 Human scutellarein affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of scutellarein CTD PMID:19666078 CYP1A2 Human secobarbital increases expression ISO Cyp1a2 (Mus musculus) 6480464 Secobarbital results in increased expression of CYP1A2 mRNA CTD PMID:10064569 CYP1A2 Human selenium atom multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased more ... CTD PMID:21424224 CYP1A2 Human senecionine increases expression EXP 6480464 senecionine results in increased expression of CYP1A2 mRNA CTD PMID:26100227 CYP1A2 Human senecionine decreases expression ISO Cyp1a2 (Mus musculus) 6480464 senecionine results in decreased expression of CYP1A2 mRNA CTD PMID:31606820 CYP1A2 Human Sesamex increases expression ISO Cyp1a2 (Mus musculus) 6480464 sesamex results in increased expression of CYP1A2 mRNA CTD PMID:8722114 CYP1A2 Human Shikonin decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 shikonin results in decreased activity of CYP1A2 protein CTD PMID:28941798 CYP1A2 Human Shikonin decreases activity EXP 6480464 shikonin results in decreased activity of CYP1A2 protein CTD PMID:28941798 CYP1A2 Human silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of CYP1A2 mRNA CTD PMID:23806026 CYP1A2 Human silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CYP1A2 mRNA CTD PMID:25351596 CYP1A2 Human simazine increases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Simazine results in increased activity of CYP1A2 protein CTD PMID:9711812 CYP1A2 Human simazine decreases response to substance EXP 6480464 CYP1A2 protein results in decreased susceptibility to Simazine CTD PMID:26771455 CYP1A2 Human simazine increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Simazine results in increased expression of CYP1A2 protein CTD PMID:9711812 CYP1A2 Human sinensetin increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of sinensetin CTD PMID:19666078 CYP1A2 Human skatole increases expression EXP 6480464 Skatole results in increased expression of CYP1A2 mRNA; Skatole results in increased expression of CYP1A2 more ... CTD PMID:28571685|PMID:31201936 CYP1A2 Human sodium arsenite multiple interactions EXP 6480464 [Estradiol co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression more ... CTD PMID:11162773|PMID:20188822|PMID:35747940 CYP1A2 Human sodium arsenite increases methylation EXP 6480464 sodium arsenite results in increased methylation of CYP1A2 intron CTD PMID:32844245 CYP1A2 Human sodium arsenite decreases expression ISO Cyp1a2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of CYP1A2 mRNA CTD PMID:17451858|PMID:25065748 CYP1A2 Human sodium arsenite increases expression ISO Cyp1a2 (Mus musculus) 6480464 sodium arsenite results in increased expression of CYP1A2 mRNA; sodium arsenite results in increased expression more ... CTD PMID:22535251|PMID:29044176|PMID:33933676 CYP1A2 Human sodium arsenite multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 NFE2L2 protein affects the reaction [sodium arsenite results in increased expression of CYP1A2 mRNA]; sodium more ... CTD PMID:22535251|PMID:33933676|PMID:36893905 CYP1A2 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CYP1A2; sodium arsenite results in decreased expression of more ... CTD PMID:23052196|PMID:29301061|PMID:32844245 CYP1A2 Human sodium arsenite decreases activity EXP 6480464 sodium arsenite results in decreased activity of CYP1A2 protein CTD PMID:11162773 CYP1A2 Human sodium dichromate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with sodium bichromate] results in decreased expression of CYP1A2 mRNA CTD PMID:22613061 CYP1A2 Human sodium fluoride decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of CYP1A2 mRNA CTD PMID:21340527 CYP1A2 Human sophoraflavanone B increases expression EXP 6480464 8-prenylnaringenin results in increased expression of CYP1A2 mRNA CTD PMID:15672752 CYP1A2 Human sophoraflavanone B decreases activity EXP 6480464 8-prenylnaringenin results in decreased activity of CYP1A2 protein CTD PMID:19770484 CYP1A2 Human sporidesmin A affects expression EXP 6480464 sporidesmin affects the expression of CYP1A2 mRNA CTD PMID:28193462 CYP1A2 Human sterigmatocystin multiple interactions EXP 6480464 [CYP1A2 protein results in increased glutathionylation of and results in increased hydroxylation of Sterigmatocystin] which more ... CTD PMID:20929267 CYP1A2 Human steviol increases expression EXP 6480464 steviol results in increased expression of CYP1A2 mRNA; steviol results in increased expression of CYP1A2 more ... CTD PMID:28887089 CYP1A2 Human stevioside increases expression EXP 6480464 stevioside results in increased expression of CYP1A2 mRNA; stevioside results in increased expression of CYP1A2 more ... CTD PMID:28887089 CYP1A2 Human streptozocin decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Streptozocin results in decreased expression of CYP1A2 protein CTD PMID:12700423 CYP1A2 Human streptozocin decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Streptozocin results in decreased expression of CYP1A2 mRNA CTD PMID:25905778 CYP1A2 Human streptozocin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Streptozocin co-treated with Dietary Fats] results in decreased expression of CYP1A2 mRNA CTD PMID:29127188 CYP1A2 Human streptozocin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [resveratrol co-treated with Streptozocin] results in decreased expression of CYP1A2 mRNA; [Streptozocin results in increased more ... CTD PMID:17442507|PMID:25905778 CYP1A2 Human streptozocin increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Streptozocin results in increased expression of CYP1A2 protein CTD PMID:17442507 CYP1A2 Human styrene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Styrene results in increased expression of CYP1A2 mRNA; Styrene results in increased expression of CYP1A2 more ... CTD PMID:16418063|PMID:18202523 CYP1A2 Human styrene multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP1A2 protein] CTD PMID:18202523 CYP1A2 Human Sudan I multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 1-phenylazo-2-naphthol affects the expression of and affects the activity of CYP1A2 protein; [1-phenylazo-2-naphthol co-treated with more ... CTD PMID:26845733 CYP1A2 Human Sudan I increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of 1-phenylazo-2-naphthol CTD PMID:17159775 CYP1A2 Human Sudan I multiple interactions EXP 6480464 CYB5A protein promotes the reaction [CYP1A2 protein results in increased oxidation of 1-phenylazo-2-naphthol] CTD PMID:17159775 CYP1A2 Human Sudan I increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 1-phenylazo-2-naphthol results in increased expression of CYP1A2 mRNA CTD PMID:26845733 CYP1A2 Human Sudan III increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 sudan III results in increased expression of CYP1A2 protein CTD PMID:20308224 CYP1A2 Human sulfaphenazole decreases activity EXP 6480464 Sulfaphenazole results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human sulforaphane increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 sulforaphane results in increased expression of CYP1A2 protein CTD PMID:15906351 CYP1A2 Human sulforaphane multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 sulforaphane results in decreased activity of [CYP1A2 protein co-treated with CYP1A1 protein] CTD PMID:22664424 CYP1A2 Human sulforaphane multiple interactions EXP 6480464 sulforaphane inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]; sulforaphane inhibits the more ... CTD PMID:19202560|PMID:19362136 CYP1A2 Human sulforaphane decreases expression EXP 6480464 sulforaphane results in decreased expression of CYP1A2 mRNA CTD PMID:20442190 CYP1A2 Human sulfur dioxide decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Sulfur Dioxide results in decreased activity of CYP1A2 protein CTD PMID:16023800 CYP1A2 Human sulfur dioxide decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Sulfur Dioxide results in decreased expression of CYP1A2 mRNA CTD PMID:16023800 CYP1A2 Human sulindac increases expression EXP 6480464 Sulindac results in increased expression of CYP1A2 mRNA CTD PMID:17985343 CYP1A2 Human sulindac decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Sulindac results in decreased expression of CYP1A2 mRNA CTD PMID:24136188 CYP1A2 Human sulindac increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Sulindac results in increased expression of CYP1A2 mRNA CTD PMID:16531450 CYP1A2 Human sulindac sulfide increases expression EXP 6480464 sulindac sulfide results in increased expression of CYP1A2 mRNA CTD PMID:17985343 CYP1A2 Human sulpiride multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Sulpiride inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:26466350 CYP1A2 Human sulpiride decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Sulpiride results in decreased expression of CYP1A2 mRNA CTD PMID:26466350 CYP1A2 Human sunitinib increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 sunitinib results in increased expression of CYP1A2 mRNA CTD PMID:26797788 CYP1A2 Human sunitinib multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of Sunitinib] which results in increased chemical synthesis of more ... CTD PMID:29847931 CYP1A2 Human sunitinib increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of Sunitinib metabolite CTD PMID:29847931 CYP1A2 Human sunitinib increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Sunitinib CTD PMID:29847931 CYP1A2 Human Sunset Yellow FCF multiple interactions EXP 6480464 [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with more ... CTD PMID:33819548|PMID:34589561 CYP1A2 Human suramin decreases activity EXP 6480464 Suramin results in decreased activity of CYP1A2 protein CTD PMID:11124226 CYP1A2 Human tacrine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine]; Cimetidine inhibits the more ... CTD PMID:18493746|PMID:7946932 CYP1A2 Human tacrine increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Tacrine CTD PMID:7946932 CYP1A2 Human tacrine multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Tacrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human tacrine decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Tacrine results in decreased activity of CYP1A2 protein CTD PMID:15258105 CYP1A2 Human tacrine affects metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein affects the metabolism of Tacrine CTD PMID:15258105 CYP1A2 Human tamarixetin increases expression EXP 6480464 tamarixetin results in increased expression of CYP1A2 mRNA CTD PMID:19034627 CYP1A2 Human tamoxifen increases hydroxylation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased hydroxylation of Tamoxifen CTD PMID:15587933 CYP1A2 Human tamoxifen increases activity EXP 6480464 Tamoxifen metabolite results in increased activity of CYP1A2 protein CTD PMID:29285606 CYP1A2 Human tamoxifen increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Tamoxifen CTD PMID:29285606 CYP1A2 Human tamoxifen multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:23397584|PMID:29285606 CYP1A2 Human tamoxifen decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Tamoxifen results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human tangeretin multiple interactions EXP 6480464 tangeretin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:17090139 CYP1A2 Human tangeretin increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of tangeretin CTD PMID:29626627 CYP1A2 Human Tanshinone I multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [tanshinone results in increased expression of CYP1A2 mRNA]; Resveratrol inhibits the more ... CTD PMID:21262253 CYP1A2 Human Tanshinone I increases expression EXP 6480464 tanshinone results in increased expression of CYP1A2 mRNA; tanshinone results in increased expression of CYP1A2 more ... CTD PMID:21262253 CYP1A2 Human tasquinimod increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 tasquinimod analog results in increased expression of CYP1A2 mRNA CTD PMID:28433708 CYP1A2 Human tauroursodeoxycholic acid decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 ursodoxicoltaurine results in decreased expression of CYP1A2 mRNA CTD PMID:15885361 CYP1A2 Human tebuconazole multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 NR1I3 promotes the reaction [tebuconazole results in increased expression of CYP1A2 mRNA] CTD PMID:25656644 CYP1A2 Human tebuconazole multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [tebuconazole results in increased expression of CYP1A2 mRNA]; [propiconazole more ... CTD PMID:30458266|PMID:33575850 CYP1A2 Human tebuconazole increases activity EXP 6480464 tebuconazole results in increased activity of CYP1A2 protein CTD PMID:30458266 CYP1A2 Human tebuconazole increases expression EXP 6480464 tebuconazole results in increased expression of CYP1A2 mRNA CTD PMID:30458266|PMID:33575850 CYP1A2 Human tebuconazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 tebuconazole results in increased expression of CYP1A2 mRNA; tebuconazole results in increased expression of CYP1A2 more ... CTD PMID:29923317|PMID:30458266 CYP1A2 Human tebuconazole increases expression ISO Cyp1a2 (Mus musculus) 6480464 tebuconazole results in increased expression of CYP1A2 mRNA CTD PMID:25656644 CYP1A2 Human tegaserod decreases activity EXP 6480464 tegaserod results in decreased activity of CYP1A2 protein CTD PMID:11560869 CYP1A2 Human terbutryn increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of terbutryne CTD PMID:8971136 CYP1A2 Human terbutryn multiple interactions EXP 6480464 POR protein promotes the reaction [CYP1A2 protein results in increased metabolism of terbutryne] CTD PMID:8971136 CYP1A2 Human Tesaglitazar decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 tesaglitazar results in decreased expression of CYP1A2 mRNA CTD PMID:21515302 CYP1A2 Human tetrachloroethene increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Tetrachloroethylene CTD PMID:11684365 CYP1A2 Human tetrachloroethene decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Tetrachloroethylene results in decreased expression of CYP1A2 mRNA CTD PMID:28973375 CYP1A2 Human tetrachloromethane decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA; Carbon Tetrachloride results in decreased expression more ... CTD PMID:16445600|PMID:17084009|PMID:18038451|PMID:27339419|PMID:31919559|PMID:32063085 CYP1A2 Human tetrachloromethane increases expression ISO Cyp1a2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CYP1A2 mRNA; Carbon Tetrachloride results in increased expression more ... CTD PMID:24646716 CYP1A2 Human tetrachloromethane decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased activity of CYP1A2 protein CTD PMID:14706259|PMID:16288784 CYP1A2 Human tetrachloromethane increases metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased metabolism of Carbon Tetrachloride CTD PMID:15988118 CYP1A2 Human tetrachloromethane multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline promotes the reaction [Carbon Tetrachloride results in decreased expression of CYP1A2 protein]; [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated more ... CTD PMID:16288784|PMID:20930465|PMID:31150632 CYP1A2 Human tetrachloromethane decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA; Carbon Tetrachloride results in decreased expression more ... CTD PMID:14706259|PMID:16239168|PMID:17606319|PMID:20930465|PMID:31150632 CYP1A2 Human tetrachloromethane affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Carbon Tetrachloride affects the expression of CYP1A2 mRNA CTD PMID:15963342 CYP1A2 Human tetrachloromethane multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CYP1A2 mRNA; ADAM8 protein affects more ... CTD PMID:17084009|PMID:24646716|PMID:30517762|PMID:32063085 CYP1A2 Human tetrahydrocurcumin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 tetrahydrocurcumin inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 more ... CTD PMID:26102010 CYP1A2 Human tetrahydropalmatine decreases expression ISO Cyp1a2 (Mus musculus) 6480464 tetrahydropalmatine results in decreased expression of CYP1A2 mRNA; tetrahydropalmatine results in decreased expression of CYP1A2 more ... CTD PMID:28257954 CYP1A2 Human tetraphene multiple interactions EXP 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene; EPHX1 protein promotes the more ... CTD PMID:8961944 CYP1A2 Human tetraphene multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of more ... CTD PMID:37189300 CYP1A2 Human tetraphene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 benz(a)anthracene results in increased expression of CYP1A2 mRNA CTD PMID:21384493|PMID:23358148 CYP1A2 Human tetraphene increases expression EXP 6480464 benz(a)anthracene results in increased expression of CYP1A2 mRNA CTD PMID:17253728|PMID:9783729 CYP1A2 Human tetraphene decreases activity EXP 6480464 benz(a)anthracene results in decreased activity of CYP1A2 protein CTD PMID:11162773 CYP1A2 Human tetraphene affects response to substance ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein affects the susceptibility to benz(a)anthracene CTD PMID:21384493 CYP1A2 Human tetraphene increases expression ISO Cyp1a2 (Mus musculus) 6480464 benz(a)anthracene results in increased expression of CYP1A2 mRNA CTD PMID:17825862 CYP1A2 Human tetraphene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA; [CYP1A2 protein co-treated with more ... CTD PMID:17825862|PMID:7750161|PMID:8961944 CYP1A2 Human Theaflavin 3,3'-digallate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 theaflavin-3,3'-digallate inhibits the reaction [LEP gene mutant form affects the expression of CYP1A2 mRNA] CTD PMID:36105184 CYP1A2 Human theobromine increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Theobromine CTD PMID:10215755 CYP1A2 Human theobromine increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of Theobromine CTD PMID:1302044 CYP1A2 Human theobromine multiple interactions EXP 6480464 [CYP1A2 protein binds to and results in increased metabolism of Caffeine] which results in increased more ... CTD PMID:10215755|PMID:31132250 CYP1A2 Human theophylline multiple interactions EXP 6480464 [CYP1A2 protein binds to and results in increased metabolism of Caffeine] which results in increased more ... CTD PMID:11408986|PMID:31132250|PMID:9029748|PMID:9701106 CYP1A2 Human theophylline increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of Theophylline CTD PMID:1302044 CYP1A2 Human theophylline affects response to substance EXP 6480464 CYP1A2 gene SNP affects the susceptibility to Theophylline CTD PMID:12732846 CYP1A2 Human theophylline affects hydroxylation EXP 6480464 CYP1A2 promoter SNP affects the hydroxylation of Theophylline CTD PMID:16841220 CYP1A2 Human theophylline affects metabolic processing EXP 6480464 CYP1A2 gene SNP affects the metabolism of Theophylline; CYP1A2 protein affects the metabolism of Theophylline CTD PMID:12732846|PMID:15692829|PMID:15948934|PMID:15970798|PMID:16841220|PMID:20797314|PMID:9029748 CYP1A2 Human theophylline increases metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased metabolism of Theophylline CTD PMID:20096675 CYP1A2 Human theophylline increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Theophylline CTD PMID:11483122|PMID:9701106 CYP1A2 Human theophylline multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 andrographolide affects the reaction [CYP1A2 protein results in increased metabolism of Theophylline]; Plant Extracts affects more ... CTD PMID:15720787|PMID:20096675 CYP1A2 Human theophylline affects metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the metabolism of Theophylline CTD PMID:15970798 CYP1A2 Human theophylline affects metabolic processing ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein affects the metabolism of Theophylline CTD PMID:15720787|PMID:15985363 CYP1A2 Human theophylline decreases activity EXP 6480464 Theophylline results in decreased activity of CYP1A2 protein CTD PMID:11465391 CYP1A2 Human thiabendazole multiple interactions EXP 6480464 beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole] CTD PMID:10936227 CYP1A2 Human thiabendazole increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Thiabendazole results in increased expression of CYP1A2 mRNA; Thiabendazole results in increased expression of CYP1A2 more ... CTD PMID:15110098|PMID:18539377 CYP1A2 Human thiabendazole affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Thiabendazole CTD PMID:10936227|PMID:12920490 CYP1A2 Human thiabendazole increases expression EXP 6480464 Thiabendazole results in increased expression of CYP1A2 mRNA CTD PMID:18570159 CYP1A2 Human thiabendazole decreases activity EXP 6480464 Thiabendazole results in decreased activity of CYP1A2 protein CTD PMID:11124226|PMID:16261361 CYP1A2 Human thiacloprid increases expression EXP 6480464 thiacloprid results in increased expression of CYP1A2 mRNA; thiacloprid results in increased expression of CYP1A2 more ... CTD PMID:21784029|PMID:32201337 CYP1A2 Human thiacloprid multiple interactions EXP 6480464 [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in increased expression of CYP1A2 mRNA; [thiacloprid more ... CTD PMID:32201337 CYP1A2 Human thioacetamide decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of CYP1A2 mRNA CTD PMID:23411599|PMID:34492290 CYP1A2 Human thioacetamide multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP1A2 mRNA CTD PMID:28943392 CYP1A2 Human thiophanate-methyl increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Thiophanate results in increased expression of CYP1A2 protein CTD PMID:10096430 CYP1A2 Human thioridazine multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:19482014|PMID:23397584 CYP1A2 Human ticlopidine multiple interactions EXP 6480464 CYP1A2 protein results in increased oxidation of and results in increased cleavage of Ticlopidine metabolite; more ... CTD PMID:19053182|PMID:19170597 CYP1A2 Human ticlopidine decreases activity EXP 6480464 Ticlopidine results in decreased activity of CYP1A2 protein CTD PMID:10759690 CYP1A2 Human tizanidine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of tizanidine CTD PMID:15592331|PMID:16198659 CYP1A2 Human tizanidine increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of tizanidine CTD PMID:17618427 CYP1A2 Human tizanidine multiple interactions EXP 6480464 [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in more ... CTD PMID:15592331|PMID:15834531|PMID:16198659|PMID:16934051 CYP1A2 Human tofacitinib increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of tofacitinib CTD PMID:31414593 CYP1A2 Human tolcapone multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 tolcapone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human tolcapone increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 tolcapone results in increased expression of CYP1A2 mRNA CTD PMID:24136188 CYP1A2 Human tolcapone multiple interactions EXP 6480464 tolcapone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 CYP1A2 Human tolfenamic acid decreases activity EXP 6480464 tolfenamic acid results in decreased activity of CYP1A2 protein CTD PMID:17618427|PMID:18816299 CYP1A2 Human tolfenamic acid multiple interactions EXP 6480464 ALB protein inhibits the reaction [tolfenamic acid results in decreased activity of CYP1A2 protein] CTD PMID:17618427 CYP1A2 Human toluene multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 Acetone promotes the reaction [Toluene results in increased expression of CYP1A2 protein]; Methylcholanthrene promotes the more ... CTD PMID:1994898|PMID:8996725 CYP1A2 Human toluene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Toluene results in increased expression of CYP1A2 protein CTD PMID:8996725 CYP1A2 Human toluene increases oxidation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased oxidation of Toluene CTD PMID:1994898 CYP1A2 Human toxaphene increases expression ISO Cyp1a2 (Mus musculus) 6480464 Toxaphene results in increased expression of CYP1A2 mRNA CTD PMID:26187448|PMID:28218408 CYP1A2 Human toxaphene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 NR1I3 gene mutant form inhibits the reaction [Toxaphene results in increased expression of CYP1A2 mRNA] CTD PMID:28218408 CYP1A2 Human trabectedin decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 trabectedin results in decreased expression of CYP1A2 mRNA CTD PMID:12154027 CYP1A2 Human trans-1,2-dichloroethene affects expression ISO Cyp1a2 (Rattus norvegicus) 6480464 1,2-dichloroethylene affects the expression of CYP1A2 protein CTD PMID:9493318 CYP1A2 Human trans-1,2-dichloroethene decreases activity ISO Cyp1a2 (Rattus norvegicus) 6480464 1,2-dichloroethylene results in decreased activity of CYP1A2 protein CTD PMID:9671540 CYP1A2 Human trans-chalcone increases hydroxylation ISO Cyp1a2 (Rattus norvegicus) 6480464 CYP1A2 protein results in increased hydroxylation of Chalcone CTD PMID:15863696 CYP1A2 Human tranylcypromine multiple interactions EXP 6480464 Tranylcypromine affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with more ... CTD PMID:24120545 CYP1A2 Human tranylcypromine decreases activity EXP 6480464 Tranylcypromine results in decreased activity of CYP1A2 protein CTD PMID:15916432 CYP1A2 Human triadimefon increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 triadimefon results in increased expression of CYP1A2 mRNA CTD PMID:20659493 CYP1A2 Human triamterene increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Triamterene CTD PMID:16035375 CYP1A2 Human triazines multiple interactions EXP 6480464 alpha-naphthoflavone inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines]; furafylline inhibits the more ... CTD PMID:9305587 CYP1A2 Human triazines increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Triazines CTD PMID:9305587 CYP1A2 Human Tributyltin oxide increases expression EXP 6480464 bis(tri-n-butyltin)oxide results in increased expression of CYP1A2 mRNA; bis(tri-n-butyltin)oxide results in increased expression of CYP1A2 more ... CTD PMID:21784029 CYP1A2 Human trichloroethene increases expression ISO Cyp1a2 (Mus musculus) 6480464 Trichloroethylene results in increased expression of CYP1A2 mRNA CTD PMID:19254012 CYP1A2 Human trichloroethene increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of CYP1A2 mRNA CTD PMID:33387578 CYP1A2 Human trichostatin A multiple interactions EXP 6480464 trichostatin A promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:12927368 CYP1A2 Human trichostatin A multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin inhibits the reaction [trichostatin A results in increased expression of CYP1A2 mRNA] CTD PMID:15252868 CYP1A2 Human trichostatin A increases expression ISO Cyp1a2 (Mus musculus) 6480464 trichostatin A results in increased expression of CYP1A2 mRNA CTD PMID:15252868 CYP1A2 Human trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of CYP1A2 mRNA CTD PMID:12927368|PMID:28357125 CYP1A2 Human triclosan increases expression EXP 6480464 Triclosan results in increased expression of CYP1A2 mRNA CTD PMID:29849464 CYP1A2 Human triflumuron increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of triflumuron CTD PMID:31082524 CYP1A2 Human triflumuron multiple interactions EXP 6480464 furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of triflumuron] CTD PMID:31082524 CYP1A2 Human trimethoprim decreases activity EXP 6480464 Trimethoprim results in decreased activity of CYP1A2 protein CTD PMID:26599973 CYP1A2 Human trimethoprim multiple interactions EXP 6480464 [Trimethoprim results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Amodiaquine CTD PMID:26599973 CYP1A2 Human trimethylarsine oxide increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 trimethylarsine oxide results in increased expression of CYP1A2 mRNA CTD PMID:17481689 CYP1A2 Human trimethylarsine oxide increases expression ISO Cyp1a2 (Mus musculus) 6480464 trimethylarsine oxide results in increased expression of CYP1A2 mRNA; trimethylarsine oxide results in increased expression more ... CTD PMID:26144063 CYP1A2 Human triphenyl phosphate decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 triphenyl phosphate results in decreased expression of CYP1A2 mRNA CTD PMID:30589522 CYP1A2 Human triptonide increases expression ISO Cyp1a2 (Mus musculus) 6480464 triptonide results in increased expression of CYP1A2 mRNA CTD PMID:33045310 CYP1A2 Human troglitazone multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:23397584 CYP1A2 Human tryptamines multiple interactions EXP 6480464 [Tryptamines analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of more ... CTD PMID:26599973 CYP1A2 Human tryptamines decreases activity EXP 6480464 Tryptamines analog results in decreased activity of CYP1A2 protein CTD PMID:26599973 CYP1A2 Human umbelliferone multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of coumarin] which results in increased abundance of 7-hydroxycoumarin CTD PMID:34334558 CYP1A2 Human vadimezan multiple interactions EXP 6480464 Acridines analog inhibits the reaction [CYP1A2 protein results in increased oxidation of vadimezan] CTD PMID:16120190 CYP1A2 Human vadimezan increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of vadimezan CTD PMID:16120190 CYP1A2 Human valdecoxib increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 valdecoxib results in increased expression of CYP1A2 mRNA CTD PMID:24136188 CYP1A2 Human valproic acid affects expression ISO Cyp1a2 (Mus musculus) 6480464 Valproic Acid affects the expression of CYP1A2 mRNA CTD PMID:17292431 CYP1A2 Human valproic acid increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Valproic Acid results in increased expression of CYP1A2 mRNA CTD PMID:35594946 CYP1A2 Human valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of CYP1A2 gene CTD PMID:29501571 CYP1A2 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:29501571 CYP1A2 Human valproic acid decreases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 Valproic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:17381134 CYP1A2 Human vanadium atom multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity more ... CTD PMID:23423713 CYP1A2 Human vanadium(0) multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity more ... CTD PMID:23423713 CYP1A2 Human vancomycin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in more ... CTD PMID:30545405 CYP1A2 Human veliparib increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of veliparib CTD PMID:21436403 CYP1A2 Human verapamil decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Verapamil results in decreased activity of CYP1A2 protein CTD PMID:18420780 CYP1A2 Human versicolorin A increases expression EXP 6480464 versicolorin A results in increased expression of CYP1A2 mRNA CTD PMID:32106047 CYP1A2 Human vinclozolin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP1A2 protein; [fenarimol co-treated more ... CTD PMID:17686559 CYP1A2 Human vinclozolin increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 vinclozolin results in increased expression of CYP1A2 protein CTD PMID:7986207 CYP1A2 Human vitamin E affects expression ISO Cyp1a2 (Rattus norvegicus) 401900296 Vitamin E inhibits the reaction [nitroglycerine decreases Cyp1a2 protein expression in rat heart] RGD CYP1A2 Human VX nerve agent decreases expression EXP 6480464 VX-agent results in decreased expression of CYP1A2 mRNA CTD PMID:39228234 CYP1A2 Human warfarin affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Warfarin CTD PMID:14676821|PMID:15280511 CYP1A2 Human warfarin affects response to substance EXP 6480464 CYP1A2 SNP affects the susceptibility to Warfarin CTD PMID:28079798 CYP1A2 Human wortmannin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 wortmannin inhibits the reaction [INS1 protein inhibits the reaction [Benzo(a)pyrene results in increased expression of more ... CTD PMID:26466350 CYP1A2 Human Wuweizisu C decreases activity ISO Cyp1a2 (Mus musculus) 6480464 schizandrin C results in decreased activity of CYP1A2 protein CTD PMID:25753323 CYP1A2 Human xanthohumol increases expression EXP 6480464 xanthohumol results in increased expression of CYP1A2 mRNA CTD PMID:22138251 CYP1A2 Human xanthohumol multiple interactions EXP 6480464 xanthohumol inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA] CTD PMID:22138251 CYP1A2 Human yohimbine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with more ... CTD PMID:28843594 CYP1A2 Human zafirlukast multiple interactions EXP 6480464 zafirlukast inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] CTD PMID:9701106 CYP1A2 Human zaragozic acid A increases expression ISO Cyp1a2 (Rattus norvegicus) 6480464 squalestatin 1 results in increased expression of CYP1A2 mRNA CTD PMID:27225895 CYP1A2 Human zaragozic acid A increases expression ISO Cyp1a2 (Mus musculus) 6480464 squalestatin 1 results in increased expression of CYP1A2 mRNA CTD PMID:27225895 CYP1A2 Human zearalenone increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Zearalenone CTD PMID:19931366 CYP1A2 Human zearalenone decreases activity EXP 6480464 Zearalenone results in decreased activity of CYP1A2 protein CTD PMID:38341109 CYP1A2 Human zearalenone decreases abundance EXP 6480464 CYP1A2 protein results in decreased abundance of Zearalenone CTD PMID:38341109 CYP1A2 Human zearalenone multiple interactions EXP 6480464 [CYP1A2 protein results in increased hydroxylation of Zearalenone] which results in increased chemical synthesis of more ... CTD PMID:19931366 CYP1A2 Human zerumbone increases expression EXP 6480464 zerumbone results in increased expression of CYP1A2 mRNA CTD PMID:36122806 CYP1A2 Human zileuton decreases activity EXP 6480464 zileuton results in decreased activity of CYP1A2 protein CTD PMID:14570767 CYP1A2 Human zileuton multiple interactions EXP 6480464 zileuton inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] CTD PMID:14570767 CYP1A2 Human zinc atom multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased more ... CTD PMID:21424224 CYP1A2 Human zinc protoporphyrin multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated more ... CTD PMID:26747958 CYP1A2 Human zinc(0) multiple interactions ISO Cyp1a2 (Rattus norvegicus) 6480464 [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased more ... CTD PMID:21424224 CYP1A2 Human zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of CYP1A2 mRNA CTD PMID:24714768|PMID:25596134 CYP1A2 Human zolmitriptan decreases activity EXP 6480464 zolmitriptan results in decreased activity of CYP1A2 protein CTD PMID:18816299